{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "98zm6fgZD4p9"
      },
      "outputs": [],
      "source": [
        "# !pip install PyPDF2 #Extracts text from PDFs with selectable text layers.\n",
        "# !pip install pymupdf # rendering pages as images and extracting embedded images\n",
        "# !pip install pytesseract\n",
        "# !apt-get install tesseract-ocr\n",
        "# !pip install pycryptodome\n",
        "\n",
        "# !apt-get install tesseract-ocr-[language_code]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 47,
      "metadata": {
        "id": "UukyscmJnS5C",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "661d15e8-b646-4c57-a85c-5b708b73430e"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n"
          ]
        }
      ],
      "source": [
        "import pandas as pd\n",
        "import glob\n",
        "# from Crypto.Cipher import AES\n",
        "import os  # File and folder operations\n",
        "# from PyPDF2 import PdfReader  # Text layer extraction\n",
        "# import fitz  # PyMuPDF for handling PDF content (text and images)\n",
        "# from PIL import Image  # Image handling and saving\n",
        "# from pytesseract import image_to_string  # OCR text extraction from images\n",
        "import io  # Handle in-memory image data\n",
        "import warnings\n",
        "warnings.filterwarnings(\"ignore\", category=UserWarning)\n",
        "\n",
        "# Load the Drive helper and mount\n",
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# concat all extraction and export\n"
      ],
      "metadata": {
        "id": "0X8oeFEiJDMW"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Define the folder path\n",
        "export_folder = \"/content/drive/My Drive/polsky file split/\"\n",
        "\n",
        "# Get the list of all CSV files in the folder\n",
        "csv_files = glob.glob(os.path.join(export_folder, \"*.csv\"))\n",
        "# csv_files\n",
        "# Initialize an empty list to store DataFrames\n",
        "df_list = []\n",
        "\n",
        "# Loop through the list of CSV files and read them\n",
        "for file in csv_files:\n",
        "    df = pd.read_csv(file)\n",
        "    df.columns=[\"file_name\",\"text\",\"ocr_text\"]\n",
        "    print(df.columns)\n",
        "    df_list.append(df)\n",
        "\n",
        "# Concatenate all DataFrames into one\n",
        "final_df = pd.concat(df_list, ignore_index=True)\n",
        "# final_df.head()\n",
        "# df_list"
      ],
      "metadata": {
        "id": "DklZaM6wJB8c",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 605
        },
        "outputId": "80796713-eaff-4c59-8b6a-8295a0fbc512"
      },
      "execution_count": 95,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n",
            "Index(['file_name', 'text', 'ocr_text'], dtype='object')\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                           file_name  \\\n",
              "0  ARCD.P0677US_07_30_2024_Non-Final Office Actio...   \n",
              "1  ARCD.P0664CN 2024.8.1 Response to Office Actio...   \n",
              "2  ARCD.P0676EA 2024.8.7 Annuity Payment Confirma...   \n",
              "3  ARCD.P0677EP 2024.7.17 Communication  pursuant...   \n",
              "4  ARCD.P0672CN 2024.7.26 Notification on Grant o...   \n",
              "\n",
              "                                                text  \\\n",
              "0                                                NaN   \n",
              "1  意 见 陈 述 书\\n100012\\n2023.091申请号或专利号 20198006085...   \n",
              "2                                                NaN   \n",
              "3  European  Patent  Office \\n80298  MUNICH  \\nGE...   \n",
              "4                                                NaN   \n",
              "\n",
              "                                            ocr_text  \n",
              "0  --- Page 1 OCR ---\\nUnrren States Patent anp T...  \n",
              "1                                                NaN  \n",
              "2  --- Page 1 OCR ---\\nv.FUNER EBBINGHAUS FINCK H...  \n",
              "3                                                NaN  \n",
              "4  --- Page 1 OCR ---\\n \\n\\nip ARR\\n\\n \\n \\n    \\...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-40108404-0dee-49be-a754-4372af7d2078\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>file_name</th>\n",
              "      <th>text</th>\n",
              "      <th>ocr_text</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>ARCD.P0677US_07_30_2024_Non-Final Office Actio...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>--- Page 1 OCR ---\\nUnrren States Patent anp T...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>ARCD.P0664CN 2024.8.1 Response to Office Actio...</td>\n",
              "      <td>意 见 陈 述 书\\n100012\\n2023.091申请号或专利号 20198006085...</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>ARCD.P0676EA 2024.8.7 Annuity Payment Confirma...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>--- Page 1 OCR ---\\nv.FUNER EBBINGHAUS FINCK H...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>ARCD.P0677EP 2024.7.17 Communication  pursuant...</td>\n",
              "      <td>European  Patent  Office \\n80298  MUNICH  \\nGE...</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>ARCD.P0672CN 2024.7.26 Notification on Grant o...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>--- Page 1 OCR ---\\n \\n\\nip ARR\\n\\n \\n \\n    \\...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-40108404-0dee-49be-a754-4372af7d2078')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-40108404-0dee-49be-a754-4372af7d2078 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-40108404-0dee-49be-a754-4372af7d2078');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-977383ae-a099-4f24-bed8-cd527a7237ec\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-977383ae-a099-4f24-bed8-cd527a7237ec')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-977383ae-a099-4f24-bed8-cd527a7237ec button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "summary": "{\n  \"name\": \"# df_list\",\n  \"rows\": 5,\n  \"fields\": [\n    {\n      \"column\": \"file_name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"ARCD.P0664CN 2024.8.1 Response to Office Action.pdf-!!-13807591\",\n          \"ARCD.P0672CN 2024.7.26 Notification on Grant of Patent Right for Invention (with English translation).pdf-!!-13834125\",\n          \"ARCD.P0676EA 2024.8.7 Annuity Payment Confirmation.pdf-!!-13808594\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"text\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"European  Patent  Office \\n80298  MUNICH  \\nGERMANY  \\nTel:+49  89 2399 03Europ\\u00e2isches\\nPatentamt\\nEuropean  \\nPatent Office\\nOffice eui \\ndes breve'op\\u00e9en\\nQuestions  about  this communication?\\nContact  Customer  Services  at\\nwww.epo.oro/contactr n\\nPrimary  Examiner\\nName: Kirsch,  Cecile \\nTel:+49  89 2399- 2191J A Kemp  LLP \\n80 Turnmill  Street  \\nLondon  EC1M  5QU  \\nROYAUME  UNI\\nL J\\nApplication  No. Ref. Date\\n19 892 608.1 - 1109 N422048EP 17.07.2024\\nApplicant\\nThe University  of Chicago\\nCommunication  pursuant  to Article  94(3)  EPC\\nThe examination  of the above-identified  application  has revealed  that it does not meet  the requirements  of \\nthe European  Patent  Convention  for the reasons  enclosed  herewith.  If the deficiencies  indicated  are not \\nrectified  the application  may be refused  pursuant  to Article  97(2) EPC.\\nYou are invited  to file your observations  and in sofar  as the deficiencies  are such as to be rectifiable,  to \\ncorrect  the indicated  deficiencies  within  a period\\nof 4 months\\nfrom the notification  of this communication,  this period  being  computed  in accordance  with Rules  126(2)  \\nand 131(2)  and (4) EPC. One set of amendments  to the description,  claims  and drawings  is to be filed \\nwithin  the said period  on separate  sheets  (R. 50(1) EPC).\\nIf filing amendments,  you must identify  them and indicate  the basis  for them in the application  as filed.  \\nFailure  to meet  either  requirement  may lead to a communication  from the Examining  Division  requesting  \\nthat you correct  this deficiency  (R. 137(4)  EPC).\\nIn case you withdraw  the application  within  the above-mentioned  period,  the examination  fee will be \\nrefunded  at a rate of 50% (Art. 11 (b) RFees).\\nFailure  to comply  with this invitation  in due time  will result  in the application  being  deemed  to be \\nwithdrawn  (Art. 94(4) EPC).\\nRegistered  Letter\\nEPO Form 2001 11.16AUWF  (13.07.2024)Sheet  2 Date 17.07.2024 Application  No.: 19 892 608.1\\n' J>%\\n%\\n?\\nI*\\n80\\\\\\\\ftO -\\nKirsch,  Cecile  \\nPrimary  Examiner\\nFor the Examining  Division\\n3 page/s  reasons  (EPO  Form  2906) Enclosure(s):\\nEPO Form 2001 11.16AUWF  (13.07.2024)Datum\\nDate\\nDateBlatt Anmelde-Nr:  \\nApplication  No: \\nDemande  n\\u00b0:17.07.2024 19 892 608.1 Sheet 1 \\nFeuille\\nThe examination  is being  carried  out on the following  application  documents\\nDescription,  Pages\\n1-73 as published\\nClaims,  Numbers\\n1-15 filed in electronic  form on 17-04-2023\\nDrawings,  Sheets\\n1/27-27/27 as published\\n1. Amendments,  Article  123(2)  EPC\\nClaim  1 is based  on original  claim 1 limited  to the specific  embodiments  of claim  3 \\n(SN50,  capsaicin,  compound  of formula  (I)) and claims  5-7 (specific  adjuvants).  The  \\nnewly  introduced  disclaimers  cover  embodiments  which  were  originally  part of the \\noriginal  invention  (see e.g. page  3, lines 16-17  for honokiol  and page  35, 16th  \\ncompound  for magnolol).  The conditions  of G 2/10 are fulfilled  since  the subject-matter  \\nremaining  in the claim  after  the introduction  of the disclaimer  is directly  and  \\nunambiguously  derivable  by the skilled  person  using  his common  general  knowledge,  in \\nthe application  as filed.\\nClaim  2 is based  on original  claim  2 and comprises  the same  limitation  as pending  claim  \\n1. Claim  3 finds  support  in original  claims  3, 4 (alternative  a), 8 (alternative  b) and 9 \\n(alternative  c). Claim  4 is based  on original  claims  10, 11 (influenza,  dengue  or HIV), 12 \\n(dengue  antigen),  13 (DENV-2C),  14 (HIV antigen)  and 15 (gp120).  Claim  5 combines  \\nthe features  of original  claims  16 (alternative  a) and 17 (alternative  b). Claim  6 \\ncorresponds  to original  claim  18. Claim  7 is based  on original  claims  19 (alternative  a), \\n20 (alternative  b), 21 (alternative  c) and 22 (alternative  d). Claim  8 finds  support  in \\noriginal  claims  23 (alternative  a), 24 (alternative  b), 25 (alternative  c), 26 (alternative  d) \\nand 27 (alternative  e).\\nClaim  9 corresponds  to original  claim  28 limited  to the specific  embodiments  of claim  28 \\n(SN50,  capsaicin,  compound  of formula  (I)) and claims  31-33  (specific  adjuvants).  The  \\nnewly  introduced  disclaimers  cover  embodiments  which  were  originally  part of the \\noriginal  invention  (see e.g. page  3, lines 16-17  for honokiol  and page  35, 16th  \\ncompound  for magnolol).  The conditions  of G 2/10 (OJ EPO  2012,  376) are fulfilled\\nEPO Form 2906 01.91TRIDatum\\nDate\\nDateBlatt Anmelde-Nr:  \\nApplication  No: \\nDemande  n\\u00b0:17.07.2024 Sheet 2 \\nFeuille19 892 608.1\\nsince  the subject-matter  remaining  in the claim  after  the introduction  of the disclaimer  is \\ndirectly  and unambiguously  derivable  by the skilled  person  using  his common  general  \\nknowledge,  in the application  as filed.\\nClaim  10 finds  support  in original  claims  30 (alternative  a), 34 (alternative  b) and 35 \\n(alternative  c). Claim  11 is based  on original  claims  36, 37 (alternative  a), 38 (alternative  \\nb), 39 (dengue  antigen),  40 (DENV-2C),  41 (HIV),  42 (HIV antigen)  and 43 (gp120).  \\nClaim  12 combines  the features  of original  claims  44 (alternative  a) and 45 (alternative  \\nb). Claim  13 is based  on original  claims  46 (alternative  a) and 47 (alternative  b). Claims  \\n14 and 15 correspond  to original  claims  48 and 49 respectively.\\nThe newly  filed set of claims  fulfils  the requirements  of Article  123(2)  ERG.\\n2. Novelty,  Article  54 ERG\\nThe claimed  subject-matter  has been limited  to specific  NF-kB  inhibitors  which  are not \\nexplicitly  disclosed  in D5.\\nD6 does  not relate  either  to the specific  NF-kB  inhibitors  covered  by pending  claim  1. \\nHonokiol  is disclosed  in D6, however  it has been excluded  by means  of a disclaimer.\\nNovelty  over  the remaining  cited  documents  has already  been acknowledged.\\nClaims  1-15 are novel  over  the cited prior  art.\\n3. Inventive  step,  Article  56 ERG\\nTaking  into account  the limitations  introduced  in the claims,  the inventive  step objection  \\nraised  in the ESOP  is still valid.\\nD5 represents  the closest  prior  art.\\nD5 acknowledges  that adjuvants  induce  immune  \\u201cdanger  signals \\u201dleading  to activation  of \\ninnate  immune  and thereby  activation  of NF-kB  and other  inflammatory  pathways  \\n([0011]).  To counter  this negative  effect  of the adjuvant,  D5 proposes  to use an anti\\u00ad\\ninflammatory  inhibitor  of NF-kB  activation  together  with a PAMP  (adjuvant)  ([0041]).  The  \\nPAMP  may be i.a. a Toll-like  receptor  agonist  ([0074]),  Pam3CSK4,  R848,  or CpG  \\n([0075]).  Thus  D5 discloses  the use of an NF-kB  and one of the adjuvant  listed  in claim  \\n1 for reducing  inflammation  mediated  by adjuvant  in vaccines.\\nAs indicated  above,  the claimed  subject-matter  differs  from D5 because  the specific  NF- \\nkB or claim  1 are not explicitly  disclosed  in D5.\\nThe problem  to be solved  is seen in the provision  of further  vaccine  compositions  with  \\nreduced  inflammatory  response.\\nEPO Form 2906 01.91TRIDatum\\nDate\\nDateBlatt Anmelde-Nr:  \\nApplication  No: \\nDemande  n\\u00b0:17.07.2024 Sheet 3 \\nFeuille19 892 608.1\\nIn the light of the examples  provided  in the application,  this problem  has been solved.  \\nThere  is no improvement  or unexpected  effect  shown  in comparison  with the closest  \\nprior art D5.\\nD5 already  teaches  that NF-kB  inhibitors  are able to reduce  the inflammatory  response  \\ntriggered  by adjuvant.  This finding  is based  on the mechanism  of action  implied  with  \\nadjuvant.  Thus  it is clear  from D5, that not only the exemplified  inhibitors  are useful  but \\nany NF-kB  inhibitor  provides  the expected  effect.\\nThe specific  NF-kB  inhibitors  of claim  1 are well-known  in the art, see D1, D2 for SN50,  \\nD6-D10  for honokiol  and derivatives,  D11 for capsaicin.  The skilled  person  would  have  \\nthus tested  this compounds  as recommended  by D5 and would  have  expected  to obtain  \\nthe same  effect  without  the need  for inventive  skills.  The claimed  subject-matter  \\ntherefore  derive  from D5 in an obvious  manner.\\nIn this context,  the applicant  argues  that the skilled  person  would  not have  combined  D5 \\nwith any of the remaining  prior  art because  they do not relate  to vaccines.\\nThe examining  division  cannot  agree  with this approach.  D5 relates  to vaccines  and  \\nexplain  via the mechanism  of action  why the use of NF-kB  inhibitors  reduce  the \\ninflammatory  response  triggered  by an adjuvant.  Taking  a known  inhibitor,  whether  \\nalready  used in a vaccine  or not, would  be next obvious  step for the skilled  person  \\nstarting  from the teaching  of D5 as D5 already  provide  the incentive  to use such  \\ninhibitors.\\nFor these  reasons,  the claimed  subject-matter  still lacks  an inventive  step.\\n4. The applicant  is invited  to file a new set of claims  which  takes  account  of the above  \\ncomments.\\nAmendments  should  be made by filing replacement  pages.  Attention  is drawn  to the \\nrequirements  of Rule  49 ERG which  requires  the description  and the claims  to be typed  \\nor printed.  In this context  reference  is made  to the Notice  from the European  Patent  \\nOffice  published  in the Official  Journal  (OJ, 12/2013,  603).\\nIn order  to facilitate  the examination  of the conformity  of the amended  application  with  \\nthe requirements  of Article  123(2)  EPC and to comply  with the requirements  of Rule  \\n137(4)  EPC, the applicant  should  clearly  identify  the amendments  made,  irrespective  of \\nwhether  they concern  amendments  by addition,  replacement  or deletion,  and indicate  \\nthe passages  of the application  as filed on which  these amendments  are based  (see  \\nGuidelines  FI-Ill, 2.2).\\nEPO Form 2906 01.91TRI\",\n          \"\\u610f \\u89c1 \\u9648 \\u8ff0 \\u4e66\\n100012\\n2023.091\\u7533\\u8bf7\\u53f7\\u6216\\u4e13\\u5229\\u53f7 2019800608569\\n\\u53d1\\u660e\\u521b\\u9020\\u540d\\u79f0 \\u6269\\u589e\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684DNA\\u7684\\u65b9\\u6cd5\\u25cb1 \\n\\u4e13     \\u4e13\\n\\u5229\\n    \\u6216\\n\\u7533\\n\\u8bf7     \\u5229\\u7533\\u8bf7\\u4eba\\u6216\\u4e13\\u5229\\u6743\\u4eba\\uff08\\u7b2c\\u4e00\\u7f72\\u540d\\u4eba\\uff09\\u829d\\u52a0\\u54e5\\u5927\\u5b66\\n\\u25cb2\\u9648\\u8ff0\\u4e8b\\u9879\\uff1a\\u5173\\u4e8e\\u8d39\\u7528\\u7684\\u610f\\u89c1\\u9648\\u8ff0\\u8bf7\\u4f7f\\u7528\\u610f\\u89c1\\u9648\\u8ff0\\u4e66(\\u5173\\u4e8e\\u8d39\\u7528)\\n\\u4ee5\\u4e0b\\u9009\\u9879\\u53ea\\u80fd\\u9009\\u62e9\\u4e00\\u9879\\n\\u9488\\u5bf9\\u56fd\\u5bb6\\u77e5\\u8bc6\\u4ea7\\u6743\\u5c40\\u4e8e 2024 \\u5e74 02 \\u6708 23 \\u65e5\\u53d1\\u51fa\\u7684 \\u7b2c\\u4e00\\u6b21\\u5ba1\\u67e5\\u610f\\u89c1\\u901a\\u77e5\\u4e66 \\uff08\\u53d1\\u6587\\u5e8f\\u53f7 \\n2024022301623520 \\uff09\\u9648\\u8ff0\\u610f\\u89c1\\u3002\\n\\u9488\\u5bf9\\u56fd\\u5bb6\\u77e5\\u8bc6\\u4ea7\\u6743\\u5c40\\u4e8e  \\u5e74  \\u6708  \\u65e5\\u53d1\\u51fa\\u7684  \\uff08\\u53d1\\u6587\\u5e8f\\u53f7  \\uff09\\u8865\\u5145\\u9648\\u8ff0\\u610f\\u89c1\\u3002\\n\\u9488\\u5bf9\\u56fd\\u5bb6\\u77e5\\u8bc6\\u4ea7\\u6743\\u5c40\\u4e8e  \\u5e74  \\u6708  \\u65e5\\u53d1\\u51fa\\u7684\\u836f\\u54c1\\u4e13\\u5229\\u6743\\u671f\\u9650\\u8865\\u507f\\u5ba1\\u67e5\\u610f\\u89c1\\u901a\\u77e5\\u4e66\\uff08\\u53d1\\u6587\\u5e8f\\n\\u53f7  \\uff09\\u9648\\u8ff0\\u610f\\u89c1\\u3002\\n\\u4e3b\\u52a8\\u63d0\\u51fa\\u4fee\\u6539\\uff08\\u6839\\u636e\\u4e13\\u5229\\u6cd5\\u5b9e\\u65bd\\u7ec6\\u5219\\u7b2c57\\u6761\\u7b2c1\\u6b3e\\u3001\\u7b2c2\\u6b3e\\u7684\\u89c4\\u5b9a\\uff09\\n\\u516c\\u5e03\\u516c\\u544a\\u4e8b\\u9879\\n\\u5176\\u4ed6\\u4e8b\\u5b9c \\n\\u25cb3\\u9648\\u8ff0\\u7684\\u610f\\u89c1\\uff1a\\n\\u8be6\\u89c1\\u610f\\u89c1\\u9648\\u8ff0\\u4e66\\u9644\\u9875\\n\\u25cb4\\u9644\\u4ef6\\u6e05\\u5355\\n\\u3010\\u9644\\u4ef6\\u540d\\u79f0\\u3011\\u6743\\u5229\\u8981\\u6c42\\u4e66 \\n\\u3010\\u9644\\u4ef6\\u540d\\u79f0\\u3011\\u4fee\\u6539\\u5bf9\\u7167\\u9875 \\n\\u3010\\u9644\\u4ef6\\u540d\\u79f0\\u3011\\u5176\\u4ed6\\u8bc1\\u660e\\u6587\\u4ef6 \\n\\u5df2\\u5907\\u6848\\u7684\\u8bc1\\u660e\\u6587\\u4ef6\\u5907\\u6848\\u7f16\\u53f7\\uff1a  \\u610f \\u89c1 \\u9648 \\u8ff0 \\u4e66\\n100012\\n2023.092\\u25cb5\\u5f53\\u4e8b\\u4eba\\u6216\\u4e13\\u5229\\u4ee3\\u7406\\u673a\\u6784\\n\\u5317\\u4eac\\u67cf\\u6749\\u677e\\u77e5\\u8bc6\\u4ea7\\u6743\\u4ee3\\u7406\\u4e8b\\u52a1\\u6240\\uff08\\u666e\\u901a\\u5408\\u4f19\\uff09\\u7533\\u8bf7\\u53f7\\uff1a201980060856.9   \\u4ee3\\u7406\\u673a\\u6784\\u5377\\u53f7\\uff1aPP218006PF  \\n \\n1 \\n \\u610f\\u89c1\\u9648\\u8ff0\\u4e66\\u9644\\u9875  \\n\\u5c0a\\u656c\\u7684\\u5ba1\\u67e5\\u5458\\uff1a \\n\\u7533\\u8bf7\\u4eba\\u5bf9\\u5ba1\\u67e5\\u5458\\u4e3a\\u5ba1\\u67e5\\u672c\\u7533\\u8bf7\\u6240\\u4ed8\\u51fa\\u7684\\u8f9b\\u52e4\\u52b3\\u52a8\\u8868\\u793a\\u7531\\u8877\\u7684\\u611f\\u8c22\\u3002\\u9488\\u5bf9\\u5ba1\\u67e5\\u5458\\u63d0\\u51fa\\u7684\\u5ba1\\n\\u67e5\\u610f\\u89c1\\uff0c\\u7533\\u8bf7\\u4eba\\u7ecf\\u8fc7\\u8ba4\\u771f\\u8003\\u8651\\uff0c\\u505a\\u51fa\\u4ee5\\u4e0b\\u7b54\\u590d\\u610f\\u89c1\\uff1a \\n \\n\\u4fee\\u6539\\u8bf4\\u660e  \\n1. \\u5c06\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150 \\u548c53\\u4e2d\\u7684\\u65b9\\u6cd5\\u9650\\u5b9a\\u4e3a\\u201c \\u975e\\u8bca\\u65ad \\u201d\\u65b9\\u6cd5\\u3002  \\n2. \\u5c06\\u6743\\u5229\\u8981\\u6c42 3\\u4e2d\\u91cd\\u590d\\u51fa\\u73b0\\u7684\\u4e24\\u4e2a\\u201c \\uff085fC\\uff09\\u201d\\u5220\\u9664\\u4e86\\u5176\\u4e2d\\u7684\\u4e00\\u4e2a\\u3002  \\n3. \\u5c06\\u6743\\u5229\\u8981\\u6c42 51\\u4e2d\\u7684\\u201c\\u751f\\u7269\\u6807\\u5fd7\\u7269\\u201d \\u8fdb\\u4e00\\u6b65\\u9650\\u5b9a\\u4e3a\\u201c \\u7532\\u57fa\\u80de\\u5627\\u5576\\u201d \\u3002 \\n4. \\u5c06\\u6743\\u5229\\u8981\\u6c42 52\\u6539\\u5199\\u4e3a\\uff1a\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u7684\\u8854\\u63a5\\u5b50\\u5728\\u5236\\u5907\\u7528\\u4e8e\\u9274\\u5b9a\\u6765\\u81ea\\u60a3\\u8005\\u7684\\nDNA\\u5206\\u5b50\\u4e2d\\u7684 5mC\\u548c/\\u6216\\u7528\\u4e8e\\u8f85\\u52a9\\u60a3\\u8005\\u8bca\\u65ad\\u6216\\u9884\\u540e\\u7684\\u8bd5\\u5242\\u76d2\\u4e2d\\u7684\\u7528\\u9014\\uff0c\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\n\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff0c\\u5176\\u4e2d\\u6267\\u884c\\u6743\\u5229\\u8981\\u6c42 1\\u81f350\\u4e2d\\u4efb\\u4e00\\u9879\\u4e2d\\u9650\\u5b9a\\u7684\\u6b65\\u9aa4\\uff0c\\u5176\\u4e2d\\n\\u4ece\\u60a3\\u8005\\u7684\\u751f\\u7269\\u6837\\u672c\\u63d0\\u4f9b DNA\\u5206\\u5b50\\u3002 \\n5. \\u5c06\\u6743\\u5229\\u8981\\u6c42 54\\u4e2d\\u7684\\u201cRNA \\u542f\\u52a8\\u5b50\\u201d\\u8fdb\\u4e00\\u6b65\\u9650\\u5b9a\\u4e3a\\u201cRNA \\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u201d \\u3002 \\n\\u5177\\u4f53\\u4fee\\u6539\\u8be6\\u89c1\\u6743\\u5229\\u8981\\u6c42\\u4e66\\u66ff\\u6362\\u9875\\u548c\\u4fee\\u6539\\u5bf9\\u7167\\u9875\\u3002 \\n \\n\\u610f\\u89c1\\u9648\\u8ff0  \\n\\u5728\\u4e0a\\u8ff0\\u4fee\\u6539\\u7684\\u57fa\\u7840\\u4e0a\\uff0c\\u7533\\u8bf7\\u4eba\\u8fdb\\u884c\\u5982\\u4e0b\\u7684\\u610f\\u89c1\\u9648\\u8ff0\\u3002 \\n\\u4e00. \\u5173\\u4e8e\\u6743\\u5229\\u8981\\u6c42 1\\u53ca\\u5176\\u4ed6\\u6743\\u5229\\u8981\\u6c42\\u7684\\u521b\\u9020\\u6027 \\n\\u5ba1\\u67e5\\u5458\\u6307\\u51fa\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u76f8\\u5bf9\\u4e8e D1\\uff08(US2003104432A1\\uff09\\u3001 D2\\uff08Nataliya Kitsera et \\nal., Functional impacts of 5- hydroxymethylcytosine, 5- formylcytosine, and 5- carboxycytosine at \\na single hemi -modified CpG dinucleotide in a gene promoter , Nucleic Acids Research \\uff09\\u548c D3\\n\\uff08US2014322707A1\\uff09\\u4e0d\\u5177\\u5907\\u521b\\u9020\\u6027\\u3002 \\n\\u7533\\u8bf7\\u4eba\\u4e0d\\u540c\\u610f\\u5ba1\\u67e5\\u5458\\u7684\\u89c2\\u70b9\\uff0c\\u5e76\\u8ba4\\u4e3a\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u5177\\u5907\\u521b\\n\\u9020\\u6027\\uff0c\\u5177\\u4f53\\u7406\\u7531\\u9648\\u8ff0\\u5982\\u4e0b\\u3002 \\n\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u8981\\u6c42\\u4fdd\\u62a4\\uff1a \\n1\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u6269\\u589e\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684\\u8131\\u6c27\\u6838\\u7cd6\\u6838\\u9178(DNA)\\u5206\\u5b50\\u7684\\u65b9\\u6cd5\\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\uff1a \\n(a)\\u4f7f\\u8854\\u63a5\\u5b50\\u4e0eDNA \\u5206\\u5b50\\u8fde\\u63a5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u5305\\u62ecRNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\uff0c\\u6240\\u8ff0RNA \\u805a\\u5408\\u9176\\u542f\\n\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff1b  \\n(b)\\u7528\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u8fde\\u63a5\\u7684DNA\\u5206\\u5b50\\uff1b \\u7533\\u8bf7\\u53f7\\uff1a201980060856.9   \\u4ee3\\u7406\\u673a\\u6784\\u5377\\u53f7\\uff1aPP218006PF  \\n \\n2 \\n (c)\\u4f7f\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684DNA\\u5206\\u5b50\\u4e0e\\u5f15\\u7269\\u6742\\u4ea4\\uff1b  \\n(d)\\u5ef6\\u4f38\\u7ecf\\u6742\\u4ea4\\u7684\\u5f15\\u7269\\u4ee5\\u4ea7\\u751f\\u53cc\\u94feDNA\\uff1b\\u548c \\n(e)\\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94feDNA\\u4ee5\\u4ea7\\u751fRNA\\u3002   \\nD1\\u6d89\\u53ca\\u5408\\u6210\\u548c\\u6269\\u589e RNA\\u7684\\u65b9\\u6cd5\\u3002\\u5728\\u4e00\\u4e9b\\u5b9e\\u65bd\\u65b9\\u6848\\u4e2d\\uff0c\\u5355\\u94fe cDNA\\u5206\\u5b50\\u53ef\\u64cd\\u4f5c\\u5730\\u8fde\\n\\u63a5\\u5230\\u542b\\u6709 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u533a\\u7684\\u8854\\u63a5\\u5b50\\uff0c\\u4ee5\\u4ea7\\u751f\\u4fee\\u9970\\u7684 cDNA\\u5206\\u5b50\\u3002 cDNA\\u548c\\u8854\\u63a5\\u5b50\\u53ef\\n\\u4ee5\\u901a\\u8fc7\\u8fde\\u63a5\\u6216\\u8005\\u5728\\u9006\\u8f6c\\u5f55\\u8fc7\\u7a0b\\u4e2d\\u901a\\u8fc7\\u6a21\\u677f\\u8f6c\\u6362\\u800c\\u7ed3\\u5408\\u3002\\u7ecf\\u4fee\\u9970\\u7684 cDNA\\u53ef\\u4ee5\\u88ab\\u8f6c\\u5f55\\u4ee5\\u4ea7\\n\\u751f\\u6709\\u4e49 RNA\\u3002 \\n\\u5982\\u5728\\u5ba1\\u67e5\\u610f\\u89c1\\u901a\\u77e5\\u4e66\\u4e2d\\u6240\\u8ff0\\uff0cD1 \\u4e0e\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u533a\\u522b\\u6280\\u672f\\u7279\\u5f81\\u5728\\u4e8e\\uff1a\\u672c\\u7533\\u8bf7\\n\\u6743\\u5229\\u8981\\u6c42 1\\u6d89\\u53ca\\u6269\\u589e\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u65b9\\u6cd5\\uff0c\\u4ece\\u800c\\u8fd8\\u5305\\u62ec\\u6b65\\u9aa4 b\\uff0c\\u4e14 RNA\\u805a\\u5408\\u9176\\n\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\u3002\\u4e5f\\u5c31\\u662f\\u8bf4\\uff0c D1\\u6ca1\\u6709\\u516c\\u5f00\\u4f7f\\u7528\\u5177\\u6709\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\n\\u7684\\u80de\\u5627\\u5576\\u7684\\u8854\\u63a5\\u5b50\\u6765\\u6269\\u589e\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u5206\\u5b50\\u3002  \\nD2\\u516c\\u5f00\\u4e86\\u542b\\u6709\\u7528\\u7532\\u57fa\\u80de\\u5627\\u5576\\u4fee\\u9970\\u7684 cAMP\\u53cd\\u5e94\\u5143\\u4ef6 \\uff08CRE \\uff09 \\u7684\\u8868\\u8fbe\\u8f7d\\u4f53\\u3002 CRE\\u4e0eCREB\\n\\uff08\\u4e00\\u79cd\\u8f6c\\u5f55\\u56e0\\u5b50\\uff09\\u7ed3\\u5408\\uff0c\\u542f\\u52a8\\u8f6c\\u5f55\\u3002\\u503c\\u5f97\\u6ce8\\u610f\\u7684\\u662f\\uff0c CREB\\u662f\\u4e00\\u79cd\\u8f6c\\u5f55\\u56e0\\u5b50\\uff0c\\u8fd9\\u610f\\u5473\\u7740\\u5b83\\n\\u53ef\\u4ee5\\u901a\\u8fc7\\u81f3\\u5c11\\u52df\\u96c6\\u6216\\u6291\\u5236 RNA\\u805a\\u5408\\u9176\\u590d\\u5408\\u7269\\u7684\\u52df\\u96c6\\u6765\\u8c03\\u8282\\u57fa\\u56e0\\u8868\\u8fbe\\uff08\\u53c2\\u89c1\\u4f8b\\u5982\\uff0c\\nConkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB, Montminy M. \\nTORCs: transducers of regulated CREB activity.  Mol Cell. 2003 Aug;12(2):413- 23\\uff09\\u3002  \\n\\u7533\\u8bf7\\u4eba\\u6ce8\\u610f\\u5230\\uff0c\\u76f4\\u63a5\\u4e0e RNA\\u805a\\u5408\\u9176\\u590d\\u5408\\u7269\\u86cb\\u767d\\u7ed3\\u5408\\u7684 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\uff0c\\u4f8b\\u5982 T3\\u3001\\nT7\\u6216Sp6\\uff0c\\u4e0e CRE\\u8f6c\\u5f55\\u56e0\\u5b50\\u7ed3\\u5408\\u4f4d\\u70b9\\u663e\\u8457\\u4e0d\\u540c\\u3002\\u56e0\\u6b64 D2\\u516c\\u5f00\\u4e86\\u5305\\u542b\\u7532\\u57fa\\u80de\\u5627\\u5576\\u7684 \\u8c03\\u63a7\\n\\u5143\\u4ef6\\uff0c\\u800c \\u6ca1\\u6709\\u516c\\u5f00\\u7528\\u7532\\u57fa\\u80de\\u5627\\u5576 \\u4fee\\u9970\\u7684RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u3002\\u56e0\\u6b64\\uff0c\\u7533\\u8bf7\\u4eba\\u8ba4\\u4e3a\\uff0c\\u81f3\\u5c11\\u57fa\\n\\u4e8e\\u8be5\\u539f\\u56e0\\uff0c\\u5ba1\\u67e5\\u5458\\u4e0d\\u5e94\\u5f53\\u5728 D1\\u516c\\u5f00\\u7684\\u57fa\\u7840\\u4e0a\\u7ed3\\u5408 D2\\u6765\\u5426\\u5b9a\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u975e\\u663e\\u800c\\n\\u6613\\u89c1\\u6027\\u3002 \\n\\u6b64\\u5916\\uff0c D2\\u516c\\u5f00\\u8868\\u660e\\u80de\\u5627\\u5576\\u7684\\u7532\\u57fa\\u5316\\u663e\\u8457\\u964d\\u4f4e\\u4e86\\u8f6c\\u5f55\\uff08\\u4f8b\\u5982\\uff0c\\u57fa\\u56e0\\u4ea7\\u7269\\u7684\\u8868\\u8fbe\\uff09 \\u3002\\u4f8b\\u5982\\uff0c\\nCRE\\u4e2d\\u7684\\u4e00\\u4e2a\\u7532\\u57fa\\u5316\\u80de\\u5627\\u5576\\u4f7f\\u62a5\\u544a\\u57fa\\u56e0\\u7684\\u8868\\u8fbe\\u964d\\u4f4e\\u4e86\\u7ea6 25%\\uff0c\\u800c\\u4e09\\u4e2a\\u7532\\u57fa\\u5316\\u80de\\u5627\\u5576\\u4f7f\\u8868\\n\\u8fbe\\u964d\\u4f4e\\u4e86\\u7ea6 50%\\uff08\\u964d\\u4f4e\\u81f3\\u4e0d\\u542b CRE\\u7684\\u5bf9\\u7167\\u8f7d\\u4f53\\u7684\\u6c34\\u5e73\\uff1b\\u53c2\\u89c1 D2\\u7b2c11036\\u9875\\u5de6\\u680f\\uff0c\\u4ee5\\u53ca\\n\\u56fe1E\\u548c2A\\uff09\\u3002 \\n\\u8fdb\\u4e00\\u6b65\\u5730\\uff0c D2\\u8fd8\\u516c\\u5f00\\uff0c\\u5355\\u4e2a\\u7532\\u57fa\\u5316\\u80de\\u5627\\u5576\\u4f1a\\u4f7f CREB\\u4e0eCRE\\u7684\\u7ed3\\u5408\\u51cf\\u5c11 2-3\\u500d\\uff0c\\u5e76\\n\\u4e14\\u8f7d\\u4f53\\u7684\\u5b8c\\u5168\\u7532\\u57fa\\u5316\\u4f1a\\u5b8c\\u5168\\u6d88\\u9664\\u8868\\u8fbe\\uff08\\u53c2\\u89c1 D2\\u7b2c11036\\u9875\\u5de6\\u680f\\uff0c\\u4ee5\\u53ca\\u8865\\u5145\\u56fe S2\\uff09 \\u3002\\u56e0\\u6b64\\uff0c\\nD2\\u6559\\u5bfc\\u4e86\\u8c03\\u63a7\\u5143\\u4ef6\\u7684\\u7532\\u57fa\\u5316\\uff08\\u751a\\u81f3\\u662f\\u534a\\u7532\\u57fa\\u5316\\uff09\\u4f1a\\u6291\\u5236\\u8f6c\\u5f55\\uff0c \\u8be5\\u6559\\u5bfc\\u5b8c\\u5168\\u504f\\u79bb\\u4e86\\u672c\\u8eab\\u7533\\n\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u6280\\u672f\\u65b9\\u6848\\u3002\\u4e8b\\u5b9e\\u4e0a\\uff0c\\u6839\\u636e D2\\u7684\\u6559\\u5bfc\\uff0c\\u672c\\u9886\\u57df\\u6280\\u672f\\u4eba\\u5458\\u4f1a\\u5408\\u7406\\u5730\\u9884\\u671f\\u5305\\u542b\\n\\u7532\\u57fa\\u80de\\u5627\\u5576\\u7684 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\uff08\\u672c\\u7533\\u8bf7\\u7684\\u4e00\\u4e9b\\u5b9e\\u65bd\\u65b9\\u6848\\u542b\\u6709 7\\u4e2a\\uff0c\\u53c2\\u89c1\\u4f8b\\u5982\\u5b9e\\u65bd\\u4f8b 1\\uff0c\\u7533\\u8bf7\\u53f7\\uff1a201980060856.9   \\u4ee3\\u7406\\u673a\\u6784\\u5377\\u53f7\\uff1aPP218006PF  \\n \\n3 \\n C.\\u65b9\\u6cd5\\u4e2d\\u7684 3.T7\\u8854\\u63a5\\u5b50\\u7684\\u5236\\u5907\\uff0c\\u8bf4\\u660e\\u4e66\\u30100227\\u3011- \\u30100228\\u3011\\u6bb5\\uff09\\u4f1a\\u4f7f\\u5f97\\u672c\\u7533\\u8bf7\\u4e0d\\u53ef\\u5b9e\\u73b0\\uff0c\\n\\u4f8b\\u5982\\uff0c \\u5b83\\u4e0d\\u4f1a\\u4fc3\\u8fdb\\u672c\\u9886\\u57df\\u6280\\u672f\\u4eba\\u5458\\u5f97\\u5230\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u4e2d\\u7684\\u6b65\\u9aa4 \\u201c(e) \\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94fe DNA\\n\\u4ee5\\u4ea7\\u751f RNA\\u201d \\u3002\\u56e0\\u6b64\\uff0c\\u7533\\u8bf7\\u4eba\\u8ba4\\u4e3a\\uff0c \\u8fdb\\u4e00\\u6b65\\u81f3\\u5c11\\u57fa\\u4e8e\\u8be5\\u539f\\u56e0\\uff0c\\u5ba1\\u67e5\\u5458\\u4e0d\\u5e94\\u5f53\\u5728 D1\\u516c\\u5f00\\u7684\\n\\u57fa\\u7840\\u4e0a\\u7ed3\\u5408 D2\\u6765\\u5426\\u5b9a\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u975e\\u663e\\u800c\\u6613\\u89c1\\u6027\\u3002 \\nD3\\u516c\\u5f00\\u4e86\\u4fee\\u9970 5mC\\u548c/\\u62165hmC\\uff0c\\u5e76\\u968f\\u540e\\u68c0\\u6d4b\\u3001\\u8bc4\\u4f30\\u3001\\u6d4b\\u5e8f\\u548c/ \\u6216\\u7ed8\\u5236\\u6838\\u9178\\u5206\\u5b50\\u4e2d 5mC\\n\\u4fee\\u9970-\\u80de\\u5627\\u5576\\u78b1\\u57fa\\u548c 5hmC\\u4fee\\u9970-\\u80de\\u5627\\u5576\\u78b1\\u57fa\\u7684\\u65b9\\u6cd5\\u548c\\u7ec4\\u5408\\u7269\\u3002D3 \\u4e5f\\u6ca1\\u6709\\u516c\\u5f00\\u672c\\u7533\\u8bf7\\u6743\\u5229\\n\\u8981\\u6c42 1\\u4e2d\\u9650\\u5b9a\\u7684\\u4f7f\\u7528\\u5177\\u6709\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\u7684\\u8854\\u63a5\\u5b50\\u6765\\u6269\\u589e\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684\\nDNA\\u5206\\u5b50\\u3002 \\n\\u7efc\\u4e0a\\uff0cD1 \\u3001D2\\u548cD3\\u7684\\u7ed3\\u5408\\u5e76\\u6ca1\\u6709\\u6559\\u5bfc\\u6216\\u6697\\u793a\\u4f7f\\u5f97\\u672c\\u9886\\u57df\\u6280\\u672f\\u4eba\\u5458\\u5f97\\u5230\\u672c\\u7533\\u8bf7\\u6743\\u5229\\n\\u8981\\u6c42 1\\u7684\\u6280\\u672f\\u65b9\\u6848\\u3002\\u56e0\\u6b64\\uff0c \\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u7684\\u7ed3\\u5408\\u5177\\u6709\\u975e\\u663e\\u800c\\u6613\\n\\u89c1\\u6027\\u3002 \\n\\u672c\\u7533\\u8bf7\\u8bf4\\u660e\\u4e66\\u30100007 \\u3011\\u6bb5\\u8bb0\\u8f7d\\uff1a\\u76ee\\u524d\\u7684\\u65b9\\u6cd5\\u90fd\\u4e0d\\u80fd\\u5bf9\\u5c11\\u91cf DNA(\\u7eb3\\u514b\\u7ea7\\u6216\\u4e9a\\u7eb3\\u514b\\u7ea7 )\\n\\u4e2d\\u7684 5mC\\u548c5hmC\\u8fdb\\u884c\\u6d4b\\u5e8f\\uff0c\\u6216\\u5728\\u5355\\u7ec6\\u80de\\u6c34\\u5e73\\u4e2d\\u83b7\\u5f97\\u8fd9\\u4e9b\\u4fee\\u9970\\u7684\\u4fe1\\u606f\\u3002  \\n\\u672c\\u7533\\u8bf7\\u8bf4\\u660e\\u4e66\\u30100008\\u3011\\u6bb5\\u8bb0\\u8f7d\\uff1a\\u672c\\u516c\\u5f00\\u7684\\u65b9\\u6cd5\\u3001\\u7ec4\\u5408\\u7269\\u548c\\u8bd5\\u5242\\u76d2\\u63d0\\u4f9b\\u4e86\\u4e00\\u79cd\\u7528\\u4e8e\\u6574\\u4e2a\\n\\u57fa\\u56e0\\u7ec4\\u7684\\u6709\\u6548\\u65b9\\u6cd5\\uff0c\\u5373\\u65e0\\u504f DNA\\u5206\\u6790\\u65b9\\u6cd5\\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\u53ef\\u4ee5\\u5728\\u6709\\u9650\\u91cf\\u7684 DNA\\u4e0a\\u8fdb\\u884c\\u5e76\\u4e14\\n\\u53ef\\u4ee5\\u6709\\u6548\\u6d4b\\u5b9a DNA\\u7684\\u4fee\\u9970\\u72b6\\u6001\\u3002  \\n\\u672c\\u7533\\u8bf7\\u8bf4\\u660e\\u4e66\\u30100219\\u3011\\u6bb5\\u8bb0\\u8f7d\\uff1a\\u9664\\u8840\\u6db2\\u5916\\uff0c\\u8be5\\u6280\\u672f\\u8fd8\\u53ef\\u4f5c\\u7528\\u4e8e\\u5305\\u62ec\\u4f46\\u4e0d\\u9650\\u4e8e\\u5c3f\\u6db2\\u3001\\u8111\\n\\u810a\\u6db2(CSF) \\u548c\\u623f\\u6c34 cfDNA\\uff0c\\u636e\\u62a5\\u544a\\u5176 DNA\\u7247\\u6bb5\\u5177\\u6709\\u6bd4\\u8840\\u6db2\\u4e2d\\u7684 DNA\\u7247\\u6bb5\\u66f4\\u5c0f\\u7684\\u5c3a\\u5bf8\\u6216\\n\\u66f4\\u4f4e\\u7684\\u6d53\\u5ea6\\u3002LAB- seq\\u8fd8\\u53ef\\u7528\\u4e8e\\u5355\\u7ec6\\u80de\\u7814\\u7a76\\u3002\\u4f7f\\u7528\\u8f6c\\u5ea7\\u9176\\u6216\\u6838\\u9178\\u9176\\u7b49\\u4f7f\\u5355\\u7ec6\\u80de gDNA\\u7247\\n\\u6bb5\\u5316\\u4e4b\\u540e\\uff0c\\u8be5\\u6280\\u672f\\u53ef\\u4ee5\\u7528\\u4e8e\\u5c06\\u51e0\\u5fae\\u5fae\\u514b\\u7684\\u6750\\u6599\\u6269\\u589e\\u81f3\\u7eb3\\u514b\\u3002\\u5b83\\u4e3a\\u7814\\u7a76\\u4eba\\u5458\\u63d0\\u4f9b\\u4e86\\u6709\\u529b\\u4e14\\n\\u51c6\\u786e\\u7684\\u5de5\\u5177\\u4ee5\\u5229\\u7528\\u5bf9\\u764c\\u75c7\\u548c\\u80da\\u80ce\\u53d1\\u80b2\\u7684\\u6df1\\u5165\\u4e86\\u89e3\\uff0c\\u89c2\\u5bdf\\u5faa\\u73af\\u80bf\\u7624\\u7ec6\\u80de\\u3001\\u7ec6\\u80de\\u5f02\\u8d28\\u6027\\u548c\\u80da\\n\\u80ce\\u4e2d\\u6574\\u4e2a\\u57fa\\u56e0\\u7ec4\\u7684\\u8868\\u89c2\\u9057\\u4f20\\u5b66\\u53d8\\u5316\\u3002  \\n\\u6839\\u636e\\u4e0a\\u8ff0\\u8bb0\\u8f7d\\u53ef\\u77e5\\uff0c \\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u6280\\u672f\\u65b9\\u6848\\u89e3\\u51b3\\u4e86\\u73b0\\u6709\\u6280\\u672f\\u4e2d\\u5e0c\\u671b\\u89e3\\u51b3\\u7684\\u6280\\u672f\\n\\u95ee\\u9898\\uff0c\\u5e76\\u4e14\\u76f8\\u5bf9\\u4e8e\\u73b0\\u6709\\u6280\\u672f\\u5177\\u6709\\u663e\\u8457\\u7684\\u6280\\u672f\\u6548\\u679c\\u3002 \\n\\u7efc\\u4e0a\\u6240\\u8ff0\\uff0c\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u6280\\u672f\\u65b9\\u6848\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u5177\\u5907\\u7a81\\u51fa\\u7684\\u5b9e\\u8d28\\u6027\\u7279\\n\\u70b9\\u548c\\u663e\\u8457\\u7684\\u6280\\u672f\\u8fdb\\u6b65\\uff0c\\u5177\\u6709\\u521b\\u9020\\u6027\\u3002 \\n\\u5173\\u4e8e\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150\\u548c54\\u7684\\u521b\\u9020\\u6027\\uff0c\\u57fa\\u4e8e\\u4e0e\\u6743\\u5229\\u8981\\u6c42 1\\u9648\\u8ff0\\u7684\\u76f8\\u540c\\u7406\\u7531\\uff0c\\u7533\\u8bf7\\u4eba\\n\\u8ba4\\u4e3a\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150 \\u548c54\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u4e5f\\u5177\\u6709\\u521b\\u9020\\u6027\\u3002 \\n\\u6743\\u5229\\u8981\\u6c42 4-49\\u3001 51-53\\u548c55-72\\u5206\\u522b\\u76f4\\u63a5\\u6216\\u95f4\\u63a5\\u5f15\\u7528\\u6743\\u5229\\u8981\\u6c42 1\\u30012\\u30013\\u300150\\u548c54\\uff0c\\u5728\\n\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150\\u548c54\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u5177\\u6709\\u521b\\u9020\\u6027\\u7684\\u524d\\u63d0\\u4e0b\\uff0c \\u6743\\u5229\\u8981\\u6c42 4-49\\u300151-53\\n\\u548c55-72\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u4e5f\\u5177\\u6709\\u521b\\u9020\\u6027\\u3002 \\u7533\\u8bf7\\u53f7\\uff1a201980060856.9   \\u4ee3\\u7406\\u673a\\u6784\\u5377\\u53f7\\uff1aPP218006PF  \\n \\n4 \\n  \\n\\u4e8c. \\u4e0d\\u6388\\u4e88\\u4e13\\u5229\\u6743\\u7684\\u4e3b\\u9898 \\n\\u5ba1\\u67e5\\u5458\\u6307\\u51fa\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150- 53\\u548c4-49\\u5c5e\\u4e8e\\u75be\\u75c5\\u7684\\u8bca\\u65ad\\u4e0e\\u6cbb\\u7597\\u65b9\\u6cd5\\u3002 \\n\\u7533\\u8bf7\\u4eba\\u4e0d\\u540c\\u610f\\u5ba1\\u67e5\\u5458\\u7684\\u8be5\\u89c2\\u70b9\\uff0c\\u56e0\\u4e3a\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u548c50\\u7684\\u76f4\\u63a5\\u76ee\\u7684\\u662f\\u9274\\u5b9a DNA\\u5206\\u5b50\\u4e2d\\n\\u7532\\u57fa\\u80de\\u5627\\u5576\\u7684\\u53d8\\u4f53\\u3002\\u8fd9\\u4e9b\\u65b9\\u6cd5\\u53ef\\u7528\\u4e8e\\u5de5\\u4e1a\\u548c/ \\u6216\\u5b66\\u672f\\u754c\\uff0c\\u4f8b\\u5982\\u7528\\u4e8e\\u7814\\u7a76\\u76ee\\u7684\\u3002\\u6b64\\u5916\\uff0c\\u5728 DNA\\n\\u6837\\u672c\\u4e2d\\u68c0\\u6d4b\\u7532\\u57fa\\u80de\\u5627\\u5576\\u53ca\\u5176\\u53d8\\u4f53\\u672c\\u8eab\\u5e76\\u4e0d\\u662f\\u4e00\\u79cd\\u8bca\\u65ad\\u65b9\\u6cd5\\u3002\\u8bca\\u65ad\\u9700\\u8981\\u4e0e\\u75be\\u75c5\\u6570\\u636e\\u5e93\\u8fdb\\u884c\\u6bd4\\u8f83\\n\\u548c\\u5206\\u6790\\u3002\\u56e0\\u6b64\\uff0c\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u548c50\\u4e0d\\u5e94\\u88ab\\u89c6\\u4e3a\\u7528\\u4e8e\\u8bca\\u65ad\\u75be\\u75c5\\u7684\\u8bca\\u65ad\\u4e0e\\u6cbb\\u7597\\u65b9\\u6cd5\\u3002 \\n\\u4f46\\u4e3a\\u4e86\\u52a0\\u901f\\u5ba1\\u67e5\\u8fc7\\u7a0b\\uff0c\\u7533\\u8bf7\\u4eba\\u4fee\\u6539\\u4e86\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u548c50\\uff0c\\u5c06\\u8fd9\\u4e9b\\u65b9\\u6cd5\\u8fdb\\u4e00\\u6b65\\u9650\\u5b9a\\u4e3a\\u201c\\u975e\\n\\u8bca\\u65ad\\u65b9\\u6cd5\\u2026\\u2026\\u201d \\u3002\\u53e6\\u5916\\uff0c\\u7533\\u8bf7\\u4eba\\u5c06\\u6743\\u5229\\u8981\\u6c42 52\\u6539\\u5199\\u4e3a\\u5236\\u836f\\u7528\\u9014\\u6743\\u5229\\u8981\\u6c42\\uff0c\\u5177\\u4f53\\u53c2\\u89c1\\u4e0a\\u8ff0\\u4fee\\u6539\\n\\u8bf4\\u660e\\u4ee5\\u53ca\\u6743\\u5229\\u8981\\u6c42\\u4e66\\u66ff\\u6362\\u9875\\u548c\\u4fee\\u6539\\u5bf9\\u7167\\u9875\\u3002  \\n\\u56e0\\u6b64\\uff0c\\u672c\\u7533\\u8bf7\\u4fee\\u6539\\u540e\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150- 53\\u548c4-49\\u4e0d\\u518d\\u5c5e\\u4e8e\\u75be\\u75c5\\u7684\\u8bca\\u65ad\\u4e0e\\u6cbb\\u7597\\u65b9\\u6cd5\\uff0c\\u5c5e\\n\\u4e8e\\u88ab\\u6388\\u4e88\\u4e13\\u5229\\u6743\\u7684\\u8303\\u56f4\\u3002 \\n \\n\\u4e09. \\u5355\\u4e00\\u6027         \\n\\u300a\\u4e13\\u5229\\u6cd5\\u300b\\u7b2c 31\\u6761\\u89c4\\u5b9a\\uff1a \\u201c\\u5c5e\\u4e8e\\u4e00\\u4e2a\\u603b\\u7684\\u53d1\\u660e\\u6784\\u601d\\u7684\\u4e24\\u9879\\u4ee5\\u4e0a\\u7684\\u53d1\\u660e\\u6216\\u8005\\u5b9e\\u7528\\u65b0\\u578b\\uff0c\\u53ef\\n\\u4ee5\\u4f5c\\u4e3a\\u4e00\\u4ef6\\u7533\\u8bf7\\u63d0\\u51fa\\u3002 \\u201d \\n\\u5ba1\\u67e5\\u5458\\u6307\\u51fa\\uff0c\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 2\\u548c3\\u4e0e\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u5171\\u540c\\u6280\\u672f\\u7279\\u5f81\\u5728\\u4e8e\\uff1a\\u6b65\\u9aa4 a-e\\u3002\\u5728\\u6743\\n\\u5229\\u8981\\u6c42 1\\u76f8\\u5bf9\\u4e8e D1-D3\\u4e0d\\u5177\\u5907\\u521b\\u9020\\u6027\\u7684\\u524d\\u63d0\\u4e0b\\uff0c\\u6b65\\u9aa4 a-e\\u9650\\u5b9a\\u7684\\u65b9\\u6cd5\\u4e0d\\u5c5e\\u4e8e\\u5bf9\\u73b0\\u6709\\u6280\\u672f\\u4f5c\\u51fa\\n\\u521b\\u9020\\u6027\\u8d21\\u732e\\u7684\\u7279\\u5b9a\\u6280\\u672f\\u7279\\u5f81\\u3002\\u7531\\u6b64\\u6307\\u51fa\\u6743\\u5229\\u8981\\u6c42 2\\u548c3\\u4e0e\\u6743\\u5229\\u8981\\u6c42 1\\u4e4b\\u95f4\\u7f3a\\u4e4f\\u76f8\\u540c\\u6216\\u76f8\\u5e94\\u7684\\n\\u7279\\u5b9a\\u6280\\u672f\\u7279\\u5f81\\uff0c\\u4e0d\\u5177\\u6709\\u5355\\u4e00\\u6027\\u3002 \\n\\u5982\\u524d\\u6240\\u8ff0\\uff0c\\u7533\\u8bf7\\u4eba\\u8ba4\\u4e3a\\u6743\\u5229\\u8981\\u6c42 1\\u76f8\\u5bf9\\u4e8e D1-D3\\u5177\\u6709\\u521b\\u9020\\u6027\\uff0c\\u6b65\\u9aa4 a-e\\u9650\\u5b9a\\u7684\\u65b9\\u6cd5\\u5c5e\\u4e8e\\n\\u5bf9\\u73b0\\u6709\\u6280\\u672f\\u505a\\u51fa\\u521b\\u9020\\u6027\\u8d21\\u732e\\u7684\\u6280\\u672f\\u7279\\u5f81\\uff0c\\u56e0\\u6b64\\uff0c\\u6743\\u5229\\u8981\\u6c42 2\\u548c3\\u4e0e\\u6743\\u5229\\u8981\\u6c42 1\\u4e4b\\u95f4\\u5177\\u6709\\u76f8\\u540c\\n\\u6216\\u76f8\\u5e94\\u7684\\u7279\\u5b9a\\u6280\\u672f\\u7279\\u5f81\\uff0c\\u5177\\u6709\\u5355\\u4e00\\u6027\\u3002\\u76f4\\u63a5\\u5f15\\u7528\\u6743\\u5229\\u8981\\u6c42 1-3\\u7684\\u6743\\u5229\\u8981\\u6c42 4-49\\u3001 51-53\\u4e4b\\u95f4\\u4e5f\\n\\u5177\\u6709\\u5355\\u4e00\\u6027\\u3002 \\n \\n\\u8bf7\\u5ba1\\u67e5\\u5458\\u5728\\u6b64\\u57fa\\u7840\\u4e0a\\u7ee7\\u7eed\\u8fdb\\u884c\\u5ba1\\u67e5\\uff0c\\u5e76\\u76fc\\u65e9\\u65e5\\u6388\\u6743\\u3002\\u82e5\\u5ba1\\u67e5\\u5458\\u5728\\u540e\\u7eed\\u5ba1\\u67e5\\u7a0b\\u5e8f\\u4e2d\\u6709\\u4efb\\u4f55\\n\\u610f\\u89c1\\uff0c\\u6073\\u8bf7\\u518d\\u7ed9\\u4e88\\u4e00\\u6b21\\u9648\\u8ff0\\u610f\\u89c1/ \\u4fee\\u6539/\\u4f1a\\u6664\\u7684\\u673a\\u4f1a\\u3002\\u6700\\u540e\\uff0c\\u7533\\u8bf7\\u4eba\\u5bf9\\u5ba1\\u67e5\\u5458\\u4e3a\\u5ba1\\u67e5\\u672c\\u7533\\u8bf7\\u6240\\u4ed8\\n\\u51fa\\u7684\\u8f9b\\u52e4\\u52b3\\u52a8\\u8868\\u793a\\u7531\\u8877\\u7684\\u611f\\u8c22\\u3002 \\n\\u5317\\u4eac\\u67cf\\u6749\\u677e\\u77e5\\u8bc6\\u4ea7\\u6743\\u4ee3\\u7406\\u4e8b\\u52a1\\u6240\\uff08\\u666e\\u901a\\u5408\\u4f19\\uff09 \\n                                               \\u8054\\u7cfb\\u7535\\u8bdd\\uff1a010- 84109559- \\uff088952 \\uff09     \\n 1PP218006PF-OA1\\n \\n \\n1\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u6269\\u589e\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684\\u8131\\u6c27\\u6838\\u7cd6\\u6838\\u9178 (DNA)\\u5206\\u5b50\\u7684\\u65b9\\u6cd5\\uff0c\\n\\u6240\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\uff1a  \\n(a)\\u4f7f\\u8854\\u63a5\\u5b50\\u4e0e DNA\\u5206\\u5b50\\u8fde\\u63a5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\uff0c\\n\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff1b   \\n(b)\\u7528\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u8fde\\u63a5\\u7684 DNA\\u5206\\u5b50\\uff1b  \\n(c)\\u4f7f\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u5206\\u5b50\\u4e0e\\u5f15\\u7269\\u6742\\u4ea4\\uff1b   \\n(d)\\u5ef6\\u4f38\\u7ecf\\u6742\\u4ea4\\u7684\\u5f15\\u7269\\u4ee5\\u4ea7\\u751f\\u53cc\\u94fe DNA\\uff1b\\u548c  \\n(e)\\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94fe DNA\\u4ee5\\u4ea7\\u751f RNA\\u3002   \\n2\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u9274\\u5b9a DNA\\u5206\\u5b50\\u4e2d\\u7684 5-\\u7f9f\\u7532\\u57fa\\u80de\\u5627\\u5576 (5hmC)\\u7684\\u975e\\u8bca\\u65ad\\u65b9\\u6cd5\\uff0c\\u6240\\n\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\uff1a  \\n(1)\\u4fee\\u9970 DNA\\u5206\\u5b50\\u4e2d\\u7684 5hmC\\u4ee5\\u4fdd\\u62a4\\u5b83\\u514d\\u4e8e\\u6c27\\u5316\\uff1b  \\n(2)\\u7528\\u7532\\u57fa\\u80de\\u5627\\u5576\\u53cc\\u52a0\\u6c27\\u9176\\u6c27\\u5316\\u6765\\u81ea (1)\\u7684\\u7ecf\\u4fee\\u9970\\u7684 DNA\\u5206\\u5b50\\uff0c\\u4ee5\\u5c06 5-\\u7532\\u57fa\\n\\u80de\\u5627\\u5576 (5mC)\\u8f6c\\u5316\\u4e3a 5-\\u7fa7\\u57fa\\u80de\\u5627\\u5576 (5caC)\\uff1b \\n(3)\\u8fdb\\u884c\\u5305\\u62ec\\u4ee5\\u4e0b\\u6b65\\u9aa4\\u7684\\u65b9\\u6cd5\\uff1a  \\n(a)\\u4f7f\\u8854\\u63a5\\u5b50\\u4e0e DNA\\u5206\\u5b50\\u8fde\\u63a5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\n\\u5b50\\uff0c\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff1b  \\n(b)\\u7528\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u8fde\\u63a5\\u7684 DNA\\u5206\\u5b50\\uff1b  \\n(c)\\u4f7f\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u5206\\u5b50\\u4e0e\\u5f15\\u7269\\u6742\\u4ea4\\uff1b   \\n(d)\\u5ef6\\u4f38\\u7ecf\\u6742\\u4ea4\\u7684\\u5f15\\u7269\\u4ee5\\u4ea7\\u751f\\u53cc\\u94fe DNA\\uff1b\\u548c  \\n(e)\\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94fe DNA\\u4ee5\\u4ea7\\u751f RNA\\u3002   \\n3\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u9274\\u5b9a DNA\\u5206\\u5b50\\u4e2d\\u7684 5mC\\u7684\\u975e\\u8bca\\u65ad\\u65b9\\u6cd5\\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\uff1a  \\n(1)\\u7528\\u6c27\\u5316\\u5242\\u6c27\\u5316 DNA\\u5206\\u5b50\\u4ee5\\u5c06 5hmC\\u6c27\\u5316\\u6210 5-\\u7532\\u9170\\u57fa\\u80de\\u5627\\u5576 (5fC)\\u62165caC\\uff1b \\n(2)\\u8fdb\\u884c\\u5305\\u62ec\\u4ee5\\u4e0b\\u6b65\\u9aa4\\u7684\\u65b9\\u6cd5\\uff1a  \\u6743  \\u5229 \\u8981 \\u6c42 \\u4e66-OA1\\n \\n 2PP218006PF-OA1\\n(a)\\u4f7f\\u8854\\u63a5\\u5b50\\u4e0e DNA\\u5206\\u5b50\\u8fde\\u63a5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\n\\u5b50\\uff0c\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff1b  \\n(b)\\u7528\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u8fde\\u63a5\\u7684 DNA\\u5206\\u5b50\\uff1b  \\n(c)\\u4f7f\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u5206\\u5b50\\u4e0e\\u5f15\\u7269\\u6742\\u4ea4\\uff1b   \\n(d)\\u5ef6\\u4f38\\u7ecf\\u6742\\u4ea4\\u7684\\u5f15\\u7269\\u4ee5\\u4ea7\\u751f\\u53cc\\u94fe DNA\\uff1b\\u548c  \\n(e)\\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94fe DNA\\u4ee5\\u4ea7\\u751f RNA\\u3002 \\n4\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f33\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240 \\u8ff0\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\n\\u80de\\u5627\\u5576\\u5305\\u62ec 5mC\\u62165hmC\\u3002 \\n5\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f33\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240 \\u8ff0\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\n\\u80de\\u5627\\u5576\\u5305\\u62ec\\u809f\\u6216\\u8159\\u4fee\\u9970\\u7684 5fC\\u3002 \\n6\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 5\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u7528\\u5305\\u542b\\u7f9f\\u80fa\\u57fa\\u3001\\u80bc\\u57fa\\u6216\\u9170\\u80bc\\u57fa\\u7684\\u5316\\u5408\\n\\u7269\\u4fee\\u9970 5fC\\u3002  \\n7\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 6\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u5316\\u5408\\u7269\\u662f\\u7f9f\\u80fa\\uff1b\\u76d0\\u9178\\u7f9f\\u80fa\\uff1b\\u786b\\u9178\\n\\u7f9f\\u94f5\\uff1b\\u78f7\\u9178\\u7f9f\\u80fa\\uff1b O-\\u7532\\u57fa\\u7f9f\\u80fa\\uff1b O-\\u5df1\\u57fa\\u7f9f\\u80fa\\uff1b O-\\u620a\\u57fa\\u7f9f\\u80fa\\uff1b O-\\u82c4\\u57fa\\u7f9f\\u80fa\\uff1b O-\\n\\u4e59\\u57fa\\u7f9f\\u80fa (EtONH 2)\\u3001O-\\u70f7\\u57fa\\u5316\\u6216 O-\\u82b3\\u57fa\\u5316\\u7f9f\\u80fa\\u3001\\u5176\\u9178\\u6216\\u76d0\\u3002   \\n8\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f33\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240 \\u8ff0\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\n\\u80de\\u5627\\u5576\\u5305\\u62ec\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684 5caC\\u3002 \\n9\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 8\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d 5caC\\u662f\\u7ecf\\u9170\\u80fa\\u4fee\\u9970\\u7684 5caC\\u3002 \\n10\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 9\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u901a\\u8fc7\\u4e0e\\u5305\\u542b\\u80fa\\u57fa\\u7684\\u5316\\u5408\\u7269\\u8fde\\u63a5\\u800c\\u5bf9\\n5caC\\u8fdb\\u884c\\u9170\\u80fa\\u4fee\\u9970\\u3002    \\n11\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 10\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u901a\\u8fc7\\u5c06 DNA\\u5206\\u5b50\\u4e0e\\u78b3\\u4e8c\\u4e9a\\u80fa\\u884d\\u751f\\u7269\\n\\u4e00\\u8d77\\u5b75\\u80b2\\u800c\\u4f7f 5caC\\u4e0e\\u80fa\\u57fa\\u8fde\\u63a5\\u3002  \\n12\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 10\\u621611\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u5305\\u542b\\u80fa\\u57fa\\u7684\\u5316\\u5408\\u7269\\u662f\\u82c4\\u80fa\\u3001\\u7ecf\\n\\u53d6\\u4ee3\\u7684\\u82c4\\u80fa\\u3001\\u70f7\\u57fa\\u80fa\\u3001\\u70f7\\u57fa\\u4e8c\\u80fa\\u3001\\u4e8c\\u7532\\u82ef\\u80fa\\u3001 \\u7ecf\\u53d6\\u4ee3\\u7684\\u4e8c\\u7532\\u82ef\\u80fa\\u3001\\u73af\\u70f7\\u57fa\\u80fa\\u3001\\n\\u73af\\u70f7\\u57fa\\u4e8c\\u80fa\\u3001\\u7f9f\\u80fa\\u6216\\u7ecf\\u53d6\\u4ee3\\u7684\\u7f9f\\u80fa\\u3002  \\n13\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f312\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8 \\n 3PP218006PF-OA1\\n\\u5b50\\u5305\\u62ec SP6\\u3001T7\\u6216T3\\u542f\\u52a8\\u5b50\\u3002  \\n14\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f313\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (a)\\u5305\\u62ec DNA\\u7684\\u672b\\u7aef\\u4fee\\n\\u9970\\u548c /\\u6216DNA\\u7684\\u672b\\u7aef\\u4fee\\u590d\\u3002  \\n15\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 14\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u672b\\u7aef\\u4fee\\u9970\\u5305\\u542b\\u672b\\u7aef\\u52a0 A\\u3002 \\n16\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f315\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (a)\\u5305\\u62ec\\u5728\\u8db3\\u4ee5\\u4f7f\\u8854\\u63a5\\n\\u5b50\\u4e0e DNA\\u5206\\u5b50\\u8fde\\u63a5\\u7684\\u6761\\u4ef6\\u4e0b\\uff0c\\u4f7f DNA\\u4e0e\\u8fde\\u63a5\\u9176\\u63a5\\u89e6\\u3002  \\n17\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f316\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u8fd8\\u5305\\u62ec 3\\u2019\\n\\u672b\\u7aef\\u5c01\\u95ed\\u5206\\u5b50\\u3002  \\n18\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f317\\u4e2d\\u4efb\\u4e00\\u9879\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u662f\\u90e8\\u5206\\u53cc\\u94fe\\u7684\\u3002  \\n19\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f318\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (d)\\u5305\\u62ec\\u4f7f DNA\\u5206\\u5b50\\u4e0e\\nDNA\\u805a\\u5408\\u9176\\u63a5\\u89e6\\u3002  \\n20\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f319\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (d)\\u5305\\u62ec\\u5728\\u5141\\u8bb8\\u53cc\\u94fe\\nDNA\\u53d8\\u6027\\u4e3a\\u5355\\u94fe DNA\\u7684\\u53d8\\u6027\\u6761\\u4ef6\\u4e0b\\u5b75\\u80b2 DNA\\u3002 \\n21\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 20\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (d)\\u5305\\u62ec\\u5728\\u8db3\\u4ee5\\u4f7f\\u5f15\\u7269\\u9000\\u706b\\u81f3\\u5355\\u94fe\\nDNA\\u7684\\u6761\\u4ef6\\u4e0b\\u5b75\\u80b2 DNA\\u3002 \\n22\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 21\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (d)\\u5305\\u62ec\\u5728\\u8db3\\u4ee5\\u4f7f\\u5f15\\u7269\\u5ef6\\u4f38\\u4ee5\\u4ea7\\u751f\\u53cc\\n\\u94feDNA\\u7684\\u6761\\u4ef6\\u4e0b\\u5b75\\u80b2 DNA\\u3002 \\n23\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f322\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (e)\\u5305\\u62ec\\u4f7f DNA\\u5206\\u5b50\\u4e0e\\nRNA\\u805a\\u5408\\u9176\\u548c\\u6838\\u82f7\\u4e09\\u78f7\\u9178\\u63a5\\u89e6\\u3002   \\n24\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f323\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u8fd8\\u5305\\u62ec\\u4e00\\u4e2a\\n\\u6216\\u591a\\u4e8e\\u4e00\\u4e2a\\u7eaf\\u5316\\u6b65\\u9aa4\\u3002  \\n25\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 24\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u7eaf\\u5316\\u6b65\\u9aa4\\u5305\\u62ec\\u56fa\\u76f8\\u53ef\\u9006\\u56fa\\u5b9a\\u5316\\n(SPRI)\\u73e0\\u3002  \\n26\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f325\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u8fd8\\u5305\\u62ec (e)\\u7684\\nRNA\\u5206\\u5b50\\u7684\\u7eaf\\u5316\\u3002  \\n27\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f326\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u8fd8\\u5305\\u62ec\\u5bf9 (e) \\n 4PP218006PF-OA1\\n\\u7684RNA\\u5206\\u5b50\\u8fdb\\u884c\\u9006\\u8f6c\\u5f55\\u4ee5\\u4ea7\\u751f\\u76f8\\u5e94\\u7684 DNA\\u5206\\u5b50\\u3002  \\n28\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f3\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (a)\\u81f3(e)\\u6309\\u987a\\u5e8f\\u6267\\u884c\\u3002  \\n29\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 27\\u621628\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u8fd8\\u5305\\u62ec\\u76f8\\u5e94 DNA\\u5206\\u5b50\\n\\u7684\\u6587\\u5e93\\u6784\\u5efa\\u3002    \\n30\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 27\\u81f329\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u8fd8\\u5305\\u62ec\\u5bf9\\u76f8\\n\\u5e94DNA\\u5206\\u5b50\\u8fdb\\u884c\\u6d4b\\u5e8f\\u3002  \\n31\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f330\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u662f\\u7247\\u6bb5\\n\\u5316\\u7684\\u3002  \\n32\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 31\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u7247\\u6bb5\\u7684\\u957f\\u5ea6\\u4e3a 100bp\\u81f3300bp\\u3002 \\n33\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 31\\u621632\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d DNA\\u5206\\u5b50\\u662f\\u751f\\u7269\\u7247\\u6bb5\\u3002  \\n34\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f333\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u4e0d\\u5305\\u62ec\\u5bcc\\u96c6\\n\\u6b65\\u9aa4\\u3002  \\n35\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f334\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u5305\\u62ec\\u6e38\\n\\u79bbDNA (cfDNA) \\u3002 \\n36\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f335\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u5305\\u62ec\\u57fa\\n\\u56e0\\u7ec4 DNA\\u3002 \\n37\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f336\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u7684\\u91cf\\u4e3a\\n1pg\\u81f3100ng\\u3002 \\n38\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f337\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u4ece\\u5bf9\\u8c61\\n\\u7684\\u6837\\u672c\\u4e2d\\u5206\\u79bb\\u3002  \\n39\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f338\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u4ece\\u6d3b\\u68c0\\n\\u6837\\u672c\\u4e2d\\u5206\\u79bb\\u3002  \\n40\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 39\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6837\\u672c\\u662f\\u6db2\\u4f53\\u6837\\u672c\\u3002  \\n41\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 2\\u62164\\u81f340\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u7532\\u57fa\\u80de\\u5627\\u5576\\u53cc\\n\\u52a0\\u6c27\\u9176\\u662f TET1\\u3001TET2\\u6216TET3\\u3001\\u6216\\u5176\\u540c\\u7cfb\\u7269\\u3002  \\n42\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 2\\u62164\\u81f340\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u7528\\u8461\\u8404\\u7cd6\\u6216\\u7ecf\\u4fee\\u9970 \\n 5PP218006PF-OA1\\n\\u7684\\u8461\\u8404\\u7cd6\\u6765\\u4fee\\u9970 5hmC\\u3002 \\n43\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 42\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u901a\\u8fc7\\u5305\\u62ec\\u5c06\\u6838\\u9178\\u5206\\u5b50\\u4e0e \\u03b2-\\u8461\\u7cd6\\u57fa\\u8f6c\\n\\u79fb\\u9176\\u548c\\u8461\\u8404\\u7cd6\\u6216\\u7ecf\\u4fee\\u9970\\u7684\\u8461\\u8404\\u7cd6\\u5206\\u5b50\\u4e00\\u8d77\\u5b75\\u80b2\\u7684\\u65b9\\u6cd5\\u6765\\u4fee\\u9970 5hmC\\u3002 \\n44\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 43\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u8461\\u8404\\u7cd6\\u5206\\u5b50\\u662f\\u5c3f\\u82f7\\u4e8c\\u78f7\\u9178\\u8461\\u8404\\u7cd6\\u5206\\n\\u5b50\\u3002  \\n45\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 44\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u7ecf\\u4fee\\u9970\\u7684\\u8461\\u8404\\u7cd6\\u5206\\u5b50\\u662f\\u7ecf\\u4fee\\u9970\\u7684\\u5c3f\\n\\u82f7\\u4e8c\\u78f7\\u9178\\u8461\\u8404\\u7cd6\\u5206\\u5b50\\u3002  \\n46\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 3\\u81f340\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6c27\\u5316\\u4f5c\\u7528\\u9009\\u62e9\\u6027\\u5730\\u6c27\\n\\u53165hmC\\u6b8b\\u57fa\\u3002   \\n47\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 3\\u81f340\\u621646\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u6c27\\u5316\\u5242\\u662f\\u5316\\n\\u5b66\\u6c27\\u5316\\u5242\\u3002    \\n48\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 3\\u81f340\\u621646\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u6c27\\u5316\\u5242\\u662f\\u8fc7\\n\\u948c\\u9178\\u76d0\\u6c27\\u5316\\u5242\\u3002   \\n49\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 3\\u81f340\\u621646\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u6c27\\u5316\\u5242\\u5305\\u62ec\\nKRuO 4\\u3002 \\n50\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u9274\\u5b9a DNA\\u5206\\u5b50\\u4e2d\\u7684 5mC\\u7684\\u975e\\u8bca\\u65ad\\u65b9\\u6cd5\\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\uff1a  \\n(a)\\u4f7f\\u8854\\u63a5\\u5b50\\u4e0e DNA\\u5206\\u5b50\\u8fde\\u63a5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\uff0c\\n\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff1b  \\n(b)\\u7528\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u8fde\\u63a5\\u7684 DNA\\u5206\\u5b50\\uff1b  \\n(c)\\u4f7f\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u5206\\u5b50\\u4e0e\\u5f15\\u7269\\u6742\\u4ea4\\uff1b   \\n(d)\\u5ef6\\u4f38\\u7ecf\\u6742\\u4ea4\\u7684\\u5f15\\u7269\\u4ee5\\u4ea7\\u751f\\u53cc\\u94fe DNA\\uff1b\\u548c  \\n(e)\\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94fe DNA\\u4ee5\\u4ea7\\u751f RNA\\uff1b \\n(f)\\u9006\\u8f6c\\u5f55 RNA\\u4ee5\\u4ea7\\u751f DNA\\uff1b \\n(g)\\u5bf9DNA\\u8fdb\\u884c\\u6d4b\\u5e8f\\u5e76\\u5c06\\u7ecf\\u6d4b\\u5e8f\\u7684 DNA\\u4e2d\\u7684 5mC\\u9274\\u5b9a\\u4e3a\\u5e8f\\u5217\\u4e2d\\u7684 \\u201cC\\u201d\\u3002 \\n51\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u9274\\u5b9a\\u5305\\u542b DNA\\u5206\\u5b50\\u7684\\u6837\\u672c\\u4e2d\\u7684\\u7532\\u57fa\\u80de\\u5627\\u5576\\u7684\\u65b9\\u6cd5\\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\n\\u5305\\u62ec\\u6267\\u884c\\u6743\\u5229\\u8981\\u6c42 1\\u81f350\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\u3002   \\n 6PP218006PF-OA1\\n52\\u3001\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u7684\\u8854\\u63a5\\u5b50\\u5728\\u5236\\u5907\\u7528\\u4e8e\\u9274\\u5b9a\\u6765\\u81ea\\u60a3\\u8005\\u7684 DNA\\u5206\\u5b50\\n\\u4e2d\\u7684 5mC\\u548c/\\u6216\\u7528\\u4e8e\\u8f85\\u52a9\\u60a3\\u8005\\u8bca\\u65ad\\u6216\\u9884\\u540e\\u7684\\u8bd5\\u5242\\u76d2\\u4e2d\\u7684\\u7528\\u9014\\uff0c\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\n\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de \\u5627\\u5576\\uff0c\\u5176\\u4e2d\\u6267\\u884c\\u6743\\u5229\\u8981\\u6c42 1\\u81f350\\u4e2d\\u4efb\\u4e00\\u9879\\u4e2d\\u9650\\n\\u5b9a\\u7684\\u6b65\\u9aa4\\uff0c\\u5176\\u4e2d\\u4ece\\u60a3\\u8005\\u7684\\u751f\\u7269\\u6837\\u672c\\u63d0\\u4f9b\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u3002  \\n53\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u8bc4\\u4f30\\u5355\\u7ec6\\u80de\\u7684\\u975e\\u8bca\\u65ad\\u65b9\\u6cd5 \\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\u6267\\u884c\\u6743\\u5229\\u8981\\u6c42 1\\u81f3\\n33\\u621637\\u81f350\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u4ece\\u5355\\u7ec6\\u80de\\u7684\\u57fa\\u56e0\\u7ec4 DNA\\u63d0\\u4f9b DNA\\u5206\\u5b50\\u3002  \\n54\\u3001\\u4e00\\u79cd\\u5305\\u542b DNA\\u8854\\u63a5\\u5b50\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0 DNA\\u8854\\u63a5\\u5b50\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\n\\u52a8\\u5b50\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u7684\\u80de\\u5627\\u5576\\u662f\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u3002  \\n55\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u62ec\\u8fde\\u63a5\\u9176\\u548c /\\u6216\\u8fde\\u63a5\\u9176\\n\\u7f13\\u51b2\\u6db2\\u3002  \\n56\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u621655\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u3002  \\n57\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f357\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u62ec\\u4e0e\\u6240\\n\\u8ff0\\u8854\\u63a5\\u5b50\\u4e92\\u8865\\u7684\\u5f15\\u7269\\u3002  \\n58\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f357\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u62ec\\ndNTP\\u3002 \\n59\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f358\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b DNA\\n\\u805a\\u5408\\u9176\\u3002  \\n60\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f358\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u62ec\\u65e0\\u6838\\n\\u9178\\u9176\\u6c34\\u3002  \\n61\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f360\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u86cb\\u767d\\n\\u9176\\u3002  \\n62\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f361\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b RNA\\n\\u805a\\u5408\\u9176\\u3002  \\n63\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f362\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c \\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b NTP\\u3002 \\n64\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f363\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u6c27\\u5316\\n\\u5242\\u3002  \\n65\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f364\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u53cc\\u52a0 \\n 7PP218006PF-OA1\\n\\u6c27\\u9176\\u3002  \\n66\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 64\\u81f365\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u542b\\u6709\\n\\u7f9f\\u80fa\\u57fa\\u3001\\u80bc\\u57fa\\u6216\\u9170\\u80bc\\u57fa\\u7684\\u5316\\u5408\\u7269\\u3002  \\n67\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f366\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u542b\\u6709\\n\\u80fa\\u57fa\\u7684\\u5316\\u5408\\u7269\\u3002  \\n68\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f367\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b 3\\u2019\\u672b\\n\\u7aef\\u5c01\\u95ed\\u5206\\u5b50\\u3002  \\n69\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f368\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b SPRI\\n\\u73e0\\u3002  \\n70\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f369\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u9006\\u8f6c\\n\\u5f55\\u9176\\u3002  \\n71\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f370\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u8461\\u8404\\n\\u7cd6\\u6216\\u7ecf\\u4fee\\u9970\\u7684\\u8461\\u8404\\u7cd6\\u3002  \\n72\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f371\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b \\u03b2-\\u8461\\n\\u7cd6\\u57fa\\u8f6c\\u79fb\\u9176\\u3002  \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"ocr_text\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"--- Page 1 OCR ---\\nUnrren States Patent anp TRADEMARK OFFICE\\n\\n  \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nNoon Rose Plvgh US LLP a\\n\\nSan Jain Blvd Tan RECT OR\\n\\nSuite 1100\\n\\n\\u2018Nasi, TX 7701 rane Eo\\n\\nPlease find below and/or attached an Office communication concerning this application or proceeding.\\n\\n\\u2018The time period for reply, if any, is set inthe attached commi\\n\\n \\n\\ntation,\\nNotice of the Office communication was sent electronically on above-indicated \\\"Notification Date\\\" to the\\n\\nfollowing e-mail address(es):\\noipdocke@ nortoarsefulbightcom\\n\\f\\n--- Page 2 OCR ---\\n \\n\\n\\u2018Rpplcaion Wo. ephcanisy\\n\\n \\n\\n#77997,810 ESSER-KANI et\\nOffice Action Summary Traminer Ce\\nNICOLE BABSON ve (Yes\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nee a\\nwoven\\n\\neres arzronyrenco fon ens $e Ye SCH FROMTHE AA\\non eaeseansec \\\"\\n\\nEES seSh erate eteenermtereterrar\\n\\nStatus\\n1)R_Responsive to communications) fled on 7/8/24,\\n(DA declaration(s)atidavi(s) under 37 CFR 1.190(b) wasiwore flog on __\\n\\n2a)0) This action is FINAL. This action is ron-fnal\\n\\n3)0) An election was made by the applicant in response to a restriction requirement set forth during the interview\\n\\u2018on _ the restriction requirement and election have been incorporated into this action\\n\\n410 \\u2018Since this application isin condtion for alowance except for formal matters, prosecution as to the merits is\\n<losed in accordance with tho practice undor Ex parte Quayle, 1935 C.D. 11, 453 0.G. 213.\\n\\n      \\n\\n \\n\\n \\n\\nDisposition of Claims*\\n5) & Claim(s) 1.3-46-10,12,14,17,21-22.26 48 and 5051 is/are pending inthe application.\\n5a) Of the above clakn(s)4,6,8.12,17,26 and 51 is/are withdrawn trom consideration,\\n6) \\u00a9 Claims) _islare alowed\\n7) & Claim(s) 13,7,9-10,14.21-22,48 and 50 is/are relected\\n8) CO) Claims) __isvare objected to.\\n9) O Claims) ___ are subject to restriction andior election requirement\\n*ttany claims have been detemnined alloable. you may be eigble to benef rom the Patent Prosecution Highway program at\\nparicpatngntotecual propery ofSo forthe corresponing applcation. For more information, lease\\nbuaashiacovnstenisint eventsootlndesisa or send an Inquey to BPAtsedbackuspto.oo4.\\nApplication Papers\\n10)C) The specification is objacted to by the Examiner.\\n11)@ The drawing(s) fled on 6/4/21 ise: a)[) accepted or byZ; objected to by the Examiner.\\n\\u2018optical may no request ths any objection to the drawings) be hed insbayance. S20 37 CFR 1.85(ah\\nFeplacemor raving sheets incluting the comectonis required i he awings) is cbjeted to. See 37 CFR 1.12114),\\nPriority under 35 US.C. \\u00a7 119\\n12)C) Acknowledgment is made ofa claim for foreign priorty under 35 U.S.C. \\u00a7 119(a)() oF).\\nCertitied copies:\\na0 Al bj) Some\\\" @)C) None ofthe:\\n1.0. Certified copies ofthe priority documents have been received.\\n2.0) Certed copies ofthe prionty documents have been received in Application No.\\n3.0. Copies ofthe certiod copies o he priority documents have been received inthis National Stage\\napplication from the Intemational Bureau (PCT le 17.2().\\nc0 the atached detaied Olen action ra st ofthe cated copies not recetved.\\n\\n \\n\\n \\n\\n \\n\\nAacrmenn)\\n1) Notee t Rerenoes tes PTO 82) 8) ern Surman T0418)\\n\\nns Pree Ne) Dae\\n2 oan Dare Steere (PIOSADRA anderPFOSBEED) \\u2014 yy\\n\\n \\n\\n \\n\\n \\n\\n \\n\\f\\n--- Page 3 OCR ---\\nApplication/Control Number: 17/837,610 Page 2\\n\\u2018Ant Unit: 1619\\n\\nNotice of Pre-AIA or AIA Status\\n\\u2018The present application, filed on or after March 16,2013, is being examined under the\\nFirst inventor to file provisions of the AIA.\\n\\nDETAILED ACTION\\n\\n \\n\\n(Claims 1, 3,4, 6-10, 12, 14, 17,21,22, 26,48, 50 and are pending.\\n\\nElection/Restrictions\\nApplicant's election without traverse of the Invention of Group I, claims 1, 3.4, 6-10, 12,\\n\\n14,17,21\\n\\n \\n\\n26, 48,50 and $1, andthe species of\\n\\n{50 asthe NFKB inhibitor,\\n\\n \\n\\nCpe asthe species of adjuvant,\\nantigenic fragments of HIV asthe addtional agent, and\\n~ administration ofthe inhibitor and adjuvant inthe same composition;\\nin the reply Filed on 7/8/24 is acknowledged\\nClaims, 6,8, 12.17.26, and $1 are withdrawn as not being dirctedto the elected species\\n(Cains 1,3,7,9, 10, 14,21, 22,48 and $0 are under consideration tothe extent thatthe\\nmethod comprises SNSO asthe NEKB inhibitor, Cpgas the species of adjuvant antigenic\\nfragments of HIV asthe addtional agent, and administration of the inhibitor and adjuvant in the\\n\\nsame composition.\\n\\nInformation Disclosure Statement\\n\\u2018Acknowledgement is made of Applicant's information disclosure statements (IDS)\\n\\nsubmited on 9/17/21, 10/21/12and 1 1/6/23 . The submissions are in compliance with the\\n\\f\\n--- Page 4 OCR ---\\nApplication/Control Number: 17/837,610 Page 3\\n\\u2018Ant Unit: 1619\\n\\nprovisions of 37 CFR 1.97. Acconiingly, the information disclosure statement has been\\n\\n\\u2018considered by the examiner,\\n\\nDrawings\\n\\n\\u2018The drawings are objected to because in Figure 3M the labels along the x-axis are\\nunreadable.\\n\\n(Corrected drawing sheets in compliance with 37 CFR 1.121 (@) are required in reply to\\nthe Office action to avoid abandonment ofthe application. Any amended replacement drawing\\nsheet should includeall of the figures appearing on the immediate prior version ofthe sheet,\\neven if only one figure is being amended. The figure or figure number of an amended drawing\\n\\nshould not be labeled as \\u201camended.\\u201d\\n\\n \\n\\nFa drawing figures tobe canceled, the appropriate Figure\\ntnust be removed from the replacement sheet, and where necessary, the remaining figures must\\nbbe renumbered and appropriate changes madeto the brief description of the several views ofthe\\n<rawings for consistency. Additional replacement sheets may be necessary to show the\\nrenumberingof the remaining figures. Each drawing shoot submited afterthe Filing date ofan\\napplication mustbe labeled in the top margin as ither\\u201cReplacement Sheet\\u201d o*New Sheet\\u201d\\npursuantvo 37 CFR 1.1214, Ifthe changes are not acceped by the examine, the applicant will\\nbe notified and informed of any requredcomrectiveaeton in the next Office action. The\\n\\nobjection tothe drawings will not be held in abeyance.\\n\\n\\u2018Claim Rejections - 35 USC \\u00a7 112\\n\\n\\u2018The followingis a quotation of 35 U.S.C. 11206):\\n\\f\\n--- Page 5 OCR ---\\nApplication/Control Number: 17/837,610 Page +\\n\\u2018Ant Unit: 1619\\n\\n \\n\\n(B) CONCLUSION. \\u2014The specification shall conclude with oneor more claims particularly\\npointing out and distinctly claiming the subject matter which the inventor or a joint inventor\\nregards asthe invention\\n\\n\\u2018The following isa quotation of 35 U.S.C. 112 pre-AIA), second paragraph:\\n\\n\\u2018The specification shall conclude with one or more claims particularly pointing out and distinctly\\nclaiming the subject matter which the applicant regards as his invention.\\n\\n \\n\\n(Claim 48 rejected under 35 U.S.C. 112(b) oF 38 U.S.C. 112(pre-AIA), second\\nparagraph, as being indefinite For ailing to particularly point out and disinety elim the\\nsubject mater which the inventor ora joint inventor, or For pre-ATA the applicant regards as the\\n(Cuim 48 includes reference to acanceledclaim. Therefore, the metesand bounds of\\nthe claim eannotbe determined because itis unclear wha s comprised inthe composition to be\\n{administeed, is noted that canceled claim 28 included only & NFKB inhibitor and an adjuvant\\n\\nina composition, andif claim 48 was to be amended to recite the limitations from canceled chim\\n\\n28, then claim 48 would bea duplicate of claim 21\\n\\nClaim Rejections - 35 USC \\u00a7 103\\n\\u2018The following is a quotation of 35 U.S.C, 103 which forms the basis forall obviousness\\nrejections set forth inthis Office action:\\n\\nA pact fora claimed iaventon may not he obsined, ctwidstanding th the cial invention a0\\n\\u2018envealy dncloed a tfc in scton 1020 thie i the derenoss hereon the Cm\\nInvenio ane poor tar such ha the lama invention av whole would hve bee evs\\nfore the fective ing eof te climat nvesoe wo a eson ving onary sil new 0\\n\\u2018his ine cimed invention pean Pabiy shall be nega y he mann in wich\\ninsemon wn ak\\n\\n \\n\\f\\n--- Page 6 OCR ---\\nApplication/Control Number: 17/837,610 Page 5\\n\\u2018Ant Unit: 1619\\n\\n\\u2018The factual inquiries sot forthin Graham v, John Deere Co., 383 U.S. 1, 148 USPQ.459\\n(1966), that are applied for establishing a background for determining ob viousness under 35\\nUS.C. 103 are summarized as follows\\n\\n1. Determining the scope and contents of the prior an.\\n\\n \\n\\nAscertaining the differences between the priorant and the elaimsat issue\\n3. Resolving the level of ordinary skill in the pentinent art\\n4. Considering objective evidence present inthe application indicating obviousness oF\\nnonobviousness\\n\\u2018Claims 1,3,7,9, 10, 14, 21,22, 48 and 50 are rejected under 38 U.S.C. 103 as being\\n\\n\\u2018unpatentable over Petrovsky (US 2014/0314739; cited in IDS) in view of Hawiger et al. (US.\\n2004/0235746; cited in IDS).\\n\\nPetrov sky teach a vaccine composition comprising inulin particles for use in the\\n\\n \\n\\nreduction orinhibition of inflammation, andor for eating or preventing inflanmatey disease,\\nina subject (\\u00a9. abstract, Petrosky teaches thatthe composition compriscs an NFKB inhibitor\\nand an adjuvant, which may be CpG (\\u20ac-\\u00a2 paragraphs 0047, 0048, 0075; Claim 8), Perovsky\\nteaches that the components are administered together (6. paragraph 0223)\\n\\nPetrov sky does not teach that the NFKB inhibitor is SNSO. This\\n\\n \\n\\nmade up for by the\\nteachings of Hawiger tal.\\n\\nHawigeret al teach the delivery of biologically active molecules, such as peptides, into\\n\\n \\n\\nthe interior of cell by administering the ces a complex comprising the molecule linked to sn\\nimporation competent signal peptide (abstract). Hawiger tal. each thatthe peptide isthe\\nNE-KB inhibitor SNSO (c.g. paragraphs 0027: Examples)\\n\\nRegarding Claims 1, 3,7,21,and 48, it would have been obvious to one of ordinary skill\\n\\ninthe arta\\n\\n \\n\\nime of filing to select the SNSO of Haviger etal as the NF&B inhibitor of the\\n\\n\\u2018compositions of Petrovsky. I! would have been obvious to one of ordinary skill in the art vo\\n\\f\\n--- Page 7 OCR ---\\nApplication/Control Number: 17/837,610 Page 6\\n\\u2018Ant Unit: 1619\\n\\n\\u2018combine the elements as claimed by known methods with no change in their respective\\n\\nfunctions, and the combination yielding nothing more than predictable results, One of ordinary\\n\\n \\n\\nskill in the art would have predicted success as both Petrovsky and Hawigerare directed to\\nvaccines comprising NFKB inhibitors. Simple substitution of one known element for another to\\n\\u2018obtain predictable results is obvious.\\n\\nRegarding Claims9, 10, 14, and 50, Petrovsky further teach the inclusion of HIV.\\n\\nantigens (eg. paragraph 0210).\\n\\n \\n\\nRegarding Claim 22, Potrovsky teaches that the composition may be administered to an\\n\\n \\n\\n\\u2018adult human subject i a range of | to 100 mg per dose, such as 220 mg per dose, which is\\n\\n \\n\\nwithin the e Teast 12 mg\\\" (e.g. paragraph 0167).\\n\\n \\n\\ned range 0\\n\\nConclusion\\n\\nNo claimis allowed.\\n\\n\\u2018Any inquiry concerning this communication or earlier communications from the\\n\\u2018examiner should be directed to NICOLE PLOURDE BABSON whose telephone number is,\\n($71)272-3085, The examiner ean normally be reached M-Th 8-4:30; F 8-12:30.\\n\\nExaminer interviews are available via telephone, in-person, and video conferencing using,\\na USPTO supplied web-based collaboration tool. To schedule an interview, applicant is\\nencouraged t0 use the USPTO Automated Interview Request (AIR) at\\nupswww.uspto.gov/interviewpractice.\\n\\nattempts to reach the examinerby telephone are unsuccessful, the examiner's\\n\\n \\n\\nsupervisor, David Blanchard can be reached on 571-272-0827, The fax phone number forthe\\n\\n\\u2018organization where this application or proceeding is assigned is $71 -273-8300.\\n\\f\\n--- Page 8 OCR ---\\nApplication/Control Number: 17/837,610 Page 7\\n\\u2018Ant Unit: 1619\\n\\nInformation regarding the status of published or unpublished applications may be\\n\\u2018obtained from Patent Center, Unpublished application information in Patent Center is available\\n\\nwo nt submissions in Patent Center, visit:\\n\\n \\n\\nistered users, To file and manage pa\\n\\n \\n\\nhups:/patentcenterasplo gov. Visit hupss/www.uspo.gov/patentvapply/paten-center for more\\ninformation about Patent Center andhips:/iwww asplo.gov/patens/docx for information about\\nfiingin DOCX format, Fo additional questions, contact the Electtonic Business Center (EBC)\\n81 866-217-9197 (ol-fee). If you would like assistance froma USPTO Customer Service\\n\\nRepresentative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000,\\n\\nINICOLE P BABSON\\u2019\\nPrimary Examiner, Ant Unit 1619)\\n\\f\\n--- Page 9 OCR ---\\nReceipt date: 11/06/2023 17/337,610 ~ Gau: 1619\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nPage Loft\\nForm PTO-1449 massa) \\u2018Aly. Docket N Seria No\\n\\u2018ARCD Pe TUS/O011 70166 171337610\\n{Lis of Patents and Publications for Applicant's [Applicant\\n\\u2018THE UNIVERSITY OF CHICAGO\\nINFORMATION DISCLOSURE STATEMENT\\nGroupe\\n(ese tec acon) Not Yet Auigned\\nTS: Paton Documents orsign Patent Documents Other Art\\nSee Page! See Page 1 See Pagel\\nU.S. Patent Documents\\nExam.] Ref. | Document | Date Name\\nTit. | Des. | Number\\no\\nForeign Patent Documents\\nExam.] Ref. | Document | Date Country Language\\nTait | Des. | Number\\na\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nOther Art (Including Author, Title, Date Pertinent Pages, Etc.)\\n\\nExam. | Ref, Citation\\ninit. | Des,\\n\\n \\n\\n \\n\\nKHALID etal, \\u201cAntnyperalgesic Properties of Honokol in Intammatory Pain Models\\n\\n61 _| by Targeting !NF-\\u00abB and Nrf2 Signaling.\\\" Front Pharmacol, 0(140) 1-18, March\\n2018.\\n\\n\\u2018G2 _| Die Communication issued a Chinese Patent Applcalon No 207980001407.3,\\ndated October 14, 2023. English transtaton) (Attorney Docket No. ARCD.PO677CN)\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nEXAMINER: NICOLE \\u00ae BAB\\n\\n   \\n\\n07/24/2024\\n\\n \\n\\n       \\n\\nINFORMATION DISCLOSURE STATEMENT \\u2014 PTO-1449 (MODIFLED)\\n\\nALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /N.P.\\n\\n \\n\\f\\n--- Page 10 OCR ---\\nReceipt date: 10/21/2022 17/337,610 ~ Gau: 1619\\n\\n \\n\\nPage Loft\\n\\n \\n\\nForm PTO-1449 masse \\u2018ity Docket No Serial Nes\\n17337610\\n\\n \\n\\n \\n\\nst of\\n\\n \\n\\nats und Publications for Applicant's [Applicant\\n\\u2018THE UNIVERSITY OF CHICAGO\\nINFORMATION DISCLOSURE STATEMENT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nling Date: \\u2018Group:\\n(Caeser sheets taney) \\u2018Juve 3, 2021 Not yet assigned\\nTUS. Patent Documents reign Patent Documents Other Art\\nSee Page 1 See Page 1 See Page 1\\n\\n \\n\\n \\n\\n \\n\\nU.S. Patent Documents\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nExam.] Ret. | Document | Date Name\\nInit. | es. | Number\\nA | Poowoess7as | riesioe Hawiger etal\\nForeign Patent Documents\\nExam. | Ret. | Document | Date Country Language\\ninit. | Des. | Number\\nBi | wo 2008083787 | 017/08 WIPO. English\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nOther Art (Including Author, Title, Date Pertinent Pages, Etc.)\\n\\n\\u2018Exam. | Ret \\u2018Ghation\\nInit | Des,\\n\\n \\n\\n \\n\\n\\u2018Exiended Eurepean Search Report issued in corresponding European Application No\\n\\n+19882608.1,datod Soptomber 26, 2022 (Atorney Docket no. ARCD PO677EP),\\n\\nKimani eta. \\u201cimproving the Adjuvant of Small Molecule immune Potentators\\n\\nc2_ | Using Covatondy Lnkod NF-xf Modulators\\\" ACS Mociinal Chomistry Letiors 202%,\\n5219), pos 1465-1448,\\n\\n\\u2018Singh otal, \\u201cCapsaicin (@-methy/-N-vanily-6-nonenamice) isa potent nhbitor of\\n\\n.\\u00a23_| nucear vanscrption factor kappa B activation by dvorse agonts.\\\"J Immuno} 1996;\\ntras12 4020,\\n\\nce\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n  \\n\\nINFORMATION DISCLOSURE STATEMENT \\u2014 PTO-1449 (MODIFIED)\\n\\n(ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /N.P.B/\\n\\f\\n--- Page 11 OCR ---\\nReceipt date: 09/17/2021 17/337,610 ~ Gau: 1619\\n\\n \\n\\nPage Lof3\\nSerial Nes\\nWas7610\\n\\n \\n\\nForm PTO-1449 gman\\n\\n  \\n\\n \\n\\nst of\\n\\n \\n\\nats und Publications for Applicant's [Applicant\\n\\u2018THE UNIVERSITY OF CHICAGO\\nINFORMATION DISCLOSURE STATEMENT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nling Date: \\u201cGroupe\\n(Coe seret ste acer) \\u201cJone 32021 168s\\n\\nTUS. Patent Documents orsign Patent Documents \\u2018Other Art\\nSee Page 1 See Page 1 See Page 13,\\n\\n \\n\\n \\n\\n \\n\\nU.S. Patent Documents\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nExam. | Ret. | Document | Date Name\\ntnt\\u201d | Des. | Number\\n\\nai] sorrsar | oaaans Thomas etal\\n\\nna] Poogor49420 | 06/1109 Raccerstot otal\\n\\nCe Porwsky\\n\\nForeign Patent Documents\\n\\nRet. | Document | Date Country Language\\n\\nDes. | \\u201cNumber\\n\\n81] sPaoosi94ae5 | 0721/05 Japan \\u201capanoso (English Abad\\n\\n22 | wOzoosto7ast | 107208 wiPo Engish\\n\\n2 | wozooas:296 | 1217/09 wiPo Engish\\n\\n \\n\\n \\n\\nOther Art (Including Author, Title, Date Pertinent Pages, Etc.)\\n\\nRet, \\u2018hation\\nDes.\\n\\n \\n\\n \\n\\n \\n\\nBachor etal, \\u201cThe NF-KB Pathway as a Potential Target or Autolmmune Disease\\n\\u201cTherapy.\\u201d Cur. Pharm, Dos. 2004, 10(23), 2827-37.\\n\\n\\u2018Gz_| Bacuote et a. Function and Actvaton of NF-kappa inthe Immune Syiom\\u2122 Annu\\nFee. lmmunol 1986, 12, 141-179.\\n\\nBode ofa, \\\"CpG DNA as a vaccine adjuvant\\\" Expert Rev. Vaccines 2011, 10,498.\\n\\nce\\n\\n \\n\\n \\n\\n \\n\\nisn\\n\\u2018ca Cotman etal \\\"Vaccine Adjuvants Putting inate immunity to Wome Immunity 2070,\\n33, 492.503,\\n\\n \\n\\n \\n\\n \\n\\n    \\n\\n      \\n\\nINFORMATION DISCLOSURE STATEMENT \\u2014 PTO-1449 (MODIFIED)\\n\\n(ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /N.P.B/\\n\\f\\n--- Page 12 OCR ---\\n \\n\\n+ 09/27/2023 17/337,610 ~ au: 1619\\n\\nPage 2063\\nSerial Nes\\n17337610\\n\\n \\n\\nForm PTO-1449 gman\\n\\n \\n\\n \\n\\nst of\\n\\n \\n\\nsents und Publications for Applicant's\\n\\u2018THE UNIVERSITY OF CHICAGO\\nINFORMATION DISCLOSURE STATEMENT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nling Date: \\u201cGroupe\\n(Coe seret ste acer) \\u201cJone 32021 168s\\n\\nTUS. Patent Documents orsign Patent Documents \\u2018Other Art\\nSee Page 1 See Page 1 See Page 13,\\n\\n \\n\\n \\n\\n \\n\\nOther Art (Including Author, Title, Date Pertinent Pages, Etc.)\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nExam. | Ret. ation\\nInit. | Des,\\n\\n\\u2018cs _| Gimmore etal. \\u201cInhibtors of NFB signaling: 785 and courting\\\" Oncogene 2006,\\n23151), 6867-99,\\nInternational Search Roport and Writon Opinion issued in Coresponding PCT\\n\\n66 | Application No. PCT/US2019/064888, datad March 2, 2020 (Atorney Docket No.\\n\\u2018ABCD .P0s77WO},\\n\\n\\u2018G7 _| Kerdler etal, \\u201cTherapeutic targeting of imate mmurity with Tol-ikerecepior agonists\\n\\u2018ang antagonists.\\u201d Nat Med 2007, 13, 552589,\\n\\n\\u2018ca _| Kinman ot al, \\u201cCpG oligonucleotides improve the protecive immune response\\ninducod by the lconsed anthrax vaceine\\u201d Ann. N \\u00a5 Acad Sel-2006, 1082, 137-180.\\n\\n\\u2018ca _| Kilog: AM. \\u201cToke recoptor 9 (TLRS) agonists in the weatment of cancer Oncogene\\n2008, 27. 161-167.\\n\\ncro | bow etal, \\\"New adjuvants for human vaccines\\u201d Gur. Opn. immunol. 2010, 2,411\\n\\n416\\n\\n\\u2018Moser eal, immune protocton for increased safety and improved protection of\\n11 | vaccinos by NF-KB moduator\\u2122bioRv,10 Doc. 2078, 20 pagos, DOA 489732; do\\npsd \\u2018Accessed 17 March 2019,\\n\\nPlank, M. 6's. \\u201cInhblors of AP-1 and NF-kappa B modiaiod vansorplional acivaton\\n12_| merapeute potential in autoimmune diseases and structural dversiy\\u201d Cur. Med\\nChem. 2002, 92) 219-227.\\n\\n\\u2018Sinchoz Poris otal, \\u201cSyrthos's of honokol analogues and evaluation of hol\\n\\nCc13_| modulating acson of VEGF protein secretion and loomerase slated gone\\n\\u2018oxprossions\\\" Chom Bio Drug Des 2017, 89, 877-584\\n\\n\\u2018van Duin etal, \\u201cTriggering TLR signaling in vaccination\\u201d Trends Immunol 2006, 27,\\n\\n4955,\\n\\n\\u2018Wang otal, Distinct Roles of iferont NF-KB Subunits Regulating Infarnmatory\\n15 | and T Coll Sumulatory Gone Expression in Dendrite Cols\\u201d J. mmunol. 2007, 178,\\n6777-6788,\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\ncn\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n      \\n \\n\\n;AMINER! /NICOLE P BABSON/\\n\\n    \\n\\nINFORMATION DISCLOSURE STATEMENT \\u2014 PTO-1449 (MODIFIED)\\n\\n(ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /N.P.B/\\n\\f\\n--- Page 13 OCR ---\\nReceipt date: 09/17/2021 17/337,610 ~ Gau: 1619\\n\\nPage 303\\n\\n \\n\\nForm PTO-1449 gman Serial Nes\\n\\nWas7610\\n\\n \\n\\n \\n\\nst of\\n\\n \\n\\nats und Publications for Applicant's [Applicant\\n\\n\\u2018THE UNIVERSITY OF CHICAGO\\nINFORMATION DISCLOSURE STATEMENT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nling Date: \\u201cGroupe\\n(Coe seret ste acer) \\u201cJone 32021 168s\\n\\nTUS Patent Dosa orsign Patent Documents \\u2018ther Art\\nSee Page 1 See Page 1 See Page 13,\\n\\n \\n\\n \\n\\n \\n\\nOther Art (Including Author, Title, Date Pertinent Pages, Etc.)\\n\\nExam. | Ret ation\\nInit. | Des,\\n\\n \\n\\n \\n\\n\\u2018We etal, \\u201cPolysaccharides trom Diosoorea (Shan Yao) and Other Phytochomicals\\nC616 | Enhance Antitumor Etfocts Inducod by DNA Vaccine Against Melanoma\\u201d Journal of\\nTradtonal and Complementary Medicine 2014, 4, \\u00ab2-48.\\n\\niz | Xela. NFB, an active player in human cancers.\\u201d Cancer immuno. Res, 2014, 2,\\n823.830.\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n           \\n\\n \\n\\nINFORMATION DISCLOSURE STATEMENT \\u2014 PTO-1449 (MODIFIED)\\n\\nALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /\\u00a5.P.B/\\n\\f\\n\",\n          \"--- Page 1 OCR ---\\nv.FUNER EBBINGHAUS FINCK HANO\\n\\n \\n\\n \\n\\n \\n\\nE-Mail: laurie. steliman@nortonrosefullbright.com\\nCC E-Mail: gina shishima@nortonrosofullbright.com'; DR ncount w rows\\n\\u2018aoipdocket@nortonrosefullbright.com; Di ican cannacrien\\nrichard ortiz@nortonrosefullbright.com\\n\\n \\n\\n \\n\\nNorton Rose Fulbright a\\n98 San Jacinto Blvd. CUnontakeb we\\nSuite 1100\\n\\n\\u201cAustin, TX 78701-4255 nussia Moscow\\nUNITED STATES OF AMERICA, LER Pasha\\n\\n\\u2018August 7, 2024 Mowoous Uueanmanran\\n\\nEurasian Patent No, 04662\\n\\n\\u2018Methods and compositions comprising Staphylococcus protein A (SPA) voriants\\n\\n\\u2018The University of Chicago\\n\\nYour ref : ARCD.PO676EA/1001187627 (J84: SPC61BBEAEAT1) - Our ref.: EAAA-141303\\n\\n\\u2018SONFIRATION OF PAYMENT\\n\\n15\\\" annuities Due Date: July 13, 2024\\nDear Mr Ortiz,\\n\\nThe 1%5% annuities have been paid in time. The present protective right has been\\nmaintained in Armenia, Azerbaijan, Belarus, Kyrgyz Republic, Kazakhstan, Russian\\nFederation, Tajikstan, Turkmenistan. The confirmation of payment is enclosed.\\n\\n\\u2018The next 6\\\" annuity fee will become due on May 13, 2025.\\n\\nVery truly yours,\\n-, FONER EBBINGHAUS FINCK HANO\\n\\nEnclosure:\\nConfirmation\\n\\f\\n--- Page 2 OCR ---\\n \\n\\nATTIMRaO\\n\\n@ EBPA3IICKAS MATEHTHAS OPTAHV3AUMS (EANIO)\\nEurasian Patent Organization\\n\\n\\u2014\\u2014 \\u00a2 \\u2014\\u2014\\u2014\\u2014\\nEBPASMVACKOE MATEHTHOE BEAOMCTBO (EANB)\\nEurasian Patent Otlice\\n\\n \\n\\n \\n\\nNe 141046662-21 ry Becennuxomy MB\\nor 46.07.2024\\nQJIEKTPOHHO |\\n\\nYaexomaenne o suecennu B Peectp enpasniicknx marenTon cBexennii\\n\\u00a9 NoutepaKANMM eBpasHiteKoro NaTeHTA B CHIE\\n\\n \\n\\n[Homep narewra 046662 ara nnavexa 12/07/2024\\nHomepsaxu 202193110\\n\\n \\n\\n\\u2018Cpox oepemiore 1370572025\\nante\\nIMarewronaarenen [13E}OHMBEPCHTH 0 4HKATO (US)\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nB Peectp espasniicxnx narenton sitecent cpeaenia 06 yniiare roxowolt now\\nsa 1-5 roam aciicrsna narewra m noanepxanmm ero B cine B cneayioUUX\\nHorosapusaiouuixcs rocyaapersax (omuevenss 6 xiemxax):\\n\\nam Maz Rey RKz Rko Ro rm Bru Op\\n\\nC.Baitaxon \\u2014\\n(Ores peectpa enpaanicxix nareston 3 ===.\\n\\nCenmeon TOCRCICTSEnT\\n\\u2018Saree CNsBafaaise C\\neinen 442 20084042 2028\\n\\n \\n\\n++1(495)411-61-61%415\\n\\f\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 95
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "export_folder=\"/content/drive/My Drive/polsky file split/\"\n",
        "output_path=os.path.join(export_folder,\"final_df.csv\")\n",
        "final_df.to_csv(output_path,index=False)"
      ],
      "metadata": {
        "id": "rJ6ERaobsVrj"
      },
      "execution_count": 100,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "pAAoLOEqJoJr"
      },
      "execution_count": 89,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "# exam export quality"
      ],
      "metadata": {
        "id": "pKTy02qjzx1D"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "export_folder=\"/content/drive/My Drive/polsky file split/\"\n",
        "output_path=os.path.join(export_folder,\"final_df.csv\")\n",
        "df=pd.read_csv(output_path)\n",
        "df.head()\n",
        "df[\"new\"] = df.apply(lambda x: 0 if (pd.isnull(x[\"text_extract\"]) and pd.isnull(x[\"ocr_extract\"])) else 1,axis=1)\n",
        "df[\"new\"] = df.apply(lambda x: 0 if (pd.isnull(x[\"text\"]) and pd.isnull(x[\"ocr_text\"])) else 1,axis=1)\n",
        "df[\"new\"].sum()"
      ],
      "metadata": {
        "id": "UM4rNh7Pz4hY",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 258
        },
        "outputId": "176b4af4-3f14-4ff3-ace6-81df0dc02ee2"
      },
      "execution_count": 103,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                           file_name  \\\n",
              "0  ARCD.P0677US_07_30_2024_Non-Final Office Actio...   \n",
              "1  ARCD.P0664CN 2024.8.1 Response to Office Actio...   \n",
              "2  ARCD.P0676EA 2024.8.7 Annuity Payment Confirma...   \n",
              "3  ARCD.P0677EP 2024.7.17 Communication  pursuant...   \n",
              "4  ARCD.P0672CN 2024.7.26 Notification on Grant o...   \n",
              "\n",
              "                                                text  \\\n",
              "0                                                NaN   \n",
              "1  意 见 陈 述 书\\n100012\\n2023.091申请号或专利号 20198006085...   \n",
              "2                                                NaN   \n",
              "3  European  Patent  Office \\n80298  MUNICH  \\nGE...   \n",
              "4                                                NaN   \n",
              "\n",
              "                                            ocr_text  \n",
              "0  --- Page 1 OCR ---\\nUnrren States Patent anp T...  \n",
              "1                                                NaN  \n",
              "2  --- Page 1 OCR ---\\nv.FUNER EBBINGHAUS FINCK H...  \n",
              "3                                                NaN  \n",
              "4  --- Page 1 OCR ---\\n \\n\\nip ARR\\n\\n \\n \\n    \\...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-ea2661ec-f6ae-4d08-bf0e-c20ace6aa045\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>file_name</th>\n",
              "      <th>text</th>\n",
              "      <th>ocr_text</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>ARCD.P0677US_07_30_2024_Non-Final Office Actio...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>--- Page 1 OCR ---\\nUnrren States Patent anp T...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>ARCD.P0664CN 2024.8.1 Response to Office Actio...</td>\n",
              "      <td>意 见 陈 述 书\\n100012\\n2023.091申请号或专利号 20198006085...</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>ARCD.P0676EA 2024.8.7 Annuity Payment Confirma...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>--- Page 1 OCR ---\\nv.FUNER EBBINGHAUS FINCK H...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>ARCD.P0677EP 2024.7.17 Communication  pursuant...</td>\n",
              "      <td>European  Patent  Office \\n80298  MUNICH  \\nGE...</td>\n",
              "      <td>NaN</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>ARCD.P0672CN 2024.7.26 Notification on Grant o...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>--- Page 1 OCR ---\\n \\n\\nip ARR\\n\\n \\n \\n    \\...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-ea2661ec-f6ae-4d08-bf0e-c20ace6aa045')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-ea2661ec-f6ae-4d08-bf0e-c20ace6aa045 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-ea2661ec-f6ae-4d08-bf0e-c20ace6aa045');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-9e320731-6486-45bc-9f1e-f797a7955194\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-9e320731-6486-45bc-9f1e-f797a7955194')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-9e320731-6486-45bc-9f1e-f797a7955194 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "summary": "{\n  \"name\": \"# df[\\\"new\\\"]\",\n  \"rows\": 5,\n  \"fields\": [\n    {\n      \"column\": \"file_name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"ARCD.P0664CN 2024.8.1 Response to Office Action.pdf-!!-13807591\",\n          \"ARCD.P0672CN 2024.7.26 Notification on Grant of Patent Right for Invention (with English translation).pdf-!!-13834125\",\n          \"ARCD.P0676EA 2024.8.7 Annuity Payment Confirmation.pdf-!!-13808594\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"text\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"European  Patent  Office \\n80298  MUNICH  \\nGERMANY  \\nTel:+49  89 2399 03Europ\\u00e2isches\\nPatentamt\\nEuropean  \\nPatent Office\\nOffice eui \\ndes breve'op\\u00e9en\\nQuestions  about  this communication?\\nContact  Customer  Services  at\\nwww.epo.oro/contactr n\\nPrimary  Examiner\\nName: Kirsch,  Cecile \\nTel:+49  89 2399- 2191J A Kemp  LLP \\n80 Turnmill  Street  \\nLondon  EC1M  5QU  \\nROYAUME  UNI\\nL J\\nApplication  No. Ref. Date\\n19 892 608.1 - 1109 N422048EP 17.07.2024\\nApplicant\\nThe University  of Chicago\\nCommunication  pursuant  to Article  94(3)  EPC\\nThe examination  of the above-identified  application  has revealed  that it does not meet  the requirements  of \\nthe European  Patent  Convention  for the reasons  enclosed  herewith.  If the deficiencies  indicated  are not \\nrectified  the application  may be refused  pursuant  to Article  97(2) EPC.\\nYou are invited  to file your observations  and in sofar  as the deficiencies  are such as to be rectifiable,  to \\ncorrect  the indicated  deficiencies  within  a period\\nof 4 months\\nfrom the notification  of this communication,  this period  being  computed  in accordance  with Rules  126(2)  \\nand 131(2)  and (4) EPC. One set of amendments  to the description,  claims  and drawings  is to be filed \\nwithin  the said period  on separate  sheets  (R. 50(1) EPC).\\nIf filing amendments,  you must identify  them and indicate  the basis  for them in the application  as filed.  \\nFailure  to meet  either  requirement  may lead to a communication  from the Examining  Division  requesting  \\nthat you correct  this deficiency  (R. 137(4)  EPC).\\nIn case you withdraw  the application  within  the above-mentioned  period,  the examination  fee will be \\nrefunded  at a rate of 50% (Art. 11 (b) RFees).\\nFailure  to comply  with this invitation  in due time  will result  in the application  being  deemed  to be \\nwithdrawn  (Art. 94(4) EPC).\\nRegistered  Letter\\nEPO Form 2001 11.16AUWF  (13.07.2024)Sheet  2 Date 17.07.2024 Application  No.: 19 892 608.1\\n' J>%\\n%\\n?\\nI*\\n80\\\\\\\\ftO -\\nKirsch,  Cecile  \\nPrimary  Examiner\\nFor the Examining  Division\\n3 page/s  reasons  (EPO  Form  2906) Enclosure(s):\\nEPO Form 2001 11.16AUWF  (13.07.2024)Datum\\nDate\\nDateBlatt Anmelde-Nr:  \\nApplication  No: \\nDemande  n\\u00b0:17.07.2024 19 892 608.1 Sheet 1 \\nFeuille\\nThe examination  is being  carried  out on the following  application  documents\\nDescription,  Pages\\n1-73 as published\\nClaims,  Numbers\\n1-15 filed in electronic  form on 17-04-2023\\nDrawings,  Sheets\\n1/27-27/27 as published\\n1. Amendments,  Article  123(2)  EPC\\nClaim  1 is based  on original  claim 1 limited  to the specific  embodiments  of claim  3 \\n(SN50,  capsaicin,  compound  of formula  (I)) and claims  5-7 (specific  adjuvants).  The  \\nnewly  introduced  disclaimers  cover  embodiments  which  were  originally  part of the \\noriginal  invention  (see e.g. page  3, lines 16-17  for honokiol  and page  35, 16th  \\ncompound  for magnolol).  The conditions  of G 2/10 are fulfilled  since  the subject-matter  \\nremaining  in the claim  after  the introduction  of the disclaimer  is directly  and  \\nunambiguously  derivable  by the skilled  person  using  his common  general  knowledge,  in \\nthe application  as filed.\\nClaim  2 is based  on original  claim  2 and comprises  the same  limitation  as pending  claim  \\n1. Claim  3 finds  support  in original  claims  3, 4 (alternative  a), 8 (alternative  b) and 9 \\n(alternative  c). Claim  4 is based  on original  claims  10, 11 (influenza,  dengue  or HIV), 12 \\n(dengue  antigen),  13 (DENV-2C),  14 (HIV antigen)  and 15 (gp120).  Claim  5 combines  \\nthe features  of original  claims  16 (alternative  a) and 17 (alternative  b). Claim  6 \\ncorresponds  to original  claim  18. Claim  7 is based  on original  claims  19 (alternative  a), \\n20 (alternative  b), 21 (alternative  c) and 22 (alternative  d). Claim  8 finds  support  in \\noriginal  claims  23 (alternative  a), 24 (alternative  b), 25 (alternative  c), 26 (alternative  d) \\nand 27 (alternative  e).\\nClaim  9 corresponds  to original  claim  28 limited  to the specific  embodiments  of claim  28 \\n(SN50,  capsaicin,  compound  of formula  (I)) and claims  31-33  (specific  adjuvants).  The  \\nnewly  introduced  disclaimers  cover  embodiments  which  were  originally  part of the \\noriginal  invention  (see e.g. page  3, lines 16-17  for honokiol  and page  35, 16th  \\ncompound  for magnolol).  The conditions  of G 2/10 (OJ EPO  2012,  376) are fulfilled\\nEPO Form 2906 01.91TRIDatum\\nDate\\nDateBlatt Anmelde-Nr:  \\nApplication  No: \\nDemande  n\\u00b0:17.07.2024 Sheet 2 \\nFeuille19 892 608.1\\nsince  the subject-matter  remaining  in the claim  after  the introduction  of the disclaimer  is \\ndirectly  and unambiguously  derivable  by the skilled  person  using  his common  general  \\nknowledge,  in the application  as filed.\\nClaim  10 finds  support  in original  claims  30 (alternative  a), 34 (alternative  b) and 35 \\n(alternative  c). Claim  11 is based  on original  claims  36, 37 (alternative  a), 38 (alternative  \\nb), 39 (dengue  antigen),  40 (DENV-2C),  41 (HIV),  42 (HIV antigen)  and 43 (gp120).  \\nClaim  12 combines  the features  of original  claims  44 (alternative  a) and 45 (alternative  \\nb). Claim  13 is based  on original  claims  46 (alternative  a) and 47 (alternative  b). Claims  \\n14 and 15 correspond  to original  claims  48 and 49 respectively.\\nThe newly  filed set of claims  fulfils  the requirements  of Article  123(2)  ERG.\\n2. Novelty,  Article  54 ERG\\nThe claimed  subject-matter  has been limited  to specific  NF-kB  inhibitors  which  are not \\nexplicitly  disclosed  in D5.\\nD6 does  not relate  either  to the specific  NF-kB  inhibitors  covered  by pending  claim  1. \\nHonokiol  is disclosed  in D6, however  it has been excluded  by means  of a disclaimer.\\nNovelty  over  the remaining  cited  documents  has already  been acknowledged.\\nClaims  1-15 are novel  over  the cited prior  art.\\n3. Inventive  step,  Article  56 ERG\\nTaking  into account  the limitations  introduced  in the claims,  the inventive  step objection  \\nraised  in the ESOP  is still valid.\\nD5 represents  the closest  prior  art.\\nD5 acknowledges  that adjuvants  induce  immune  \\u201cdanger  signals \\u201dleading  to activation  of \\ninnate  immune  and thereby  activation  of NF-kB  and other  inflammatory  pathways  \\n([0011]).  To counter  this negative  effect  of the adjuvant,  D5 proposes  to use an anti\\u00ad\\ninflammatory  inhibitor  of NF-kB  activation  together  with a PAMP  (adjuvant)  ([0041]).  The  \\nPAMP  may be i.a. a Toll-like  receptor  agonist  ([0074]),  Pam3CSK4,  R848,  or CpG  \\n([0075]).  Thus  D5 discloses  the use of an NF-kB  and one of the adjuvant  listed  in claim  \\n1 for reducing  inflammation  mediated  by adjuvant  in vaccines.\\nAs indicated  above,  the claimed  subject-matter  differs  from D5 because  the specific  NF- \\nkB or claim  1 are not explicitly  disclosed  in D5.\\nThe problem  to be solved  is seen in the provision  of further  vaccine  compositions  with  \\nreduced  inflammatory  response.\\nEPO Form 2906 01.91TRIDatum\\nDate\\nDateBlatt Anmelde-Nr:  \\nApplication  No: \\nDemande  n\\u00b0:17.07.2024 Sheet 3 \\nFeuille19 892 608.1\\nIn the light of the examples  provided  in the application,  this problem  has been solved.  \\nThere  is no improvement  or unexpected  effect  shown  in comparison  with the closest  \\nprior art D5.\\nD5 already  teaches  that NF-kB  inhibitors  are able to reduce  the inflammatory  response  \\ntriggered  by adjuvant.  This finding  is based  on the mechanism  of action  implied  with  \\nadjuvant.  Thus  it is clear  from D5, that not only the exemplified  inhibitors  are useful  but \\nany NF-kB  inhibitor  provides  the expected  effect.\\nThe specific  NF-kB  inhibitors  of claim  1 are well-known  in the art, see D1, D2 for SN50,  \\nD6-D10  for honokiol  and derivatives,  D11 for capsaicin.  The skilled  person  would  have  \\nthus tested  this compounds  as recommended  by D5 and would  have  expected  to obtain  \\nthe same  effect  without  the need  for inventive  skills.  The claimed  subject-matter  \\ntherefore  derive  from D5 in an obvious  manner.\\nIn this context,  the applicant  argues  that the skilled  person  would  not have  combined  D5 \\nwith any of the remaining  prior  art because  they do not relate  to vaccines.\\nThe examining  division  cannot  agree  with this approach.  D5 relates  to vaccines  and  \\nexplain  via the mechanism  of action  why the use of NF-kB  inhibitors  reduce  the \\ninflammatory  response  triggered  by an adjuvant.  Taking  a known  inhibitor,  whether  \\nalready  used in a vaccine  or not, would  be next obvious  step for the skilled  person  \\nstarting  from the teaching  of D5 as D5 already  provide  the incentive  to use such  \\ninhibitors.\\nFor these  reasons,  the claimed  subject-matter  still lacks  an inventive  step.\\n4. The applicant  is invited  to file a new set of claims  which  takes  account  of the above  \\ncomments.\\nAmendments  should  be made by filing replacement  pages.  Attention  is drawn  to the \\nrequirements  of Rule  49 ERG which  requires  the description  and the claims  to be typed  \\nor printed.  In this context  reference  is made  to the Notice  from the European  Patent  \\nOffice  published  in the Official  Journal  (OJ, 12/2013,  603).\\nIn order  to facilitate  the examination  of the conformity  of the amended  application  with  \\nthe requirements  of Article  123(2)  EPC and to comply  with the requirements  of Rule  \\n137(4)  EPC, the applicant  should  clearly  identify  the amendments  made,  irrespective  of \\nwhether  they concern  amendments  by addition,  replacement  or deletion,  and indicate  \\nthe passages  of the application  as filed on which  these amendments  are based  (see  \\nGuidelines  FI-Ill, 2.2).\\nEPO Form 2906 01.91TRI\",\n          \"\\u610f \\u89c1 \\u9648 \\u8ff0 \\u4e66\\n100012\\n2023.091\\u7533\\u8bf7\\u53f7\\u6216\\u4e13\\u5229\\u53f7 2019800608569\\n\\u53d1\\u660e\\u521b\\u9020\\u540d\\u79f0 \\u6269\\u589e\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684DNA\\u7684\\u65b9\\u6cd5\\u25cb1 \\n\\u4e13     \\u4e13\\n\\u5229\\n    \\u6216\\n\\u7533\\n\\u8bf7     \\u5229\\u7533\\u8bf7\\u4eba\\u6216\\u4e13\\u5229\\u6743\\u4eba\\uff08\\u7b2c\\u4e00\\u7f72\\u540d\\u4eba\\uff09\\u829d\\u52a0\\u54e5\\u5927\\u5b66\\n\\u25cb2\\u9648\\u8ff0\\u4e8b\\u9879\\uff1a\\u5173\\u4e8e\\u8d39\\u7528\\u7684\\u610f\\u89c1\\u9648\\u8ff0\\u8bf7\\u4f7f\\u7528\\u610f\\u89c1\\u9648\\u8ff0\\u4e66(\\u5173\\u4e8e\\u8d39\\u7528)\\n\\u4ee5\\u4e0b\\u9009\\u9879\\u53ea\\u80fd\\u9009\\u62e9\\u4e00\\u9879\\n\\u9488\\u5bf9\\u56fd\\u5bb6\\u77e5\\u8bc6\\u4ea7\\u6743\\u5c40\\u4e8e 2024 \\u5e74 02 \\u6708 23 \\u65e5\\u53d1\\u51fa\\u7684 \\u7b2c\\u4e00\\u6b21\\u5ba1\\u67e5\\u610f\\u89c1\\u901a\\u77e5\\u4e66 \\uff08\\u53d1\\u6587\\u5e8f\\u53f7 \\n2024022301623520 \\uff09\\u9648\\u8ff0\\u610f\\u89c1\\u3002\\n\\u9488\\u5bf9\\u56fd\\u5bb6\\u77e5\\u8bc6\\u4ea7\\u6743\\u5c40\\u4e8e  \\u5e74  \\u6708  \\u65e5\\u53d1\\u51fa\\u7684  \\uff08\\u53d1\\u6587\\u5e8f\\u53f7  \\uff09\\u8865\\u5145\\u9648\\u8ff0\\u610f\\u89c1\\u3002\\n\\u9488\\u5bf9\\u56fd\\u5bb6\\u77e5\\u8bc6\\u4ea7\\u6743\\u5c40\\u4e8e  \\u5e74  \\u6708  \\u65e5\\u53d1\\u51fa\\u7684\\u836f\\u54c1\\u4e13\\u5229\\u6743\\u671f\\u9650\\u8865\\u507f\\u5ba1\\u67e5\\u610f\\u89c1\\u901a\\u77e5\\u4e66\\uff08\\u53d1\\u6587\\u5e8f\\n\\u53f7  \\uff09\\u9648\\u8ff0\\u610f\\u89c1\\u3002\\n\\u4e3b\\u52a8\\u63d0\\u51fa\\u4fee\\u6539\\uff08\\u6839\\u636e\\u4e13\\u5229\\u6cd5\\u5b9e\\u65bd\\u7ec6\\u5219\\u7b2c57\\u6761\\u7b2c1\\u6b3e\\u3001\\u7b2c2\\u6b3e\\u7684\\u89c4\\u5b9a\\uff09\\n\\u516c\\u5e03\\u516c\\u544a\\u4e8b\\u9879\\n\\u5176\\u4ed6\\u4e8b\\u5b9c \\n\\u25cb3\\u9648\\u8ff0\\u7684\\u610f\\u89c1\\uff1a\\n\\u8be6\\u89c1\\u610f\\u89c1\\u9648\\u8ff0\\u4e66\\u9644\\u9875\\n\\u25cb4\\u9644\\u4ef6\\u6e05\\u5355\\n\\u3010\\u9644\\u4ef6\\u540d\\u79f0\\u3011\\u6743\\u5229\\u8981\\u6c42\\u4e66 \\n\\u3010\\u9644\\u4ef6\\u540d\\u79f0\\u3011\\u4fee\\u6539\\u5bf9\\u7167\\u9875 \\n\\u3010\\u9644\\u4ef6\\u540d\\u79f0\\u3011\\u5176\\u4ed6\\u8bc1\\u660e\\u6587\\u4ef6 \\n\\u5df2\\u5907\\u6848\\u7684\\u8bc1\\u660e\\u6587\\u4ef6\\u5907\\u6848\\u7f16\\u53f7\\uff1a  \\u610f \\u89c1 \\u9648 \\u8ff0 \\u4e66\\n100012\\n2023.092\\u25cb5\\u5f53\\u4e8b\\u4eba\\u6216\\u4e13\\u5229\\u4ee3\\u7406\\u673a\\u6784\\n\\u5317\\u4eac\\u67cf\\u6749\\u677e\\u77e5\\u8bc6\\u4ea7\\u6743\\u4ee3\\u7406\\u4e8b\\u52a1\\u6240\\uff08\\u666e\\u901a\\u5408\\u4f19\\uff09\\u7533\\u8bf7\\u53f7\\uff1a201980060856.9   \\u4ee3\\u7406\\u673a\\u6784\\u5377\\u53f7\\uff1aPP218006PF  \\n \\n1 \\n \\u610f\\u89c1\\u9648\\u8ff0\\u4e66\\u9644\\u9875  \\n\\u5c0a\\u656c\\u7684\\u5ba1\\u67e5\\u5458\\uff1a \\n\\u7533\\u8bf7\\u4eba\\u5bf9\\u5ba1\\u67e5\\u5458\\u4e3a\\u5ba1\\u67e5\\u672c\\u7533\\u8bf7\\u6240\\u4ed8\\u51fa\\u7684\\u8f9b\\u52e4\\u52b3\\u52a8\\u8868\\u793a\\u7531\\u8877\\u7684\\u611f\\u8c22\\u3002\\u9488\\u5bf9\\u5ba1\\u67e5\\u5458\\u63d0\\u51fa\\u7684\\u5ba1\\n\\u67e5\\u610f\\u89c1\\uff0c\\u7533\\u8bf7\\u4eba\\u7ecf\\u8fc7\\u8ba4\\u771f\\u8003\\u8651\\uff0c\\u505a\\u51fa\\u4ee5\\u4e0b\\u7b54\\u590d\\u610f\\u89c1\\uff1a \\n \\n\\u4fee\\u6539\\u8bf4\\u660e  \\n1. \\u5c06\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150 \\u548c53\\u4e2d\\u7684\\u65b9\\u6cd5\\u9650\\u5b9a\\u4e3a\\u201c \\u975e\\u8bca\\u65ad \\u201d\\u65b9\\u6cd5\\u3002  \\n2. \\u5c06\\u6743\\u5229\\u8981\\u6c42 3\\u4e2d\\u91cd\\u590d\\u51fa\\u73b0\\u7684\\u4e24\\u4e2a\\u201c \\uff085fC\\uff09\\u201d\\u5220\\u9664\\u4e86\\u5176\\u4e2d\\u7684\\u4e00\\u4e2a\\u3002  \\n3. \\u5c06\\u6743\\u5229\\u8981\\u6c42 51\\u4e2d\\u7684\\u201c\\u751f\\u7269\\u6807\\u5fd7\\u7269\\u201d \\u8fdb\\u4e00\\u6b65\\u9650\\u5b9a\\u4e3a\\u201c \\u7532\\u57fa\\u80de\\u5627\\u5576\\u201d \\u3002 \\n4. \\u5c06\\u6743\\u5229\\u8981\\u6c42 52\\u6539\\u5199\\u4e3a\\uff1a\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u7684\\u8854\\u63a5\\u5b50\\u5728\\u5236\\u5907\\u7528\\u4e8e\\u9274\\u5b9a\\u6765\\u81ea\\u60a3\\u8005\\u7684\\nDNA\\u5206\\u5b50\\u4e2d\\u7684 5mC\\u548c/\\u6216\\u7528\\u4e8e\\u8f85\\u52a9\\u60a3\\u8005\\u8bca\\u65ad\\u6216\\u9884\\u540e\\u7684\\u8bd5\\u5242\\u76d2\\u4e2d\\u7684\\u7528\\u9014\\uff0c\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\n\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff0c\\u5176\\u4e2d\\u6267\\u884c\\u6743\\u5229\\u8981\\u6c42 1\\u81f350\\u4e2d\\u4efb\\u4e00\\u9879\\u4e2d\\u9650\\u5b9a\\u7684\\u6b65\\u9aa4\\uff0c\\u5176\\u4e2d\\n\\u4ece\\u60a3\\u8005\\u7684\\u751f\\u7269\\u6837\\u672c\\u63d0\\u4f9b DNA\\u5206\\u5b50\\u3002 \\n5. \\u5c06\\u6743\\u5229\\u8981\\u6c42 54\\u4e2d\\u7684\\u201cRNA \\u542f\\u52a8\\u5b50\\u201d\\u8fdb\\u4e00\\u6b65\\u9650\\u5b9a\\u4e3a\\u201cRNA \\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u201d \\u3002 \\n\\u5177\\u4f53\\u4fee\\u6539\\u8be6\\u89c1\\u6743\\u5229\\u8981\\u6c42\\u4e66\\u66ff\\u6362\\u9875\\u548c\\u4fee\\u6539\\u5bf9\\u7167\\u9875\\u3002 \\n \\n\\u610f\\u89c1\\u9648\\u8ff0  \\n\\u5728\\u4e0a\\u8ff0\\u4fee\\u6539\\u7684\\u57fa\\u7840\\u4e0a\\uff0c\\u7533\\u8bf7\\u4eba\\u8fdb\\u884c\\u5982\\u4e0b\\u7684\\u610f\\u89c1\\u9648\\u8ff0\\u3002 \\n\\u4e00. \\u5173\\u4e8e\\u6743\\u5229\\u8981\\u6c42 1\\u53ca\\u5176\\u4ed6\\u6743\\u5229\\u8981\\u6c42\\u7684\\u521b\\u9020\\u6027 \\n\\u5ba1\\u67e5\\u5458\\u6307\\u51fa\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u76f8\\u5bf9\\u4e8e D1\\uff08(US2003104432A1\\uff09\\u3001 D2\\uff08Nataliya Kitsera et \\nal., Functional impacts of 5- hydroxymethylcytosine, 5- formylcytosine, and 5- carboxycytosine at \\na single hemi -modified CpG dinucleotide in a gene promoter , Nucleic Acids Research \\uff09\\u548c D3\\n\\uff08US2014322707A1\\uff09\\u4e0d\\u5177\\u5907\\u521b\\u9020\\u6027\\u3002 \\n\\u7533\\u8bf7\\u4eba\\u4e0d\\u540c\\u610f\\u5ba1\\u67e5\\u5458\\u7684\\u89c2\\u70b9\\uff0c\\u5e76\\u8ba4\\u4e3a\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u5177\\u5907\\u521b\\n\\u9020\\u6027\\uff0c\\u5177\\u4f53\\u7406\\u7531\\u9648\\u8ff0\\u5982\\u4e0b\\u3002 \\n\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u8981\\u6c42\\u4fdd\\u62a4\\uff1a \\n1\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u6269\\u589e\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684\\u8131\\u6c27\\u6838\\u7cd6\\u6838\\u9178(DNA)\\u5206\\u5b50\\u7684\\u65b9\\u6cd5\\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\uff1a \\n(a)\\u4f7f\\u8854\\u63a5\\u5b50\\u4e0eDNA \\u5206\\u5b50\\u8fde\\u63a5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u5305\\u62ecRNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\uff0c\\u6240\\u8ff0RNA \\u805a\\u5408\\u9176\\u542f\\n\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff1b  \\n(b)\\u7528\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u8fde\\u63a5\\u7684DNA\\u5206\\u5b50\\uff1b \\u7533\\u8bf7\\u53f7\\uff1a201980060856.9   \\u4ee3\\u7406\\u673a\\u6784\\u5377\\u53f7\\uff1aPP218006PF  \\n \\n2 \\n (c)\\u4f7f\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684DNA\\u5206\\u5b50\\u4e0e\\u5f15\\u7269\\u6742\\u4ea4\\uff1b  \\n(d)\\u5ef6\\u4f38\\u7ecf\\u6742\\u4ea4\\u7684\\u5f15\\u7269\\u4ee5\\u4ea7\\u751f\\u53cc\\u94feDNA\\uff1b\\u548c \\n(e)\\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94feDNA\\u4ee5\\u4ea7\\u751fRNA\\u3002   \\nD1\\u6d89\\u53ca\\u5408\\u6210\\u548c\\u6269\\u589e RNA\\u7684\\u65b9\\u6cd5\\u3002\\u5728\\u4e00\\u4e9b\\u5b9e\\u65bd\\u65b9\\u6848\\u4e2d\\uff0c\\u5355\\u94fe cDNA\\u5206\\u5b50\\u53ef\\u64cd\\u4f5c\\u5730\\u8fde\\n\\u63a5\\u5230\\u542b\\u6709 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u533a\\u7684\\u8854\\u63a5\\u5b50\\uff0c\\u4ee5\\u4ea7\\u751f\\u4fee\\u9970\\u7684 cDNA\\u5206\\u5b50\\u3002 cDNA\\u548c\\u8854\\u63a5\\u5b50\\u53ef\\n\\u4ee5\\u901a\\u8fc7\\u8fde\\u63a5\\u6216\\u8005\\u5728\\u9006\\u8f6c\\u5f55\\u8fc7\\u7a0b\\u4e2d\\u901a\\u8fc7\\u6a21\\u677f\\u8f6c\\u6362\\u800c\\u7ed3\\u5408\\u3002\\u7ecf\\u4fee\\u9970\\u7684 cDNA\\u53ef\\u4ee5\\u88ab\\u8f6c\\u5f55\\u4ee5\\u4ea7\\n\\u751f\\u6709\\u4e49 RNA\\u3002 \\n\\u5982\\u5728\\u5ba1\\u67e5\\u610f\\u89c1\\u901a\\u77e5\\u4e66\\u4e2d\\u6240\\u8ff0\\uff0cD1 \\u4e0e\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u533a\\u522b\\u6280\\u672f\\u7279\\u5f81\\u5728\\u4e8e\\uff1a\\u672c\\u7533\\u8bf7\\n\\u6743\\u5229\\u8981\\u6c42 1\\u6d89\\u53ca\\u6269\\u589e\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u65b9\\u6cd5\\uff0c\\u4ece\\u800c\\u8fd8\\u5305\\u62ec\\u6b65\\u9aa4 b\\uff0c\\u4e14 RNA\\u805a\\u5408\\u9176\\n\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\u3002\\u4e5f\\u5c31\\u662f\\u8bf4\\uff0c D1\\u6ca1\\u6709\\u516c\\u5f00\\u4f7f\\u7528\\u5177\\u6709\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\n\\u7684\\u80de\\u5627\\u5576\\u7684\\u8854\\u63a5\\u5b50\\u6765\\u6269\\u589e\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u5206\\u5b50\\u3002  \\nD2\\u516c\\u5f00\\u4e86\\u542b\\u6709\\u7528\\u7532\\u57fa\\u80de\\u5627\\u5576\\u4fee\\u9970\\u7684 cAMP\\u53cd\\u5e94\\u5143\\u4ef6 \\uff08CRE \\uff09 \\u7684\\u8868\\u8fbe\\u8f7d\\u4f53\\u3002 CRE\\u4e0eCREB\\n\\uff08\\u4e00\\u79cd\\u8f6c\\u5f55\\u56e0\\u5b50\\uff09\\u7ed3\\u5408\\uff0c\\u542f\\u52a8\\u8f6c\\u5f55\\u3002\\u503c\\u5f97\\u6ce8\\u610f\\u7684\\u662f\\uff0c CREB\\u662f\\u4e00\\u79cd\\u8f6c\\u5f55\\u56e0\\u5b50\\uff0c\\u8fd9\\u610f\\u5473\\u7740\\u5b83\\n\\u53ef\\u4ee5\\u901a\\u8fc7\\u81f3\\u5c11\\u52df\\u96c6\\u6216\\u6291\\u5236 RNA\\u805a\\u5408\\u9176\\u590d\\u5408\\u7269\\u7684\\u52df\\u96c6\\u6765\\u8c03\\u8282\\u57fa\\u56e0\\u8868\\u8fbe\\uff08\\u53c2\\u89c1\\u4f8b\\u5982\\uff0c\\nConkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB, Montminy M. \\nTORCs: transducers of regulated CREB activity.  Mol Cell. 2003 Aug;12(2):413- 23\\uff09\\u3002  \\n\\u7533\\u8bf7\\u4eba\\u6ce8\\u610f\\u5230\\uff0c\\u76f4\\u63a5\\u4e0e RNA\\u805a\\u5408\\u9176\\u590d\\u5408\\u7269\\u86cb\\u767d\\u7ed3\\u5408\\u7684 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\uff0c\\u4f8b\\u5982 T3\\u3001\\nT7\\u6216Sp6\\uff0c\\u4e0e CRE\\u8f6c\\u5f55\\u56e0\\u5b50\\u7ed3\\u5408\\u4f4d\\u70b9\\u663e\\u8457\\u4e0d\\u540c\\u3002\\u56e0\\u6b64 D2\\u516c\\u5f00\\u4e86\\u5305\\u542b\\u7532\\u57fa\\u80de\\u5627\\u5576\\u7684 \\u8c03\\u63a7\\n\\u5143\\u4ef6\\uff0c\\u800c \\u6ca1\\u6709\\u516c\\u5f00\\u7528\\u7532\\u57fa\\u80de\\u5627\\u5576 \\u4fee\\u9970\\u7684RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u3002\\u56e0\\u6b64\\uff0c\\u7533\\u8bf7\\u4eba\\u8ba4\\u4e3a\\uff0c\\u81f3\\u5c11\\u57fa\\n\\u4e8e\\u8be5\\u539f\\u56e0\\uff0c\\u5ba1\\u67e5\\u5458\\u4e0d\\u5e94\\u5f53\\u5728 D1\\u516c\\u5f00\\u7684\\u57fa\\u7840\\u4e0a\\u7ed3\\u5408 D2\\u6765\\u5426\\u5b9a\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u975e\\u663e\\u800c\\n\\u6613\\u89c1\\u6027\\u3002 \\n\\u6b64\\u5916\\uff0c D2\\u516c\\u5f00\\u8868\\u660e\\u80de\\u5627\\u5576\\u7684\\u7532\\u57fa\\u5316\\u663e\\u8457\\u964d\\u4f4e\\u4e86\\u8f6c\\u5f55\\uff08\\u4f8b\\u5982\\uff0c\\u57fa\\u56e0\\u4ea7\\u7269\\u7684\\u8868\\u8fbe\\uff09 \\u3002\\u4f8b\\u5982\\uff0c\\nCRE\\u4e2d\\u7684\\u4e00\\u4e2a\\u7532\\u57fa\\u5316\\u80de\\u5627\\u5576\\u4f7f\\u62a5\\u544a\\u57fa\\u56e0\\u7684\\u8868\\u8fbe\\u964d\\u4f4e\\u4e86\\u7ea6 25%\\uff0c\\u800c\\u4e09\\u4e2a\\u7532\\u57fa\\u5316\\u80de\\u5627\\u5576\\u4f7f\\u8868\\n\\u8fbe\\u964d\\u4f4e\\u4e86\\u7ea6 50%\\uff08\\u964d\\u4f4e\\u81f3\\u4e0d\\u542b CRE\\u7684\\u5bf9\\u7167\\u8f7d\\u4f53\\u7684\\u6c34\\u5e73\\uff1b\\u53c2\\u89c1 D2\\u7b2c11036\\u9875\\u5de6\\u680f\\uff0c\\u4ee5\\u53ca\\n\\u56fe1E\\u548c2A\\uff09\\u3002 \\n\\u8fdb\\u4e00\\u6b65\\u5730\\uff0c D2\\u8fd8\\u516c\\u5f00\\uff0c\\u5355\\u4e2a\\u7532\\u57fa\\u5316\\u80de\\u5627\\u5576\\u4f1a\\u4f7f CREB\\u4e0eCRE\\u7684\\u7ed3\\u5408\\u51cf\\u5c11 2-3\\u500d\\uff0c\\u5e76\\n\\u4e14\\u8f7d\\u4f53\\u7684\\u5b8c\\u5168\\u7532\\u57fa\\u5316\\u4f1a\\u5b8c\\u5168\\u6d88\\u9664\\u8868\\u8fbe\\uff08\\u53c2\\u89c1 D2\\u7b2c11036\\u9875\\u5de6\\u680f\\uff0c\\u4ee5\\u53ca\\u8865\\u5145\\u56fe S2\\uff09 \\u3002\\u56e0\\u6b64\\uff0c\\nD2\\u6559\\u5bfc\\u4e86\\u8c03\\u63a7\\u5143\\u4ef6\\u7684\\u7532\\u57fa\\u5316\\uff08\\u751a\\u81f3\\u662f\\u534a\\u7532\\u57fa\\u5316\\uff09\\u4f1a\\u6291\\u5236\\u8f6c\\u5f55\\uff0c \\u8be5\\u6559\\u5bfc\\u5b8c\\u5168\\u504f\\u79bb\\u4e86\\u672c\\u8eab\\u7533\\n\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u6280\\u672f\\u65b9\\u6848\\u3002\\u4e8b\\u5b9e\\u4e0a\\uff0c\\u6839\\u636e D2\\u7684\\u6559\\u5bfc\\uff0c\\u672c\\u9886\\u57df\\u6280\\u672f\\u4eba\\u5458\\u4f1a\\u5408\\u7406\\u5730\\u9884\\u671f\\u5305\\u542b\\n\\u7532\\u57fa\\u80de\\u5627\\u5576\\u7684 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\uff08\\u672c\\u7533\\u8bf7\\u7684\\u4e00\\u4e9b\\u5b9e\\u65bd\\u65b9\\u6848\\u542b\\u6709 7\\u4e2a\\uff0c\\u53c2\\u89c1\\u4f8b\\u5982\\u5b9e\\u65bd\\u4f8b 1\\uff0c\\u7533\\u8bf7\\u53f7\\uff1a201980060856.9   \\u4ee3\\u7406\\u673a\\u6784\\u5377\\u53f7\\uff1aPP218006PF  \\n \\n3 \\n C.\\u65b9\\u6cd5\\u4e2d\\u7684 3.T7\\u8854\\u63a5\\u5b50\\u7684\\u5236\\u5907\\uff0c\\u8bf4\\u660e\\u4e66\\u30100227\\u3011- \\u30100228\\u3011\\u6bb5\\uff09\\u4f1a\\u4f7f\\u5f97\\u672c\\u7533\\u8bf7\\u4e0d\\u53ef\\u5b9e\\u73b0\\uff0c\\n\\u4f8b\\u5982\\uff0c \\u5b83\\u4e0d\\u4f1a\\u4fc3\\u8fdb\\u672c\\u9886\\u57df\\u6280\\u672f\\u4eba\\u5458\\u5f97\\u5230\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u4e2d\\u7684\\u6b65\\u9aa4 \\u201c(e) \\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94fe DNA\\n\\u4ee5\\u4ea7\\u751f RNA\\u201d \\u3002\\u56e0\\u6b64\\uff0c\\u7533\\u8bf7\\u4eba\\u8ba4\\u4e3a\\uff0c \\u8fdb\\u4e00\\u6b65\\u81f3\\u5c11\\u57fa\\u4e8e\\u8be5\\u539f\\u56e0\\uff0c\\u5ba1\\u67e5\\u5458\\u4e0d\\u5e94\\u5f53\\u5728 D1\\u516c\\u5f00\\u7684\\n\\u57fa\\u7840\\u4e0a\\u7ed3\\u5408 D2\\u6765\\u5426\\u5b9a\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u975e\\u663e\\u800c\\u6613\\u89c1\\u6027\\u3002 \\nD3\\u516c\\u5f00\\u4e86\\u4fee\\u9970 5mC\\u548c/\\u62165hmC\\uff0c\\u5e76\\u968f\\u540e\\u68c0\\u6d4b\\u3001\\u8bc4\\u4f30\\u3001\\u6d4b\\u5e8f\\u548c/ \\u6216\\u7ed8\\u5236\\u6838\\u9178\\u5206\\u5b50\\u4e2d 5mC\\n\\u4fee\\u9970-\\u80de\\u5627\\u5576\\u78b1\\u57fa\\u548c 5hmC\\u4fee\\u9970-\\u80de\\u5627\\u5576\\u78b1\\u57fa\\u7684\\u65b9\\u6cd5\\u548c\\u7ec4\\u5408\\u7269\\u3002D3 \\u4e5f\\u6ca1\\u6709\\u516c\\u5f00\\u672c\\u7533\\u8bf7\\u6743\\u5229\\n\\u8981\\u6c42 1\\u4e2d\\u9650\\u5b9a\\u7684\\u4f7f\\u7528\\u5177\\u6709\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\u7684\\u8854\\u63a5\\u5b50\\u6765\\u6269\\u589e\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684\\nDNA\\u5206\\u5b50\\u3002 \\n\\u7efc\\u4e0a\\uff0cD1 \\u3001D2\\u548cD3\\u7684\\u7ed3\\u5408\\u5e76\\u6ca1\\u6709\\u6559\\u5bfc\\u6216\\u6697\\u793a\\u4f7f\\u5f97\\u672c\\u9886\\u57df\\u6280\\u672f\\u4eba\\u5458\\u5f97\\u5230\\u672c\\u7533\\u8bf7\\u6743\\u5229\\n\\u8981\\u6c42 1\\u7684\\u6280\\u672f\\u65b9\\u6848\\u3002\\u56e0\\u6b64\\uff0c \\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u7684\\u7ed3\\u5408\\u5177\\u6709\\u975e\\u663e\\u800c\\u6613\\n\\u89c1\\u6027\\u3002 \\n\\u672c\\u7533\\u8bf7\\u8bf4\\u660e\\u4e66\\u30100007 \\u3011\\u6bb5\\u8bb0\\u8f7d\\uff1a\\u76ee\\u524d\\u7684\\u65b9\\u6cd5\\u90fd\\u4e0d\\u80fd\\u5bf9\\u5c11\\u91cf DNA(\\u7eb3\\u514b\\u7ea7\\u6216\\u4e9a\\u7eb3\\u514b\\u7ea7 )\\n\\u4e2d\\u7684 5mC\\u548c5hmC\\u8fdb\\u884c\\u6d4b\\u5e8f\\uff0c\\u6216\\u5728\\u5355\\u7ec6\\u80de\\u6c34\\u5e73\\u4e2d\\u83b7\\u5f97\\u8fd9\\u4e9b\\u4fee\\u9970\\u7684\\u4fe1\\u606f\\u3002  \\n\\u672c\\u7533\\u8bf7\\u8bf4\\u660e\\u4e66\\u30100008\\u3011\\u6bb5\\u8bb0\\u8f7d\\uff1a\\u672c\\u516c\\u5f00\\u7684\\u65b9\\u6cd5\\u3001\\u7ec4\\u5408\\u7269\\u548c\\u8bd5\\u5242\\u76d2\\u63d0\\u4f9b\\u4e86\\u4e00\\u79cd\\u7528\\u4e8e\\u6574\\u4e2a\\n\\u57fa\\u56e0\\u7ec4\\u7684\\u6709\\u6548\\u65b9\\u6cd5\\uff0c\\u5373\\u65e0\\u504f DNA\\u5206\\u6790\\u65b9\\u6cd5\\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\u53ef\\u4ee5\\u5728\\u6709\\u9650\\u91cf\\u7684 DNA\\u4e0a\\u8fdb\\u884c\\u5e76\\u4e14\\n\\u53ef\\u4ee5\\u6709\\u6548\\u6d4b\\u5b9a DNA\\u7684\\u4fee\\u9970\\u72b6\\u6001\\u3002  \\n\\u672c\\u7533\\u8bf7\\u8bf4\\u660e\\u4e66\\u30100219\\u3011\\u6bb5\\u8bb0\\u8f7d\\uff1a\\u9664\\u8840\\u6db2\\u5916\\uff0c\\u8be5\\u6280\\u672f\\u8fd8\\u53ef\\u4f5c\\u7528\\u4e8e\\u5305\\u62ec\\u4f46\\u4e0d\\u9650\\u4e8e\\u5c3f\\u6db2\\u3001\\u8111\\n\\u810a\\u6db2(CSF) \\u548c\\u623f\\u6c34 cfDNA\\uff0c\\u636e\\u62a5\\u544a\\u5176 DNA\\u7247\\u6bb5\\u5177\\u6709\\u6bd4\\u8840\\u6db2\\u4e2d\\u7684 DNA\\u7247\\u6bb5\\u66f4\\u5c0f\\u7684\\u5c3a\\u5bf8\\u6216\\n\\u66f4\\u4f4e\\u7684\\u6d53\\u5ea6\\u3002LAB- seq\\u8fd8\\u53ef\\u7528\\u4e8e\\u5355\\u7ec6\\u80de\\u7814\\u7a76\\u3002\\u4f7f\\u7528\\u8f6c\\u5ea7\\u9176\\u6216\\u6838\\u9178\\u9176\\u7b49\\u4f7f\\u5355\\u7ec6\\u80de gDNA\\u7247\\n\\u6bb5\\u5316\\u4e4b\\u540e\\uff0c\\u8be5\\u6280\\u672f\\u53ef\\u4ee5\\u7528\\u4e8e\\u5c06\\u51e0\\u5fae\\u5fae\\u514b\\u7684\\u6750\\u6599\\u6269\\u589e\\u81f3\\u7eb3\\u514b\\u3002\\u5b83\\u4e3a\\u7814\\u7a76\\u4eba\\u5458\\u63d0\\u4f9b\\u4e86\\u6709\\u529b\\u4e14\\n\\u51c6\\u786e\\u7684\\u5de5\\u5177\\u4ee5\\u5229\\u7528\\u5bf9\\u764c\\u75c7\\u548c\\u80da\\u80ce\\u53d1\\u80b2\\u7684\\u6df1\\u5165\\u4e86\\u89e3\\uff0c\\u89c2\\u5bdf\\u5faa\\u73af\\u80bf\\u7624\\u7ec6\\u80de\\u3001\\u7ec6\\u80de\\u5f02\\u8d28\\u6027\\u548c\\u80da\\n\\u80ce\\u4e2d\\u6574\\u4e2a\\u57fa\\u56e0\\u7ec4\\u7684\\u8868\\u89c2\\u9057\\u4f20\\u5b66\\u53d8\\u5316\\u3002  \\n\\u6839\\u636e\\u4e0a\\u8ff0\\u8bb0\\u8f7d\\u53ef\\u77e5\\uff0c \\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u6280\\u672f\\u65b9\\u6848\\u89e3\\u51b3\\u4e86\\u73b0\\u6709\\u6280\\u672f\\u4e2d\\u5e0c\\u671b\\u89e3\\u51b3\\u7684\\u6280\\u672f\\n\\u95ee\\u9898\\uff0c\\u5e76\\u4e14\\u76f8\\u5bf9\\u4e8e\\u73b0\\u6709\\u6280\\u672f\\u5177\\u6709\\u663e\\u8457\\u7684\\u6280\\u672f\\u6548\\u679c\\u3002 \\n\\u7efc\\u4e0a\\u6240\\u8ff0\\uff0c\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u6280\\u672f\\u65b9\\u6848\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u5177\\u5907\\u7a81\\u51fa\\u7684\\u5b9e\\u8d28\\u6027\\u7279\\n\\u70b9\\u548c\\u663e\\u8457\\u7684\\u6280\\u672f\\u8fdb\\u6b65\\uff0c\\u5177\\u6709\\u521b\\u9020\\u6027\\u3002 \\n\\u5173\\u4e8e\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150\\u548c54\\u7684\\u521b\\u9020\\u6027\\uff0c\\u57fa\\u4e8e\\u4e0e\\u6743\\u5229\\u8981\\u6c42 1\\u9648\\u8ff0\\u7684\\u76f8\\u540c\\u7406\\u7531\\uff0c\\u7533\\u8bf7\\u4eba\\n\\u8ba4\\u4e3a\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150 \\u548c54\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u4e5f\\u5177\\u6709\\u521b\\u9020\\u6027\\u3002 \\n\\u6743\\u5229\\u8981\\u6c42 4-49\\u3001 51-53\\u548c55-72\\u5206\\u522b\\u76f4\\u63a5\\u6216\\u95f4\\u63a5\\u5f15\\u7528\\u6743\\u5229\\u8981\\u6c42 1\\u30012\\u30013\\u300150\\u548c54\\uff0c\\u5728\\n\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150\\u548c54\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u5177\\u6709\\u521b\\u9020\\u6027\\u7684\\u524d\\u63d0\\u4e0b\\uff0c \\u6743\\u5229\\u8981\\u6c42 4-49\\u300151-53\\n\\u548c55-72\\u76f8\\u5bf9\\u4e8e D1\\u3001D2\\u548cD3\\u4e5f\\u5177\\u6709\\u521b\\u9020\\u6027\\u3002 \\u7533\\u8bf7\\u53f7\\uff1a201980060856.9   \\u4ee3\\u7406\\u673a\\u6784\\u5377\\u53f7\\uff1aPP218006PF  \\n \\n4 \\n  \\n\\u4e8c. \\u4e0d\\u6388\\u4e88\\u4e13\\u5229\\u6743\\u7684\\u4e3b\\u9898 \\n\\u5ba1\\u67e5\\u5458\\u6307\\u51fa\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150- 53\\u548c4-49\\u5c5e\\u4e8e\\u75be\\u75c5\\u7684\\u8bca\\u65ad\\u4e0e\\u6cbb\\u7597\\u65b9\\u6cd5\\u3002 \\n\\u7533\\u8bf7\\u4eba\\u4e0d\\u540c\\u610f\\u5ba1\\u67e5\\u5458\\u7684\\u8be5\\u89c2\\u70b9\\uff0c\\u56e0\\u4e3a\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u548c50\\u7684\\u76f4\\u63a5\\u76ee\\u7684\\u662f\\u9274\\u5b9a DNA\\u5206\\u5b50\\u4e2d\\n\\u7532\\u57fa\\u80de\\u5627\\u5576\\u7684\\u53d8\\u4f53\\u3002\\u8fd9\\u4e9b\\u65b9\\u6cd5\\u53ef\\u7528\\u4e8e\\u5de5\\u4e1a\\u548c/ \\u6216\\u5b66\\u672f\\u754c\\uff0c\\u4f8b\\u5982\\u7528\\u4e8e\\u7814\\u7a76\\u76ee\\u7684\\u3002\\u6b64\\u5916\\uff0c\\u5728 DNA\\n\\u6837\\u672c\\u4e2d\\u68c0\\u6d4b\\u7532\\u57fa\\u80de\\u5627\\u5576\\u53ca\\u5176\\u53d8\\u4f53\\u672c\\u8eab\\u5e76\\u4e0d\\u662f\\u4e00\\u79cd\\u8bca\\u65ad\\u65b9\\u6cd5\\u3002\\u8bca\\u65ad\\u9700\\u8981\\u4e0e\\u75be\\u75c5\\u6570\\u636e\\u5e93\\u8fdb\\u884c\\u6bd4\\u8f83\\n\\u548c\\u5206\\u6790\\u3002\\u56e0\\u6b64\\uff0c\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u548c50\\u4e0d\\u5e94\\u88ab\\u89c6\\u4e3a\\u7528\\u4e8e\\u8bca\\u65ad\\u75be\\u75c5\\u7684\\u8bca\\u65ad\\u4e0e\\u6cbb\\u7597\\u65b9\\u6cd5\\u3002 \\n\\u4f46\\u4e3a\\u4e86\\u52a0\\u901f\\u5ba1\\u67e5\\u8fc7\\u7a0b\\uff0c\\u7533\\u8bf7\\u4eba\\u4fee\\u6539\\u4e86\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u548c50\\uff0c\\u5c06\\u8fd9\\u4e9b\\u65b9\\u6cd5\\u8fdb\\u4e00\\u6b65\\u9650\\u5b9a\\u4e3a\\u201c\\u975e\\n\\u8bca\\u65ad\\u65b9\\u6cd5\\u2026\\u2026\\u201d \\u3002\\u53e6\\u5916\\uff0c\\u7533\\u8bf7\\u4eba\\u5c06\\u6743\\u5229\\u8981\\u6c42 52\\u6539\\u5199\\u4e3a\\u5236\\u836f\\u7528\\u9014\\u6743\\u5229\\u8981\\u6c42\\uff0c\\u5177\\u4f53\\u53c2\\u89c1\\u4e0a\\u8ff0\\u4fee\\u6539\\n\\u8bf4\\u660e\\u4ee5\\u53ca\\u6743\\u5229\\u8981\\u6c42\\u4e66\\u66ff\\u6362\\u9875\\u548c\\u4fee\\u6539\\u5bf9\\u7167\\u9875\\u3002  \\n\\u56e0\\u6b64\\uff0c\\u672c\\u7533\\u8bf7\\u4fee\\u6539\\u540e\\u6743\\u5229\\u8981\\u6c42 2\\u30013\\u300150- 53\\u548c4-49\\u4e0d\\u518d\\u5c5e\\u4e8e\\u75be\\u75c5\\u7684\\u8bca\\u65ad\\u4e0e\\u6cbb\\u7597\\u65b9\\u6cd5\\uff0c\\u5c5e\\n\\u4e8e\\u88ab\\u6388\\u4e88\\u4e13\\u5229\\u6743\\u7684\\u8303\\u56f4\\u3002 \\n \\n\\u4e09. \\u5355\\u4e00\\u6027         \\n\\u300a\\u4e13\\u5229\\u6cd5\\u300b\\u7b2c 31\\u6761\\u89c4\\u5b9a\\uff1a \\u201c\\u5c5e\\u4e8e\\u4e00\\u4e2a\\u603b\\u7684\\u53d1\\u660e\\u6784\\u601d\\u7684\\u4e24\\u9879\\u4ee5\\u4e0a\\u7684\\u53d1\\u660e\\u6216\\u8005\\u5b9e\\u7528\\u65b0\\u578b\\uff0c\\u53ef\\n\\u4ee5\\u4f5c\\u4e3a\\u4e00\\u4ef6\\u7533\\u8bf7\\u63d0\\u51fa\\u3002 \\u201d \\n\\u5ba1\\u67e5\\u5458\\u6307\\u51fa\\uff0c\\u672c\\u7533\\u8bf7\\u6743\\u5229\\u8981\\u6c42 2\\u548c3\\u4e0e\\u6743\\u5229\\u8981\\u6c42 1\\u7684\\u5171\\u540c\\u6280\\u672f\\u7279\\u5f81\\u5728\\u4e8e\\uff1a\\u6b65\\u9aa4 a-e\\u3002\\u5728\\u6743\\n\\u5229\\u8981\\u6c42 1\\u76f8\\u5bf9\\u4e8e D1-D3\\u4e0d\\u5177\\u5907\\u521b\\u9020\\u6027\\u7684\\u524d\\u63d0\\u4e0b\\uff0c\\u6b65\\u9aa4 a-e\\u9650\\u5b9a\\u7684\\u65b9\\u6cd5\\u4e0d\\u5c5e\\u4e8e\\u5bf9\\u73b0\\u6709\\u6280\\u672f\\u4f5c\\u51fa\\n\\u521b\\u9020\\u6027\\u8d21\\u732e\\u7684\\u7279\\u5b9a\\u6280\\u672f\\u7279\\u5f81\\u3002\\u7531\\u6b64\\u6307\\u51fa\\u6743\\u5229\\u8981\\u6c42 2\\u548c3\\u4e0e\\u6743\\u5229\\u8981\\u6c42 1\\u4e4b\\u95f4\\u7f3a\\u4e4f\\u76f8\\u540c\\u6216\\u76f8\\u5e94\\u7684\\n\\u7279\\u5b9a\\u6280\\u672f\\u7279\\u5f81\\uff0c\\u4e0d\\u5177\\u6709\\u5355\\u4e00\\u6027\\u3002 \\n\\u5982\\u524d\\u6240\\u8ff0\\uff0c\\u7533\\u8bf7\\u4eba\\u8ba4\\u4e3a\\u6743\\u5229\\u8981\\u6c42 1\\u76f8\\u5bf9\\u4e8e D1-D3\\u5177\\u6709\\u521b\\u9020\\u6027\\uff0c\\u6b65\\u9aa4 a-e\\u9650\\u5b9a\\u7684\\u65b9\\u6cd5\\u5c5e\\u4e8e\\n\\u5bf9\\u73b0\\u6709\\u6280\\u672f\\u505a\\u51fa\\u521b\\u9020\\u6027\\u8d21\\u732e\\u7684\\u6280\\u672f\\u7279\\u5f81\\uff0c\\u56e0\\u6b64\\uff0c\\u6743\\u5229\\u8981\\u6c42 2\\u548c3\\u4e0e\\u6743\\u5229\\u8981\\u6c42 1\\u4e4b\\u95f4\\u5177\\u6709\\u76f8\\u540c\\n\\u6216\\u76f8\\u5e94\\u7684\\u7279\\u5b9a\\u6280\\u672f\\u7279\\u5f81\\uff0c\\u5177\\u6709\\u5355\\u4e00\\u6027\\u3002\\u76f4\\u63a5\\u5f15\\u7528\\u6743\\u5229\\u8981\\u6c42 1-3\\u7684\\u6743\\u5229\\u8981\\u6c42 4-49\\u3001 51-53\\u4e4b\\u95f4\\u4e5f\\n\\u5177\\u6709\\u5355\\u4e00\\u6027\\u3002 \\n \\n\\u8bf7\\u5ba1\\u67e5\\u5458\\u5728\\u6b64\\u57fa\\u7840\\u4e0a\\u7ee7\\u7eed\\u8fdb\\u884c\\u5ba1\\u67e5\\uff0c\\u5e76\\u76fc\\u65e9\\u65e5\\u6388\\u6743\\u3002\\u82e5\\u5ba1\\u67e5\\u5458\\u5728\\u540e\\u7eed\\u5ba1\\u67e5\\u7a0b\\u5e8f\\u4e2d\\u6709\\u4efb\\u4f55\\n\\u610f\\u89c1\\uff0c\\u6073\\u8bf7\\u518d\\u7ed9\\u4e88\\u4e00\\u6b21\\u9648\\u8ff0\\u610f\\u89c1/ \\u4fee\\u6539/\\u4f1a\\u6664\\u7684\\u673a\\u4f1a\\u3002\\u6700\\u540e\\uff0c\\u7533\\u8bf7\\u4eba\\u5bf9\\u5ba1\\u67e5\\u5458\\u4e3a\\u5ba1\\u67e5\\u672c\\u7533\\u8bf7\\u6240\\u4ed8\\n\\u51fa\\u7684\\u8f9b\\u52e4\\u52b3\\u52a8\\u8868\\u793a\\u7531\\u8877\\u7684\\u611f\\u8c22\\u3002 \\n\\u5317\\u4eac\\u67cf\\u6749\\u677e\\u77e5\\u8bc6\\u4ea7\\u6743\\u4ee3\\u7406\\u4e8b\\u52a1\\u6240\\uff08\\u666e\\u901a\\u5408\\u4f19\\uff09 \\n                                               \\u8054\\u7cfb\\u7535\\u8bdd\\uff1a010- 84109559- \\uff088952 \\uff09     \\n 1PP218006PF-OA1\\n \\n \\n1\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u6269\\u589e\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684\\u8131\\u6c27\\u6838\\u7cd6\\u6838\\u9178 (DNA)\\u5206\\u5b50\\u7684\\u65b9\\u6cd5\\uff0c\\n\\u6240\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\uff1a  \\n(a)\\u4f7f\\u8854\\u63a5\\u5b50\\u4e0e DNA\\u5206\\u5b50\\u8fde\\u63a5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\uff0c\\n\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff1b   \\n(b)\\u7528\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u8fde\\u63a5\\u7684 DNA\\u5206\\u5b50\\uff1b  \\n(c)\\u4f7f\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u5206\\u5b50\\u4e0e\\u5f15\\u7269\\u6742\\u4ea4\\uff1b   \\n(d)\\u5ef6\\u4f38\\u7ecf\\u6742\\u4ea4\\u7684\\u5f15\\u7269\\u4ee5\\u4ea7\\u751f\\u53cc\\u94fe DNA\\uff1b\\u548c  \\n(e)\\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94fe DNA\\u4ee5\\u4ea7\\u751f RNA\\u3002   \\n2\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u9274\\u5b9a DNA\\u5206\\u5b50\\u4e2d\\u7684 5-\\u7f9f\\u7532\\u57fa\\u80de\\u5627\\u5576 (5hmC)\\u7684\\u975e\\u8bca\\u65ad\\u65b9\\u6cd5\\uff0c\\u6240\\n\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\uff1a  \\n(1)\\u4fee\\u9970 DNA\\u5206\\u5b50\\u4e2d\\u7684 5hmC\\u4ee5\\u4fdd\\u62a4\\u5b83\\u514d\\u4e8e\\u6c27\\u5316\\uff1b  \\n(2)\\u7528\\u7532\\u57fa\\u80de\\u5627\\u5576\\u53cc\\u52a0\\u6c27\\u9176\\u6c27\\u5316\\u6765\\u81ea (1)\\u7684\\u7ecf\\u4fee\\u9970\\u7684 DNA\\u5206\\u5b50\\uff0c\\u4ee5\\u5c06 5-\\u7532\\u57fa\\n\\u80de\\u5627\\u5576 (5mC)\\u8f6c\\u5316\\u4e3a 5-\\u7fa7\\u57fa\\u80de\\u5627\\u5576 (5caC)\\uff1b \\n(3)\\u8fdb\\u884c\\u5305\\u62ec\\u4ee5\\u4e0b\\u6b65\\u9aa4\\u7684\\u65b9\\u6cd5\\uff1a  \\n(a)\\u4f7f\\u8854\\u63a5\\u5b50\\u4e0e DNA\\u5206\\u5b50\\u8fde\\u63a5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\n\\u5b50\\uff0c\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff1b  \\n(b)\\u7528\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u8fde\\u63a5\\u7684 DNA\\u5206\\u5b50\\uff1b  \\n(c)\\u4f7f\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u5206\\u5b50\\u4e0e\\u5f15\\u7269\\u6742\\u4ea4\\uff1b   \\n(d)\\u5ef6\\u4f38\\u7ecf\\u6742\\u4ea4\\u7684\\u5f15\\u7269\\u4ee5\\u4ea7\\u751f\\u53cc\\u94fe DNA\\uff1b\\u548c  \\n(e)\\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94fe DNA\\u4ee5\\u4ea7\\u751f RNA\\u3002   \\n3\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u9274\\u5b9a DNA\\u5206\\u5b50\\u4e2d\\u7684 5mC\\u7684\\u975e\\u8bca\\u65ad\\u65b9\\u6cd5\\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\uff1a  \\n(1)\\u7528\\u6c27\\u5316\\u5242\\u6c27\\u5316 DNA\\u5206\\u5b50\\u4ee5\\u5c06 5hmC\\u6c27\\u5316\\u6210 5-\\u7532\\u9170\\u57fa\\u80de\\u5627\\u5576 (5fC)\\u62165caC\\uff1b \\n(2)\\u8fdb\\u884c\\u5305\\u62ec\\u4ee5\\u4e0b\\u6b65\\u9aa4\\u7684\\u65b9\\u6cd5\\uff1a  \\u6743  \\u5229 \\u8981 \\u6c42 \\u4e66-OA1\\n \\n 2PP218006PF-OA1\\n(a)\\u4f7f\\u8854\\u63a5\\u5b50\\u4e0e DNA\\u5206\\u5b50\\u8fde\\u63a5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\n\\u5b50\\uff0c\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff1b  \\n(b)\\u7528\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u8fde\\u63a5\\u7684 DNA\\u5206\\u5b50\\uff1b  \\n(c)\\u4f7f\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u5206\\u5b50\\u4e0e\\u5f15\\u7269\\u6742\\u4ea4\\uff1b   \\n(d)\\u5ef6\\u4f38\\u7ecf\\u6742\\u4ea4\\u7684\\u5f15\\u7269\\u4ee5\\u4ea7\\u751f\\u53cc\\u94fe DNA\\uff1b\\u548c  \\n(e)\\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94fe DNA\\u4ee5\\u4ea7\\u751f RNA\\u3002 \\n4\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f33\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240 \\u8ff0\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\n\\u80de\\u5627\\u5576\\u5305\\u62ec 5mC\\u62165hmC\\u3002 \\n5\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f33\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240 \\u8ff0\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\n\\u80de\\u5627\\u5576\\u5305\\u62ec\\u809f\\u6216\\u8159\\u4fee\\u9970\\u7684 5fC\\u3002 \\n6\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 5\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u7528\\u5305\\u542b\\u7f9f\\u80fa\\u57fa\\u3001\\u80bc\\u57fa\\u6216\\u9170\\u80bc\\u57fa\\u7684\\u5316\\u5408\\n\\u7269\\u4fee\\u9970 5fC\\u3002  \\n7\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 6\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u5316\\u5408\\u7269\\u662f\\u7f9f\\u80fa\\uff1b\\u76d0\\u9178\\u7f9f\\u80fa\\uff1b\\u786b\\u9178\\n\\u7f9f\\u94f5\\uff1b\\u78f7\\u9178\\u7f9f\\u80fa\\uff1b O-\\u7532\\u57fa\\u7f9f\\u80fa\\uff1b O-\\u5df1\\u57fa\\u7f9f\\u80fa\\uff1b O-\\u620a\\u57fa\\u7f9f\\u80fa\\uff1b O-\\u82c4\\u57fa\\u7f9f\\u80fa\\uff1b O-\\n\\u4e59\\u57fa\\u7f9f\\u80fa (EtONH 2)\\u3001O-\\u70f7\\u57fa\\u5316\\u6216 O-\\u82b3\\u57fa\\u5316\\u7f9f\\u80fa\\u3001\\u5176\\u9178\\u6216\\u76d0\\u3002   \\n8\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f33\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240 \\u8ff0\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\n\\u80de\\u5627\\u5576\\u5305\\u62ec\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684 5caC\\u3002 \\n9\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 8\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d 5caC\\u662f\\u7ecf\\u9170\\u80fa\\u4fee\\u9970\\u7684 5caC\\u3002 \\n10\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 9\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u901a\\u8fc7\\u4e0e\\u5305\\u542b\\u80fa\\u57fa\\u7684\\u5316\\u5408\\u7269\\u8fde\\u63a5\\u800c\\u5bf9\\n5caC\\u8fdb\\u884c\\u9170\\u80fa\\u4fee\\u9970\\u3002    \\n11\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 10\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u901a\\u8fc7\\u5c06 DNA\\u5206\\u5b50\\u4e0e\\u78b3\\u4e8c\\u4e9a\\u80fa\\u884d\\u751f\\u7269\\n\\u4e00\\u8d77\\u5b75\\u80b2\\u800c\\u4f7f 5caC\\u4e0e\\u80fa\\u57fa\\u8fde\\u63a5\\u3002  \\n12\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 10\\u621611\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u5305\\u542b\\u80fa\\u57fa\\u7684\\u5316\\u5408\\u7269\\u662f\\u82c4\\u80fa\\u3001\\u7ecf\\n\\u53d6\\u4ee3\\u7684\\u82c4\\u80fa\\u3001\\u70f7\\u57fa\\u80fa\\u3001\\u70f7\\u57fa\\u4e8c\\u80fa\\u3001\\u4e8c\\u7532\\u82ef\\u80fa\\u3001 \\u7ecf\\u53d6\\u4ee3\\u7684\\u4e8c\\u7532\\u82ef\\u80fa\\u3001\\u73af\\u70f7\\u57fa\\u80fa\\u3001\\n\\u73af\\u70f7\\u57fa\\u4e8c\\u80fa\\u3001\\u7f9f\\u80fa\\u6216\\u7ecf\\u53d6\\u4ee3\\u7684\\u7f9f\\u80fa\\u3002  \\n13\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f312\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8 \\n 3PP218006PF-OA1\\n\\u5b50\\u5305\\u62ec SP6\\u3001T7\\u6216T3\\u542f\\u52a8\\u5b50\\u3002  \\n14\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f313\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (a)\\u5305\\u62ec DNA\\u7684\\u672b\\u7aef\\u4fee\\n\\u9970\\u548c /\\u6216DNA\\u7684\\u672b\\u7aef\\u4fee\\u590d\\u3002  \\n15\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 14\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u672b\\u7aef\\u4fee\\u9970\\u5305\\u542b\\u672b\\u7aef\\u52a0 A\\u3002 \\n16\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f315\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (a)\\u5305\\u62ec\\u5728\\u8db3\\u4ee5\\u4f7f\\u8854\\u63a5\\n\\u5b50\\u4e0e DNA\\u5206\\u5b50\\u8fde\\u63a5\\u7684\\u6761\\u4ef6\\u4e0b\\uff0c\\u4f7f DNA\\u4e0e\\u8fde\\u63a5\\u9176\\u63a5\\u89e6\\u3002  \\n17\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f316\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u8fd8\\u5305\\u62ec 3\\u2019\\n\\u672b\\u7aef\\u5c01\\u95ed\\u5206\\u5b50\\u3002  \\n18\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f317\\u4e2d\\u4efb\\u4e00\\u9879\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u662f\\u90e8\\u5206\\u53cc\\u94fe\\u7684\\u3002  \\n19\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f318\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (d)\\u5305\\u62ec\\u4f7f DNA\\u5206\\u5b50\\u4e0e\\nDNA\\u805a\\u5408\\u9176\\u63a5\\u89e6\\u3002  \\n20\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f319\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (d)\\u5305\\u62ec\\u5728\\u5141\\u8bb8\\u53cc\\u94fe\\nDNA\\u53d8\\u6027\\u4e3a\\u5355\\u94fe DNA\\u7684\\u53d8\\u6027\\u6761\\u4ef6\\u4e0b\\u5b75\\u80b2 DNA\\u3002 \\n21\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 20\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (d)\\u5305\\u62ec\\u5728\\u8db3\\u4ee5\\u4f7f\\u5f15\\u7269\\u9000\\u706b\\u81f3\\u5355\\u94fe\\nDNA\\u7684\\u6761\\u4ef6\\u4e0b\\u5b75\\u80b2 DNA\\u3002 \\n22\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 21\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (d)\\u5305\\u62ec\\u5728\\u8db3\\u4ee5\\u4f7f\\u5f15\\u7269\\u5ef6\\u4f38\\u4ee5\\u4ea7\\u751f\\u53cc\\n\\u94feDNA\\u7684\\u6761\\u4ef6\\u4e0b\\u5b75\\u80b2 DNA\\u3002 \\n23\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f322\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (e)\\u5305\\u62ec\\u4f7f DNA\\u5206\\u5b50\\u4e0e\\nRNA\\u805a\\u5408\\u9176\\u548c\\u6838\\u82f7\\u4e09\\u78f7\\u9178\\u63a5\\u89e6\\u3002   \\n24\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f323\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u8fd8\\u5305\\u62ec\\u4e00\\u4e2a\\n\\u6216\\u591a\\u4e8e\\u4e00\\u4e2a\\u7eaf\\u5316\\u6b65\\u9aa4\\u3002  \\n25\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 24\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u7eaf\\u5316\\u6b65\\u9aa4\\u5305\\u62ec\\u56fa\\u76f8\\u53ef\\u9006\\u56fa\\u5b9a\\u5316\\n(SPRI)\\u73e0\\u3002  \\n26\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f325\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u8fd8\\u5305\\u62ec (e)\\u7684\\nRNA\\u5206\\u5b50\\u7684\\u7eaf\\u5316\\u3002  \\n27\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f326\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u8fd8\\u5305\\u62ec\\u5bf9 (e) \\n 4PP218006PF-OA1\\n\\u7684RNA\\u5206\\u5b50\\u8fdb\\u884c\\u9006\\u8f6c\\u5f55\\u4ee5\\u4ea7\\u751f\\u76f8\\u5e94\\u7684 DNA\\u5206\\u5b50\\u3002  \\n28\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f3\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d (a)\\u81f3(e)\\u6309\\u987a\\u5e8f\\u6267\\u884c\\u3002  \\n29\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 27\\u621628\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u8fd8\\u5305\\u62ec\\u76f8\\u5e94 DNA\\u5206\\u5b50\\n\\u7684\\u6587\\u5e93\\u6784\\u5efa\\u3002    \\n30\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 27\\u81f329\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u8fd8\\u5305\\u62ec\\u5bf9\\u76f8\\n\\u5e94DNA\\u5206\\u5b50\\u8fdb\\u884c\\u6d4b\\u5e8f\\u3002  \\n31\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f330\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u662f\\u7247\\u6bb5\\n\\u5316\\u7684\\u3002  \\n32\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 31\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u7247\\u6bb5\\u7684\\u957f\\u5ea6\\u4e3a 100bp\\u81f3300bp\\u3002 \\n33\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 31\\u621632\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d DNA\\u5206\\u5b50\\u662f\\u751f\\u7269\\u7247\\u6bb5\\u3002  \\n34\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f333\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u65b9\\u6cd5\\u4e0d\\u5305\\u62ec\\u5bcc\\u96c6\\n\\u6b65\\u9aa4\\u3002  \\n35\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f334\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u5305\\u62ec\\u6e38\\n\\u79bbDNA (cfDNA) \\u3002 \\n36\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f335\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u5305\\u62ec\\u57fa\\n\\u56e0\\u7ec4 DNA\\u3002 \\n37\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f336\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u7684\\u91cf\\u4e3a\\n1pg\\u81f3100ng\\u3002 \\n38\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f337\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u4ece\\u5bf9\\u8c61\\n\\u7684\\u6837\\u672c\\u4e2d\\u5206\\u79bb\\u3002  \\n39\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 1\\u81f338\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u4ece\\u6d3b\\u68c0\\n\\u6837\\u672c\\u4e2d\\u5206\\u79bb\\u3002  \\n40\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 39\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6837\\u672c\\u662f\\u6db2\\u4f53\\u6837\\u672c\\u3002  \\n41\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 2\\u62164\\u81f340\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u7532\\u57fa\\u80de\\u5627\\u5576\\u53cc\\n\\u52a0\\u6c27\\u9176\\u662f TET1\\u3001TET2\\u6216TET3\\u3001\\u6216\\u5176\\u540c\\u7cfb\\u7269\\u3002  \\n42\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 2\\u62164\\u81f340\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u7528\\u8461\\u8404\\u7cd6\\u6216\\u7ecf\\u4fee\\u9970 \\n 5PP218006PF-OA1\\n\\u7684\\u8461\\u8404\\u7cd6\\u6765\\u4fee\\u9970 5hmC\\u3002 \\n43\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 42\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u901a\\u8fc7\\u5305\\u62ec\\u5c06\\u6838\\u9178\\u5206\\u5b50\\u4e0e \\u03b2-\\u8461\\u7cd6\\u57fa\\u8f6c\\n\\u79fb\\u9176\\u548c\\u8461\\u8404\\u7cd6\\u6216\\u7ecf\\u4fee\\u9970\\u7684\\u8461\\u8404\\u7cd6\\u5206\\u5b50\\u4e00\\u8d77\\u5b75\\u80b2\\u7684\\u65b9\\u6cd5\\u6765\\u4fee\\u9970 5hmC\\u3002 \\n44\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 43\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u8461\\u8404\\u7cd6\\u5206\\u5b50\\u662f\\u5c3f\\u82f7\\u4e8c\\u78f7\\u9178\\u8461\\u8404\\u7cd6\\u5206\\n\\u5b50\\u3002  \\n45\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 44\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u7ecf\\u4fee\\u9970\\u7684\\u8461\\u8404\\u7cd6\\u5206\\u5b50\\u662f\\u7ecf\\u4fee\\u9970\\u7684\\u5c3f\\n\\u82f7\\u4e8c\\u78f7\\u9178\\u8461\\u8404\\u7cd6\\u5206\\u5b50\\u3002  \\n46\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 3\\u81f340\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6c27\\u5316\\u4f5c\\u7528\\u9009\\u62e9\\u6027\\u5730\\u6c27\\n\\u53165hmC\\u6b8b\\u57fa\\u3002   \\n47\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 3\\u81f340\\u621646\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u6c27\\u5316\\u5242\\u662f\\u5316\\n\\u5b66\\u6c27\\u5316\\u5242\\u3002    \\n48\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 3\\u81f340\\u621646\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u6c27\\u5316\\u5242\\u662f\\u8fc7\\n\\u948c\\u9178\\u76d0\\u6c27\\u5316\\u5242\\u3002   \\n49\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 3\\u81f340\\u621646\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u6c27\\u5316\\u5242\\u5305\\u62ec\\nKRuO 4\\u3002 \\n50\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u9274\\u5b9a DNA\\u5206\\u5b50\\u4e2d\\u7684 5mC\\u7684\\u975e\\u8bca\\u65ad\\u65b9\\u6cd5\\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\uff1a  \\n(a)\\u4f7f\\u8854\\u63a5\\u5b50\\u4e0e DNA\\u5206\\u5b50\\u8fde\\u63a5\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0\\u8854\\u63a5\\u5b50\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\uff0c\\n\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de\\u5627\\u5576\\uff1b  \\n(b)\\u7528\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u8fde\\u63a5\\u7684 DNA\\u5206\\u5b50\\uff1b  \\n(c)\\u4f7f\\u7ecf\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u5904\\u7406\\u7684 DNA\\u5206\\u5b50\\u4e0e\\u5f15\\u7269\\u6742\\u4ea4\\uff1b   \\n(d)\\u5ef6\\u4f38\\u7ecf\\u6742\\u4ea4\\u7684\\u5f15\\u7269\\u4ee5\\u4ea7\\u751f\\u53cc\\u94fe DNA\\uff1b\\u548c  \\n(e)\\u4f53\\u5916\\u8f6c\\u5f55\\u53cc\\u94fe DNA\\u4ee5\\u4ea7\\u751f RNA\\uff1b \\n(f)\\u9006\\u8f6c\\u5f55 RNA\\u4ee5\\u4ea7\\u751f DNA\\uff1b \\n(g)\\u5bf9DNA\\u8fdb\\u884c\\u6d4b\\u5e8f\\u5e76\\u5c06\\u7ecf\\u6d4b\\u5e8f\\u7684 DNA\\u4e2d\\u7684 5mC\\u9274\\u5b9a\\u4e3a\\u5e8f\\u5217\\u4e2d\\u7684 \\u201cC\\u201d\\u3002 \\n51\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u9274\\u5b9a\\u5305\\u542b DNA\\u5206\\u5b50\\u7684\\u6837\\u672c\\u4e2d\\u7684\\u7532\\u57fa\\u80de\\u5627\\u5576\\u7684\\u65b9\\u6cd5\\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\n\\u5305\\u62ec\\u6267\\u884c\\u6743\\u5229\\u8981\\u6c42 1\\u81f350\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\u3002   \\n 6PP218006PF-OA1\\n52\\u3001\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u7684\\u8854\\u63a5\\u5b50\\u5728\\u5236\\u5907\\u7528\\u4e8e\\u9274\\u5b9a\\u6765\\u81ea\\u60a3\\u8005\\u7684 DNA\\u5206\\u5b50\\n\\u4e2d\\u7684 5mC\\u548c/\\u6216\\u7528\\u4e8e\\u8f85\\u52a9\\u60a3\\u8005\\u8bca\\u65ad\\u6216\\u9884\\u540e\\u7684\\u8bd5\\u5242\\u76d2\\u4e2d\\u7684\\u7528\\u9014\\uff0c\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\n\\u542f\\u52a8\\u5b50\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u80de \\u5627\\u5576\\uff0c\\u5176\\u4e2d\\u6267\\u884c\\u6743\\u5229\\u8981\\u6c42 1\\u81f350\\u4e2d\\u4efb\\u4e00\\u9879\\u4e2d\\u9650\\n\\u5b9a\\u7684\\u6b65\\u9aa4\\uff0c\\u5176\\u4e2d\\u4ece\\u60a3\\u8005\\u7684\\u751f\\u7269\\u6837\\u672c\\u63d0\\u4f9b\\u6240\\u8ff0 DNA\\u5206\\u5b50\\u3002  \\n53\\u3001\\u4e00\\u79cd\\u7528\\u4e8e\\u8bc4\\u4f30\\u5355\\u7ec6\\u80de\\u7684\\u975e\\u8bca\\u65ad\\u65b9\\u6cd5 \\uff0c\\u6240\\u8ff0\\u65b9\\u6cd5\\u5305\\u62ec\\u6267\\u884c\\u6743\\u5229\\u8981\\u6c42 1\\u81f3\\n33\\u621637\\u81f350\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u65b9\\u6cd5\\uff0c\\u5176\\u4e2d\\u4ece\\u5355\\u7ec6\\u80de\\u7684\\u57fa\\u56e0\\u7ec4 DNA\\u63d0\\u4f9b DNA\\u5206\\u5b50\\u3002  \\n54\\u3001\\u4e00\\u79cd\\u5305\\u542b DNA\\u8854\\u63a5\\u5b50\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0 DNA\\u8854\\u63a5\\u5b50\\u5305\\u62ec RNA\\u805a\\u5408\\u9176\\u542f\\n\\u52a8\\u5b50\\uff0c\\u5176\\u4e2d\\u6240\\u8ff0 RNA\\u805a\\u5408\\u9176\\u542f\\u52a8\\u5b50\\u7684\\u80de\\u5627\\u5576\\u662f\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u4fdd\\u62a4\\u7684\\u3002  \\n55\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u62ec\\u8fde\\u63a5\\u9176\\u548c /\\u6216\\u8fde\\u63a5\\u9176\\n\\u7f13\\u51b2\\u6db2\\u3002  \\n56\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u621655\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u4e9a\\u786b\\u9178\\u6c22\\u76d0\\u3002  \\n57\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f357\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u62ec\\u4e0e\\u6240\\n\\u8ff0\\u8854\\u63a5\\u5b50\\u4e92\\u8865\\u7684\\u5f15\\u7269\\u3002  \\n58\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f357\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u62ec\\ndNTP\\u3002 \\n59\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f358\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b DNA\\n\\u805a\\u5408\\u9176\\u3002  \\n60\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f358\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u62ec\\u65e0\\u6838\\n\\u9178\\u9176\\u6c34\\u3002  \\n61\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f360\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u86cb\\u767d\\n\\u9176\\u3002  \\n62\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f361\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b RNA\\n\\u805a\\u5408\\u9176\\u3002  \\n63\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f362\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c \\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b NTP\\u3002 \\n64\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f363\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u6c27\\u5316\\n\\u5242\\u3002  \\n65\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f364\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u53cc\\u52a0 \\n 7PP218006PF-OA1\\n\\u6c27\\u9176\\u3002  \\n66\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 64\\u81f365\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u542b\\u6709\\n\\u7f9f\\u80fa\\u57fa\\u3001\\u80bc\\u57fa\\u6216\\u9170\\u80bc\\u57fa\\u7684\\u5316\\u5408\\u7269\\u3002  \\n67\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f366\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u542b\\u6709\\n\\u80fa\\u57fa\\u7684\\u5316\\u5408\\u7269\\u3002  \\n68\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f367\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b 3\\u2019\\u672b\\n\\u7aef\\u5c01\\u95ed\\u5206\\u5b50\\u3002  \\n69\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f368\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b SPRI\\n\\u73e0\\u3002  \\n70\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f369\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u9006\\u8f6c\\n\\u5f55\\u9176\\u3002  \\n71\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f370\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b\\u8461\\u8404\\n\\u7cd6\\u6216\\u7ecf\\u4fee\\u9970\\u7684\\u8461\\u8404\\u7cd6\\u3002  \\n72\\u3001\\u6839\\u636e\\u6743\\u5229\\u8981\\u6c42 54\\u81f371\\u4e2d\\u4efb\\u4e00\\u9879\\u6240\\u8ff0\\u7684\\u8bd5\\u5242\\u76d2\\uff0c\\u6240\\u8ff0\\u8bd5\\u5242\\u76d2\\u8fd8\\u5305\\u542b \\u03b2-\\u8461\\n\\u7cd6\\u57fa\\u8f6c\\u79fb\\u9176\\u3002  \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"ocr_text\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"--- Page 1 OCR ---\\nUnrren States Patent anp TRADEMARK OFFICE\\n\\n  \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nNoon Rose Plvgh US LLP a\\n\\nSan Jain Blvd Tan RECT OR\\n\\nSuite 1100\\n\\n\\u2018Nasi, TX 7701 rane Eo\\n\\nPlease find below and/or attached an Office communication concerning this application or proceeding.\\n\\n\\u2018The time period for reply, if any, is set inthe attached commi\\n\\n \\n\\ntation,\\nNotice of the Office communication was sent electronically on above-indicated \\\"Notification Date\\\" to the\\n\\nfollowing e-mail address(es):\\noipdocke@ nortoarsefulbightcom\\n\\f\\n--- Page 2 OCR ---\\n \\n\\n\\u2018Rpplcaion Wo. ephcanisy\\n\\n \\n\\n#77997,810 ESSER-KANI et\\nOffice Action Summary Traminer Ce\\nNICOLE BABSON ve (Yes\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nee a\\nwoven\\n\\neres arzronyrenco fon ens $e Ye SCH FROMTHE AA\\non eaeseansec \\\"\\n\\nEES seSh erate eteenermtereterrar\\n\\nStatus\\n1)R_Responsive to communications) fled on 7/8/24,\\n(DA declaration(s)atidavi(s) under 37 CFR 1.190(b) wasiwore flog on __\\n\\n2a)0) This action is FINAL. This action is ron-fnal\\n\\n3)0) An election was made by the applicant in response to a restriction requirement set forth during the interview\\n\\u2018on _ the restriction requirement and election have been incorporated into this action\\n\\n410 \\u2018Since this application isin condtion for alowance except for formal matters, prosecution as to the merits is\\n<losed in accordance with tho practice undor Ex parte Quayle, 1935 C.D. 11, 453 0.G. 213.\\n\\n      \\n\\n \\n\\n \\n\\nDisposition of Claims*\\n5) & Claim(s) 1.3-46-10,12,14,17,21-22.26 48 and 5051 is/are pending inthe application.\\n5a) Of the above clakn(s)4,6,8.12,17,26 and 51 is/are withdrawn trom consideration,\\n6) \\u00a9 Claims) _islare alowed\\n7) & Claim(s) 13,7,9-10,14.21-22,48 and 50 is/are relected\\n8) CO) Claims) __isvare objected to.\\n9) O Claims) ___ are subject to restriction andior election requirement\\n*ttany claims have been detemnined alloable. you may be eigble to benef rom the Patent Prosecution Highway program at\\nparicpatngntotecual propery ofSo forthe corresponing applcation. For more information, lease\\nbuaashiacovnstenisint eventsootlndesisa or send an Inquey to BPAtsedbackuspto.oo4.\\nApplication Papers\\n10)C) The specification is objacted to by the Examiner.\\n11)@ The drawing(s) fled on 6/4/21 ise: a)[) accepted or byZ; objected to by the Examiner.\\n\\u2018optical may no request ths any objection to the drawings) be hed insbayance. S20 37 CFR 1.85(ah\\nFeplacemor raving sheets incluting the comectonis required i he awings) is cbjeted to. See 37 CFR 1.12114),\\nPriority under 35 US.C. \\u00a7 119\\n12)C) Acknowledgment is made ofa claim for foreign priorty under 35 U.S.C. \\u00a7 119(a)() oF).\\nCertitied copies:\\na0 Al bj) Some\\\" @)C) None ofthe:\\n1.0. Certified copies ofthe priority documents have been received.\\n2.0) Certed copies ofthe prionty documents have been received in Application No.\\n3.0. Copies ofthe certiod copies o he priority documents have been received inthis National Stage\\napplication from the Intemational Bureau (PCT le 17.2().\\nc0 the atached detaied Olen action ra st ofthe cated copies not recetved.\\n\\n \\n\\n \\n\\n \\n\\nAacrmenn)\\n1) Notee t Rerenoes tes PTO 82) 8) ern Surman T0418)\\n\\nns Pree Ne) Dae\\n2 oan Dare Steere (PIOSADRA anderPFOSBEED) \\u2014 yy\\n\\n \\n\\n \\n\\n \\n\\n \\n\\f\\n--- Page 3 OCR ---\\nApplication/Control Number: 17/837,610 Page 2\\n\\u2018Ant Unit: 1619\\n\\nNotice of Pre-AIA or AIA Status\\n\\u2018The present application, filed on or after March 16,2013, is being examined under the\\nFirst inventor to file provisions of the AIA.\\n\\nDETAILED ACTION\\n\\n \\n\\n(Claims 1, 3,4, 6-10, 12, 14, 17,21,22, 26,48, 50 and are pending.\\n\\nElection/Restrictions\\nApplicant's election without traverse of the Invention of Group I, claims 1, 3.4, 6-10, 12,\\n\\n14,17,21\\n\\n \\n\\n26, 48,50 and $1, andthe species of\\n\\n{50 asthe NFKB inhibitor,\\n\\n \\n\\nCpe asthe species of adjuvant,\\nantigenic fragments of HIV asthe addtional agent, and\\n~ administration ofthe inhibitor and adjuvant inthe same composition;\\nin the reply Filed on 7/8/24 is acknowledged\\nClaims, 6,8, 12.17.26, and $1 are withdrawn as not being dirctedto the elected species\\n(Cains 1,3,7,9, 10, 14,21, 22,48 and $0 are under consideration tothe extent thatthe\\nmethod comprises SNSO asthe NEKB inhibitor, Cpgas the species of adjuvant antigenic\\nfragments of HIV asthe addtional agent, and administration of the inhibitor and adjuvant in the\\n\\nsame composition.\\n\\nInformation Disclosure Statement\\n\\u2018Acknowledgement is made of Applicant's information disclosure statements (IDS)\\n\\nsubmited on 9/17/21, 10/21/12and 1 1/6/23 . The submissions are in compliance with the\\n\\f\\n--- Page 4 OCR ---\\nApplication/Control Number: 17/837,610 Page 3\\n\\u2018Ant Unit: 1619\\n\\nprovisions of 37 CFR 1.97. Acconiingly, the information disclosure statement has been\\n\\n\\u2018considered by the examiner,\\n\\nDrawings\\n\\n\\u2018The drawings are objected to because in Figure 3M the labels along the x-axis are\\nunreadable.\\n\\n(Corrected drawing sheets in compliance with 37 CFR 1.121 (@) are required in reply to\\nthe Office action to avoid abandonment ofthe application. Any amended replacement drawing\\nsheet should includeall of the figures appearing on the immediate prior version ofthe sheet,\\neven if only one figure is being amended. The figure or figure number of an amended drawing\\n\\nshould not be labeled as \\u201camended.\\u201d\\n\\n \\n\\nFa drawing figures tobe canceled, the appropriate Figure\\ntnust be removed from the replacement sheet, and where necessary, the remaining figures must\\nbbe renumbered and appropriate changes madeto the brief description of the several views ofthe\\n<rawings for consistency. Additional replacement sheets may be necessary to show the\\nrenumberingof the remaining figures. Each drawing shoot submited afterthe Filing date ofan\\napplication mustbe labeled in the top margin as ither\\u201cReplacement Sheet\\u201d o*New Sheet\\u201d\\npursuantvo 37 CFR 1.1214, Ifthe changes are not acceped by the examine, the applicant will\\nbe notified and informed of any requredcomrectiveaeton in the next Office action. The\\n\\nobjection tothe drawings will not be held in abeyance.\\n\\n\\u2018Claim Rejections - 35 USC \\u00a7 112\\n\\n\\u2018The followingis a quotation of 35 U.S.C. 11206):\\n\\f\\n--- Page 5 OCR ---\\nApplication/Control Number: 17/837,610 Page +\\n\\u2018Ant Unit: 1619\\n\\n \\n\\n(B) CONCLUSION. \\u2014The specification shall conclude with oneor more claims particularly\\npointing out and distinctly claiming the subject matter which the inventor or a joint inventor\\nregards asthe invention\\n\\n\\u2018The following isa quotation of 35 U.S.C. 112 pre-AIA), second paragraph:\\n\\n\\u2018The specification shall conclude with one or more claims particularly pointing out and distinctly\\nclaiming the subject matter which the applicant regards as his invention.\\n\\n \\n\\n(Claim 48 rejected under 35 U.S.C. 112(b) oF 38 U.S.C. 112(pre-AIA), second\\nparagraph, as being indefinite For ailing to particularly point out and disinety elim the\\nsubject mater which the inventor ora joint inventor, or For pre-ATA the applicant regards as the\\n(Cuim 48 includes reference to acanceledclaim. Therefore, the metesand bounds of\\nthe claim eannotbe determined because itis unclear wha s comprised inthe composition to be\\n{administeed, is noted that canceled claim 28 included only & NFKB inhibitor and an adjuvant\\n\\nina composition, andif claim 48 was to be amended to recite the limitations from canceled chim\\n\\n28, then claim 48 would bea duplicate of claim 21\\n\\nClaim Rejections - 35 USC \\u00a7 103\\n\\u2018The following is a quotation of 35 U.S.C, 103 which forms the basis forall obviousness\\nrejections set forth inthis Office action:\\n\\nA pact fora claimed iaventon may not he obsined, ctwidstanding th the cial invention a0\\n\\u2018envealy dncloed a tfc in scton 1020 thie i the derenoss hereon the Cm\\nInvenio ane poor tar such ha the lama invention av whole would hve bee evs\\nfore the fective ing eof te climat nvesoe wo a eson ving onary sil new 0\\n\\u2018his ine cimed invention pean Pabiy shall be nega y he mann in wich\\ninsemon wn ak\\n\\n \\n\\f\\n--- Page 6 OCR ---\\nApplication/Control Number: 17/837,610 Page 5\\n\\u2018Ant Unit: 1619\\n\\n\\u2018The factual inquiries sot forthin Graham v, John Deere Co., 383 U.S. 1, 148 USPQ.459\\n(1966), that are applied for establishing a background for determining ob viousness under 35\\nUS.C. 103 are summarized as follows\\n\\n1. Determining the scope and contents of the prior an.\\n\\n \\n\\nAscertaining the differences between the priorant and the elaimsat issue\\n3. Resolving the level of ordinary skill in the pentinent art\\n4. Considering objective evidence present inthe application indicating obviousness oF\\nnonobviousness\\n\\u2018Claims 1,3,7,9, 10, 14, 21,22, 48 and 50 are rejected under 38 U.S.C. 103 as being\\n\\n\\u2018unpatentable over Petrovsky (US 2014/0314739; cited in IDS) in view of Hawiger et al. (US.\\n2004/0235746; cited in IDS).\\n\\nPetrov sky teach a vaccine composition comprising inulin particles for use in the\\n\\n \\n\\nreduction orinhibition of inflammation, andor for eating or preventing inflanmatey disease,\\nina subject (\\u00a9. abstract, Petrosky teaches thatthe composition compriscs an NFKB inhibitor\\nand an adjuvant, which may be CpG (\\u20ac-\\u00a2 paragraphs 0047, 0048, 0075; Claim 8), Perovsky\\nteaches that the components are administered together (6. paragraph 0223)\\n\\nPetrov sky does not teach that the NFKB inhibitor is SNSO. This\\n\\n \\n\\nmade up for by the\\nteachings of Hawiger tal.\\n\\nHawigeret al teach the delivery of biologically active molecules, such as peptides, into\\n\\n \\n\\nthe interior of cell by administering the ces a complex comprising the molecule linked to sn\\nimporation competent signal peptide (abstract). Hawiger tal. each thatthe peptide isthe\\nNE-KB inhibitor SNSO (c.g. paragraphs 0027: Examples)\\n\\nRegarding Claims 1, 3,7,21,and 48, it would have been obvious to one of ordinary skill\\n\\ninthe arta\\n\\n \\n\\nime of filing to select the SNSO of Haviger etal as the NF&B inhibitor of the\\n\\n\\u2018compositions of Petrovsky. I! would have been obvious to one of ordinary skill in the art vo\\n\\f\\n--- Page 7 OCR ---\\nApplication/Control Number: 17/837,610 Page 6\\n\\u2018Ant Unit: 1619\\n\\n\\u2018combine the elements as claimed by known methods with no change in their respective\\n\\nfunctions, and the combination yielding nothing more than predictable results, One of ordinary\\n\\n \\n\\nskill in the art would have predicted success as both Petrovsky and Hawigerare directed to\\nvaccines comprising NFKB inhibitors. Simple substitution of one known element for another to\\n\\u2018obtain predictable results is obvious.\\n\\nRegarding Claims9, 10, 14, and 50, Petrovsky further teach the inclusion of HIV.\\n\\nantigens (eg. paragraph 0210).\\n\\n \\n\\nRegarding Claim 22, Potrovsky teaches that the composition may be administered to an\\n\\n \\n\\n\\u2018adult human subject i a range of | to 100 mg per dose, such as 220 mg per dose, which is\\n\\n \\n\\nwithin the e Teast 12 mg\\\" (e.g. paragraph 0167).\\n\\n \\n\\ned range 0\\n\\nConclusion\\n\\nNo claimis allowed.\\n\\n\\u2018Any inquiry concerning this communication or earlier communications from the\\n\\u2018examiner should be directed to NICOLE PLOURDE BABSON whose telephone number is,\\n($71)272-3085, The examiner ean normally be reached M-Th 8-4:30; F 8-12:30.\\n\\nExaminer interviews are available via telephone, in-person, and video conferencing using,\\na USPTO supplied web-based collaboration tool. To schedule an interview, applicant is\\nencouraged t0 use the USPTO Automated Interview Request (AIR) at\\nupswww.uspto.gov/interviewpractice.\\n\\nattempts to reach the examinerby telephone are unsuccessful, the examiner's\\n\\n \\n\\nsupervisor, David Blanchard can be reached on 571-272-0827, The fax phone number forthe\\n\\n\\u2018organization where this application or proceeding is assigned is $71 -273-8300.\\n\\f\\n--- Page 8 OCR ---\\nApplication/Control Number: 17/837,610 Page 7\\n\\u2018Ant Unit: 1619\\n\\nInformation regarding the status of published or unpublished applications may be\\n\\u2018obtained from Patent Center, Unpublished application information in Patent Center is available\\n\\nwo nt submissions in Patent Center, visit:\\n\\n \\n\\nistered users, To file and manage pa\\n\\n \\n\\nhups:/patentcenterasplo gov. Visit hupss/www.uspo.gov/patentvapply/paten-center for more\\ninformation about Patent Center andhips:/iwww asplo.gov/patens/docx for information about\\nfiingin DOCX format, Fo additional questions, contact the Electtonic Business Center (EBC)\\n81 866-217-9197 (ol-fee). If you would like assistance froma USPTO Customer Service\\n\\nRepresentative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000,\\n\\nINICOLE P BABSON\\u2019\\nPrimary Examiner, Ant Unit 1619)\\n\\f\\n--- Page 9 OCR ---\\nReceipt date: 11/06/2023 17/337,610 ~ Gau: 1619\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nPage Loft\\nForm PTO-1449 massa) \\u2018Aly. Docket N Seria No\\n\\u2018ARCD Pe TUS/O011 70166 171337610\\n{Lis of Patents and Publications for Applicant's [Applicant\\n\\u2018THE UNIVERSITY OF CHICAGO\\nINFORMATION DISCLOSURE STATEMENT\\nGroupe\\n(ese tec acon) Not Yet Auigned\\nTS: Paton Documents orsign Patent Documents Other Art\\nSee Page! See Page 1 See Pagel\\nU.S. Patent Documents\\nExam.] Ref. | Document | Date Name\\nTit. | Des. | Number\\no\\nForeign Patent Documents\\nExam.] Ref. | Document | Date Country Language\\nTait | Des. | Number\\na\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nOther Art (Including Author, Title, Date Pertinent Pages, Etc.)\\n\\nExam. | Ref, Citation\\ninit. | Des,\\n\\n \\n\\n \\n\\nKHALID etal, \\u201cAntnyperalgesic Properties of Honokol in Intammatory Pain Models\\n\\n61 _| by Targeting !NF-\\u00abB and Nrf2 Signaling.\\\" Front Pharmacol, 0(140) 1-18, March\\n2018.\\n\\n\\u2018G2 _| Die Communication issued a Chinese Patent Applcalon No 207980001407.3,\\ndated October 14, 2023. English transtaton) (Attorney Docket No. ARCD.PO677CN)\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nEXAMINER: NICOLE \\u00ae BAB\\n\\n   \\n\\n07/24/2024\\n\\n \\n\\n       \\n\\nINFORMATION DISCLOSURE STATEMENT \\u2014 PTO-1449 (MODIFLED)\\n\\nALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /N.P.\\n\\n \\n\\f\\n--- Page 10 OCR ---\\nReceipt date: 10/21/2022 17/337,610 ~ Gau: 1619\\n\\n \\n\\nPage Loft\\n\\n \\n\\nForm PTO-1449 masse \\u2018ity Docket No Serial Nes\\n17337610\\n\\n \\n\\n \\n\\nst of\\n\\n \\n\\nats und Publications for Applicant's [Applicant\\n\\u2018THE UNIVERSITY OF CHICAGO\\nINFORMATION DISCLOSURE STATEMENT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nling Date: \\u2018Group:\\n(Caeser sheets taney) \\u2018Juve 3, 2021 Not yet assigned\\nTUS. Patent Documents reign Patent Documents Other Art\\nSee Page 1 See Page 1 See Page 1\\n\\n \\n\\n \\n\\n \\n\\nU.S. Patent Documents\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nExam.] Ret. | Document | Date Name\\nInit. | es. | Number\\nA | Poowoess7as | riesioe Hawiger etal\\nForeign Patent Documents\\nExam. | Ret. | Document | Date Country Language\\ninit. | Des. | Number\\nBi | wo 2008083787 | 017/08 WIPO. English\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nOther Art (Including Author, Title, Date Pertinent Pages, Etc.)\\n\\n\\u2018Exam. | Ret \\u2018Ghation\\nInit | Des,\\n\\n \\n\\n \\n\\n\\u2018Exiended Eurepean Search Report issued in corresponding European Application No\\n\\n+19882608.1,datod Soptomber 26, 2022 (Atorney Docket no. ARCD PO677EP),\\n\\nKimani eta. \\u201cimproving the Adjuvant of Small Molecule immune Potentators\\n\\nc2_ | Using Covatondy Lnkod NF-xf Modulators\\\" ACS Mociinal Chomistry Letiors 202%,\\n5219), pos 1465-1448,\\n\\n\\u2018Singh otal, \\u201cCapsaicin (@-methy/-N-vanily-6-nonenamice) isa potent nhbitor of\\n\\n.\\u00a23_| nucear vanscrption factor kappa B activation by dvorse agonts.\\\"J Immuno} 1996;\\ntras12 4020,\\n\\nce\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n  \\n\\nINFORMATION DISCLOSURE STATEMENT \\u2014 PTO-1449 (MODIFIED)\\n\\n(ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /N.P.B/\\n\\f\\n--- Page 11 OCR ---\\nReceipt date: 09/17/2021 17/337,610 ~ Gau: 1619\\n\\n \\n\\nPage Lof3\\nSerial Nes\\nWas7610\\n\\n \\n\\nForm PTO-1449 gman\\n\\n  \\n\\n \\n\\nst of\\n\\n \\n\\nats und Publications for Applicant's [Applicant\\n\\u2018THE UNIVERSITY OF CHICAGO\\nINFORMATION DISCLOSURE STATEMENT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nling Date: \\u201cGroupe\\n(Coe seret ste acer) \\u201cJone 32021 168s\\n\\nTUS. Patent Documents orsign Patent Documents \\u2018Other Art\\nSee Page 1 See Page 1 See Page 13,\\n\\n \\n\\n \\n\\n \\n\\nU.S. Patent Documents\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nExam. | Ret. | Document | Date Name\\ntnt\\u201d | Des. | Number\\n\\nai] sorrsar | oaaans Thomas etal\\n\\nna] Poogor49420 | 06/1109 Raccerstot otal\\n\\nCe Porwsky\\n\\nForeign Patent Documents\\n\\nRet. | Document | Date Country Language\\n\\nDes. | \\u201cNumber\\n\\n81] sPaoosi94ae5 | 0721/05 Japan \\u201capanoso (English Abad\\n\\n22 | wOzoosto7ast | 107208 wiPo Engish\\n\\n2 | wozooas:296 | 1217/09 wiPo Engish\\n\\n \\n\\n \\n\\nOther Art (Including Author, Title, Date Pertinent Pages, Etc.)\\n\\nRet, \\u2018hation\\nDes.\\n\\n \\n\\n \\n\\n \\n\\nBachor etal, \\u201cThe NF-KB Pathway as a Potential Target or Autolmmune Disease\\n\\u201cTherapy.\\u201d Cur. Pharm, Dos. 2004, 10(23), 2827-37.\\n\\n\\u2018Gz_| Bacuote et a. Function and Actvaton of NF-kappa inthe Immune Syiom\\u2122 Annu\\nFee. lmmunol 1986, 12, 141-179.\\n\\nBode ofa, \\\"CpG DNA as a vaccine adjuvant\\\" Expert Rev. Vaccines 2011, 10,498.\\n\\nce\\n\\n \\n\\n \\n\\n \\n\\nisn\\n\\u2018ca Cotman etal \\\"Vaccine Adjuvants Putting inate immunity to Wome Immunity 2070,\\n33, 492.503,\\n\\n \\n\\n \\n\\n \\n\\n    \\n\\n      \\n\\nINFORMATION DISCLOSURE STATEMENT \\u2014 PTO-1449 (MODIFIED)\\n\\n(ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /N.P.B/\\n\\f\\n--- Page 12 OCR ---\\n \\n\\n+ 09/27/2023 17/337,610 ~ au: 1619\\n\\nPage 2063\\nSerial Nes\\n17337610\\n\\n \\n\\nForm PTO-1449 gman\\n\\n \\n\\n \\n\\nst of\\n\\n \\n\\nsents und Publications for Applicant's\\n\\u2018THE UNIVERSITY OF CHICAGO\\nINFORMATION DISCLOSURE STATEMENT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nling Date: \\u201cGroupe\\n(Coe seret ste acer) \\u201cJone 32021 168s\\n\\nTUS. Patent Documents orsign Patent Documents \\u2018Other Art\\nSee Page 1 See Page 1 See Page 13,\\n\\n \\n\\n \\n\\n \\n\\nOther Art (Including Author, Title, Date Pertinent Pages, Etc.)\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nExam. | Ret. ation\\nInit. | Des,\\n\\n\\u2018cs _| Gimmore etal. \\u201cInhibtors of NFB signaling: 785 and courting\\\" Oncogene 2006,\\n23151), 6867-99,\\nInternational Search Roport and Writon Opinion issued in Coresponding PCT\\n\\n66 | Application No. PCT/US2019/064888, datad March 2, 2020 (Atorney Docket No.\\n\\u2018ABCD .P0s77WO},\\n\\n\\u2018G7 _| Kerdler etal, \\u201cTherapeutic targeting of imate mmurity with Tol-ikerecepior agonists\\n\\u2018ang antagonists.\\u201d Nat Med 2007, 13, 552589,\\n\\n\\u2018ca _| Kinman ot al, \\u201cCpG oligonucleotides improve the protecive immune response\\ninducod by the lconsed anthrax vaceine\\u201d Ann. N \\u00a5 Acad Sel-2006, 1082, 137-180.\\n\\n\\u2018ca _| Kilog: AM. \\u201cToke recoptor 9 (TLRS) agonists in the weatment of cancer Oncogene\\n2008, 27. 161-167.\\n\\ncro | bow etal, \\\"New adjuvants for human vaccines\\u201d Gur. Opn. immunol. 2010, 2,411\\n\\n416\\n\\n\\u2018Moser eal, immune protocton for increased safety and improved protection of\\n11 | vaccinos by NF-KB moduator\\u2122bioRv,10 Doc. 2078, 20 pagos, DOA 489732; do\\npsd \\u2018Accessed 17 March 2019,\\n\\nPlank, M. 6's. \\u201cInhblors of AP-1 and NF-kappa B modiaiod vansorplional acivaton\\n12_| merapeute potential in autoimmune diseases and structural dversiy\\u201d Cur. Med\\nChem. 2002, 92) 219-227.\\n\\n\\u2018Sinchoz Poris otal, \\u201cSyrthos's of honokol analogues and evaluation of hol\\n\\nCc13_| modulating acson of VEGF protein secretion and loomerase slated gone\\n\\u2018oxprossions\\\" Chom Bio Drug Des 2017, 89, 877-584\\n\\n\\u2018van Duin etal, \\u201cTriggering TLR signaling in vaccination\\u201d Trends Immunol 2006, 27,\\n\\n4955,\\n\\n\\u2018Wang otal, Distinct Roles of iferont NF-KB Subunits Regulating Infarnmatory\\n15 | and T Coll Sumulatory Gone Expression in Dendrite Cols\\u201d J. mmunol. 2007, 178,\\n6777-6788,\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\ncn\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n      \\n \\n\\n;AMINER! /NICOLE P BABSON/\\n\\n    \\n\\nINFORMATION DISCLOSURE STATEMENT \\u2014 PTO-1449 (MODIFIED)\\n\\n(ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /N.P.B/\\n\\f\\n--- Page 13 OCR ---\\nReceipt date: 09/17/2021 17/337,610 ~ Gau: 1619\\n\\nPage 303\\n\\n \\n\\nForm PTO-1449 gman Serial Nes\\n\\nWas7610\\n\\n \\n\\n \\n\\nst of\\n\\n \\n\\nats und Publications for Applicant's [Applicant\\n\\n\\u2018THE UNIVERSITY OF CHICAGO\\nINFORMATION DISCLOSURE STATEMENT\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nling Date: \\u201cGroupe\\n(Coe seret ste acer) \\u201cJone 32021 168s\\n\\nTUS Patent Dosa orsign Patent Documents \\u2018ther Art\\nSee Page 1 See Page 1 See Page 13,\\n\\n \\n\\n \\n\\n \\n\\nOther Art (Including Author, Title, Date Pertinent Pages, Etc.)\\n\\nExam. | Ret ation\\nInit. | Des,\\n\\n \\n\\n \\n\\n\\u2018We etal, \\u201cPolysaccharides trom Diosoorea (Shan Yao) and Other Phytochomicals\\nC616 | Enhance Antitumor Etfocts Inducod by DNA Vaccine Against Melanoma\\u201d Journal of\\nTradtonal and Complementary Medicine 2014, 4, \\u00ab2-48.\\n\\niz | Xela. NFB, an active player in human cancers.\\u201d Cancer immuno. Res, 2014, 2,\\n823.830.\\n\\n \\n\\n \\n\\n \\n\\n \\n\\n           \\n\\n \\n\\nINFORMATION DISCLOSURE STATEMENT \\u2014 PTO-1449 (MODIFIED)\\n\\nALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /\\u00a5.P.B/\\n\\f\\n\",\n          \"--- Page 1 OCR ---\\nv.FUNER EBBINGHAUS FINCK HANO\\n\\n \\n\\n \\n\\n \\n\\nE-Mail: laurie. steliman@nortonrosefullbright.com\\nCC E-Mail: gina shishima@nortonrosofullbright.com'; DR ncount w rows\\n\\u2018aoipdocket@nortonrosefullbright.com; Di ican cannacrien\\nrichard ortiz@nortonrosefullbright.com\\n\\n \\n\\n \\n\\nNorton Rose Fulbright a\\n98 San Jacinto Blvd. CUnontakeb we\\nSuite 1100\\n\\n\\u201cAustin, TX 78701-4255 nussia Moscow\\nUNITED STATES OF AMERICA, LER Pasha\\n\\n\\u2018August 7, 2024 Mowoous Uueanmanran\\n\\nEurasian Patent No, 04662\\n\\n\\u2018Methods and compositions comprising Staphylococcus protein A (SPA) voriants\\n\\n\\u2018The University of Chicago\\n\\nYour ref : ARCD.PO676EA/1001187627 (J84: SPC61BBEAEAT1) - Our ref.: EAAA-141303\\n\\n\\u2018SONFIRATION OF PAYMENT\\n\\n15\\\" annuities Due Date: July 13, 2024\\nDear Mr Ortiz,\\n\\nThe 1%5% annuities have been paid in time. The present protective right has been\\nmaintained in Armenia, Azerbaijan, Belarus, Kyrgyz Republic, Kazakhstan, Russian\\nFederation, Tajikstan, Turkmenistan. The confirmation of payment is enclosed.\\n\\n\\u2018The next 6\\\" annuity fee will become due on May 13, 2025.\\n\\nVery truly yours,\\n-, FONER EBBINGHAUS FINCK HANO\\n\\nEnclosure:\\nConfirmation\\n\\f\\n--- Page 2 OCR ---\\n \\n\\nATTIMRaO\\n\\n@ EBPA3IICKAS MATEHTHAS OPTAHV3AUMS (EANIO)\\nEurasian Patent Organization\\n\\n\\u2014\\u2014 \\u00a2 \\u2014\\u2014\\u2014\\u2014\\nEBPASMVACKOE MATEHTHOE BEAOMCTBO (EANB)\\nEurasian Patent Otlice\\n\\n \\n\\n \\n\\nNe 141046662-21 ry Becennuxomy MB\\nor 46.07.2024\\nQJIEKTPOHHO |\\n\\nYaexomaenne o suecennu B Peectp enpasniicknx marenTon cBexennii\\n\\u00a9 NoutepaKANMM eBpasHiteKoro NaTeHTA B CHIE\\n\\n \\n\\n[Homep narewra 046662 ara nnavexa 12/07/2024\\nHomepsaxu 202193110\\n\\n \\n\\n\\u2018Cpox oepemiore 1370572025\\nante\\nIMarewronaarenen [13E}OHMBEPCHTH 0 4HKATO (US)\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nB Peectp espasniicxnx narenton sitecent cpeaenia 06 yniiare roxowolt now\\nsa 1-5 roam aciicrsna narewra m noanepxanmm ero B cine B cneayioUUX\\nHorosapusaiouuixcs rocyaapersax (omuevenss 6 xiemxax):\\n\\nam Maz Rey RKz Rko Ro rm Bru Op\\n\\nC.Baitaxon \\u2014\\n(Ores peectpa enpaanicxix nareston 3 ===.\\n\\nCenmeon TOCRCICTSEnT\\n\\u2018Saree CNsBafaaise C\\neinen 442 20084042 2028\\n\\n \\n\\n++1(495)411-61-61%415\\n\\f\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 103
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 104,
      "metadata": {
        "id": "vhoMnVXPKUhN",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "d91d3e12-c4d7-4155-f21a-3a9c810aba3c"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "<class 'pandas.core.frame.DataFrame'>\n",
            "RangeIndex: 21339 entries, 0 to 21338\n",
            "Data columns (total 3 columns):\n",
            " #   Column     Non-Null Count  Dtype \n",
            "---  ------     --------------  ----- \n",
            " 0   file_name  21339 non-null  object\n",
            " 1   text       16294 non-null  object\n",
            " 2   ocr_text   6397 non-null   object\n",
            "dtypes: object(3)\n",
            "memory usage: 500.3+ KB\n"
          ]
        }
      ],
      "source": [
        "df.info()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "jc0dhNoQZ95m",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 112
        },
        "outputId": "e3cd8678-9535-4bd2-d263-81d85ac1d2c3"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                                 index text ocr_text  new\n",
              "669  ARCD.P0715JP 2024.01.09 Publication No. JP 202...  NaN      NaN    0\n",
              "816  ARCD.P0731JP 2024.04.23 JP Publication No. JPA...  NaN      NaN    0"
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-d5001700-4e70-4690-bd8a-cac0eaaff654\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>index</th>\n",
              "      <th>text</th>\n",
              "      <th>ocr_text</th>\n",
              "      <th>new</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>669</th>\n",
              "      <td>ARCD.P0715JP 2024.01.09 Publication No. JP 202...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>816</th>\n",
              "      <td>ARCD.P0731JP 2024.04.23 JP Publication No. JPA...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>NaN</td>\n",
              "      <td>0</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-d5001700-4e70-4690-bd8a-cac0eaaff654')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-d5001700-4e70-4690-bd8a-cac0eaaff654 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-d5001700-4e70-4690-bd8a-cac0eaaff654');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-b467e8fd-b62a-47f5-a4c9-ebdbd296619c\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-b467e8fd-b62a-47f5-a4c9-ebdbd296619c')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-b467e8fd-b62a-47f5-a4c9-ebdbd296619c button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "repr_error": "0"
            }
          },
          "metadata": {},
          "execution_count": 24
        }
      ],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "JAjp4uBLASuH"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "JeYRSLHJR3Q2"
      },
      "outputs": [],
      "source": [
        "# 1,"
      ]
    }
  ],
  "metadata": {
    "anaconda-cloud": {},
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}